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The thymus is the primary lymphoid organ responsible for the development and 
maturation of T lymphocytes (aka T-cells) in vertebrates.  The complex architecture 
of the thymic microenvironment orchestrates the formation of a diverse and self-
tolerant T-cell repertoire capable of supporting the development and maintenance of a 
functional immune system.  The main component of this microenvironment, the 
thymic epithelium, is crucially required to direct thymus organogenesis and 
homeostasis, and to mediate T-cell repertoire development and selection.  The thymic 
epithelial progenitor cells (TEPCs) from which the mature thymus develops originate 
from the endoderm of the 3rd pharyngeal pouch by embryonic day 9 in mouse 
development (or early week 6 in human embryos).  Expression of the transcription 
factor FOXN1 is required to drive TEPCs differentiation in each thymic epithelial 
lineage (TEC), while the absence of functional FOXN1 causes athymia.  Moreover, 
forced expression of Foxn1 in mouse embryonic fibroblasts (MEFs) converts these 
MEFs into TECs that can support the development of a normal thymic system.  Despite 
the great therapeutic potential that TEPCs present in regenerative medicine, there is 
currently no detailed model describing regulation of the TEPC state and its 
differentiation into cortical (c) and medullary (m) TECs, or explaining the dominant 
role of FOXN1 in the thymic epithelial system.  Comparative transcriptomics analysis 
in conjunction with pathway enrichment analysis of the developing TEPCs could 
reveal the signalling pathways that regulate the early TEPC state and progression into 
differentiation.  Additionally, integrative bioinformatics analysis of transcriptomics 
and genomics datasets could identify the functional networks that are directly 
regulated by FOXN1 during early TEC progression.  In this thesis I provide, for the 
first time, an in silico model explaining fetal TEPC differentiation into the functionally 
distinct TEC lineages, in the cellular, molecular and signalling contexts of thymus 
early development.  Furthermore, I present evidence which suggests that FOXN1 
could be a pioneer factor, capable of fully establishing the transcriptional programme 
that underpins thymic epithelial cell identity and function.  Finally, in this thesis, I 
introduce the development of an interactive thymic-specific database that provides a 





The thymus is the organ majorly responsible for the normal function of the immune 
system.  Thymocytes (a.k.a. T-cells), specialised defence cells that attack foreign 
invaders in the body (known as antigens), are developed and trained in the thymus.   
Within the thymus, T-cell maturation takes place via another group of cells, the thymic 
epithelial cells or TECs.  TECs are of two kinds, cortical thymic epithelial cells 
(cTECs) which reside in the outer region of the thymus called the cortex, and 
medullary thymic epithelial cells (mTECs) that exist in several regions inside the 
organ, called thymic medullary regions.  During thymus development, these TEC 
populations seem to form from an earlier, more immature cell type, the thymic 
epithelial progenitor cell (TEPC) population.  This transition from TEPCs towards 
cTECs and mTECs cannot occur in the absence of a factor named FOXN1.  A block 
of FOXN1 expression in TEPCs causes athymia, while its forced expression in an 
unrelated cell type is able to support from scratch the development of a functional 
thymus.  This thesis investigates the transition model of the earlier TEPC population 
towards the more mature and specialised cTECs and mTECs, based on representative 
datasets that measure all of the genes present in the above populations.  Furthermore, 
in this thesis, I explore the signalling cues that act in the very early TEPC state, to 
identify ways to improve TEPC culture conditions.  Additionally, by comparing 
FOXN1-dependent genes in TEPCs with candidate direct FOXN1 target genes in 
cTECs, I also try to demystify how FOXN1 applies its leading role in TEC fate.  Lastly, 
I introduce the development of an online interface specific for the thymic system that 
provides an easy way to store, access and share data within experimental groups, and 
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1.0 THE THYMUS (PRÉCIS I) 
Since antiquity, a halo of mystery has surrounded the thymus organ.  Originating from 
the Greek word θύμος, meaning “warty excrescence” (like a thyme bud), the thymus 
was also misinterpreted by the ancient Greeks to mean “house of the human soul” 
(θυμός), possibly due to the location of the thymus just above the heart in the human 
body (Fanu, 1963; Fischbein, 1984; Jacobs et al., 1999).  Galen of Pergamum (130-
200 AC) was the first to note that this organ grew to its full size during childhood 
(Coleman, 1969), however it was not until 1961 that Jacqes Miller finally determined 
thymus true function in host immunity (Miller, 2002).  Miller used thymectomised 
young mice to demonstrate the importance of the thymus in the generation of key 
defence cells for their immune system, the nowadays well-known T lymphocytes (also 
known as thymocytes or T-cells). 
Today, the thymus is known as the central lymphoid organ responsible for the 
development and maturation of T-cells in vertebrates.  Circulating hematopoietic 
lymphoid precursors are attracted by the thymus and migrate inside the organ, where 
they undergo maturation to engender self-tolerant and naïve thymocytes equipped with 
a broad repertoire of antigen specific T-cell receptors (TCRs), before they are released 
back into the bloodstream (Boyd et al., 1993; van Ewijk et al., 1999; Jenkinson, 1992).  
The complex architecture of the thymic microenvironment encompasses the cellular 
crosstalk between the non-hematopoietic stromal cells residing in the thymus and the 
incoming immature hematopoietic progenitors, directing them in a patterned fashion 
through the compartments of the thymus that orchestrate thymocyte stepwise 
differentiation and selection (Benjamini and Hochberg, 1995; Takahama, 2006).  
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These processes subsequently contribute to the development and maintenance of a 
functional immune system. 
Thymocyte differentiation and specificity occurs at its highest efficacy during the very 
early stages of the thymus development.  It decreases after puberty and is almost (if 
not fully) absent during the elderly years (age-related thymus atrophy), highlighting 
the importance of the thymus structure in the early stages of life (discussed in Boehm 
and Swann, 2013).  This progressive shrinking of the thymus that advances with age 
is called thymic involution and is characterised by an acute decline in naïve T-cells.  
This sequentially impacts on the host’s immune system faculty in producing effective 
responses against pathogens (Gruver et al., 2007; Linton and Dorshkind, 2004).  
Consequently, thymic atrophy may have considerable consequences in the outcomes 
of chemotherapy and/or other cytoablative treatments on ageing patients, since these 
are heavily dependent on thymic efficacy for reconstitution of an adequate repertoire 
of T-cell receptors.  Regenerative strategies designed to prevent or invert thymus 
waning continue to be examined for clinical use (Chidgey et al., 2008). 
Thymus regeneration can be achieved through reactivation of the endogenous tissue 
(tissue regeneration) by chemically stimulating residual thymic epithelial progenitor 
cells (TEPCs) or by creating de novo thymic tissue (tissue replacement).  
Administration of cytokines and growth factors (GFs), such as Interleukin 7 (IL7) and 
Interleukin 7 (IL22) or the Fibroblast Growth Factor 7 (FGF7) and the keratinocyte 
growth factor (KGF), as well as enforced Forkhead Box Protein N1 (FOXN1) 
expression have been experimentally shown to promote thymus regeneration 
(Alpdogan, 2006; Bredenkamp et al., 2014a; Dudakov et al., 2012; Mackall et al., 
2001).  Thymic epithelial cells (TECs) can be generated through transdifferentiation 
from unrelated tissues into TECs or alternatively TEC-like cells can be generated 
through directed differentiation of pluripotent stem cells (PSCs) (Bredenkamp et al., 
2014b; Parent et al., 2013; Sun et al., 2013). TECs constitute the main component of 
the thymic stroma (which is essential in thymus development and maintenance) and 
the above findings underline the possibility of tissue replacement.  Significantly, long-
term self-renewing TEPCs and adequately compartmentalised TEC sublineage regions 
need to be contained in such tissue (Bredenkamp et al., 2015). 
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1.1 THE THYMIC MICROENVIRONMENT 
The mature thymic microenvironment comprises a complex network of various cell 
types that together establish and maintain a functional immune system.  More than 
95% of the thymic cellularity is made up by developing thymocytes (T-cells), whose 
maturation is mediated by the thymic stroma.  Within the thymic stroma, specialised 
thymic epithelial cells (TECs), neural crest (NC) – derived mesenchymal cells and 
bone marrow (BM) – derived lymphoid cells form a complex three-dimensional 
network which orchestrates T-cell development and differentiation (Boyd et al., 1993).  
Two main compartments are histologically apparent in the thymus: the cortex and 
medulla.  The thymic medulla is located in the innermost layer of the organ and is 
surrounded by the thymic cortex, forming a thin corticomedullary junction (CMJ) in 
the area of contact.  In turn, the cortex is surrounded by a thin layer of simple 
epithelium, the subcapsule, which separates it from the capsule, a thick outer layer that 
lies around the organ (Boyd et al., 1993). 
 
1.1.1 Thymic epithelial cells and other stromal cells 
Thymic epithelial cells (TECs) can be split in three main categories: cortical TECs 
(cTECs), medullary TECs (mTECs) and subcapsular epithelial cells.  cTECs reside in 
the thymus cortex where they form three-dimensional networks with densely packed 
developing thymocytes.  mTECs reside in the thymic medulla forming similar 3D 
networks with the available thymocytes, with the mTEC/thymocyte ratio  much higher 
compared to the one in the cortical compartment (Boyd et al., 1993).  In addition to 
TECs, bone marrow (BM) – derived cells reside in the thymic stroma: these are 
principally dendritic cells and macrophages.  Dendritic cells spread across the thymus, 
but mostly accumulate in the CMJ, while they express strongly MHC class II 
molecules.  Macrophages can be found in both the cortex and the CMJ compartments 
but express MHC class II molecules in varying levels contrary to the high MHC class 
II expression of dendritic cells (Duijvestijn and Hoefsmit, 1981; Milićević et al., 1987).  
Finally, mesenchymal cells consist a vital part of the thymic stroma (Boyd et al., 1993).  
Extracellular matrix (ECM) components are secreted by the thymic mesenchyme and 
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are potentially involved in the regulation of TECs (Schreiber et al., 1991; Watt et al., 
1991) and T-cells (Cardarelli and Pierschbacher, 1986; Cardarelli et al., 1988) via 
ECM receptors that the latter two populations have been found to express. 
 
1.1.2 T-cell repertoire selection 
The highly organised inner thymic architecture supports thymocyte development 
through its complex network of stromal cells.  Hematopoietic progenitors enter the 
thymic structure (early thymic progenitors; ETPs) through the corticomedullary 
junction (CMJ) and move towards the subcapsule (Wu et al., 1991).  At this early stage, 
ETPs do not express the T-cell receptor (TCR) or either of the cluster of differentiation 
4 (CD4) or cluster of differentiation 8 (CD8) co-receptors and are characterised as 
“double negative” (DN) cells.  Throughout four DN stages (DN1, DN2, DN3 and 
DN4), T-cells gradually acquire expression of the above molecules and become ready 
to undergo positive selection at the cortex.  Only cells expressing TCR, and the CD4 
and CD8 glycoproteins are destined to go through the DP stage, where they can receive 
a survival signal if they come in contact with MHC class I or MHC class II molecules 
(Jameson et al., 1995).  Cells which bind MHC class I molecules maintain expression 
of CD8 and stop expressing CD4, whereas cells that bind MHC class II molecules 
maintain expression of CD4 and stop expressing CD8.  The developing T-cells will be 
located in distinct anatomical positions based on their developmental stage.  Absence 
of MHC–DP cell interaction leads to death by neglect.  T-cells that received enough 
signal move inside the medulla, where negative selection takes place to eliminate cells 







1.2 THYMUS ORGANOGENESIS 
During early organogenesis, the thymic gland originates from the endoderm of the 3rd 
pharyngeal pouch (3rd PP), from the same primordium that gives rise to the parathyroid 
gland (shown in Figure 1.1).  Around embryonic day 10 (E10), cells from the 3rd PP 
start proliferating, leading to the formation of the bilateral primordia.  Mesenchymal 
cells in the area, derived from a transient neural crest (NC) population that has 
migrated into the pharyngeal region at E9.5 and populated the pharyngeal arches, 
surround both primordia and expand similarly to the epithelial component until 
approximately E12.5.  These cells will eventually comprise the capsules that surround 
the thymus (reviewed in Rodewald, 2008).  At E12.5, both organ structures separate 
from the pharynx and migrate to their final anatomical locations; the midline and 
laterally of the thyroid respectively.  Critical to this early separation of the thymus and 
the parathyroid structures is the expression of the glial cells missing-2 (Gcm2) 
transcription factor (TF), whose expression is apparent as early as E9.5 in mouse 
development, setting the barrier between the parathyroid and the thymic cell fate 













Figure 1.1: An overview of early thymus organogenesis.  A) Representation of the pharyngeal 
pouches (pp) structures that are aligned sequentially on the flanking structures of the foregut, with the 
3rd pair of pouches (pp3) to appear by E9.5. Gcm2 expression that marks the parathyroid region is 
already evident from E9.5 (shown in blue).  B) Appearance of the 4th pouch by E10.5.  C) Development 
of the pouches into thymus (red colour) and parathyroid (blue colour) primordia by E11.5; organs are 
identified by expression of Foxn1 and Gcm2 respectively.  D) Detachment of the primordia from the 
pharynx by E12.5.  E) Total separation of the parathyroid buds from the thymus, although they stay 
adjacent to the thyroid (purple); few parathyroid cells remain attached to the thymus.  F) Organs in final 
positions, in relevance to the heart (shown in pink).  Double-headed arrows indicate orientation: Dorsal 

















1.2.1 Origin of thymic epithelial cells 
Despite early controversy over the origin of TECs suggesting both endoderm and 
ectoderm as potential germ layers from which TECs may derive (Cordier and 
Haumont, 1980; Cordier and Heremans, 1975), cell transplantation experiments (in 
both chicken and mouse) verified the unique endodermal origin of TECs (Gordon et 
al., 2004; Le Douarin and Jotereau, 1975).  Transplantation of quail pharyngeal 
endoderm into chick hosts generated a chimeric thymus, where TECs were of donor 
origin, while mesenchymal tissue and T-cells were of host origin (Le Douarin and 
Jotereau, 1975).   Additionally, to study the potency of thymic epithelial cells in 
murine, pharyngeal tissue or reaggregated thymic organ culture (RTOC) was 
transplanted under the kidney capsule (Anderson et al., 1993; Blackburn and Manley, 
2004; Rodewald et al., 2001; Sheridan et al., 2009).  When the E9.0 3rd PP endoderm 
was dissected and grafted, it gave rise to an ectopic thymus characterised by normal 
corticomedullary regions, capable of supporting thymocyte development.  The latter 
experiment established a sole endodermic origin of TECs (Gordon et al., 2004).  
Importantly, this finding suggested that a subset of cells in the 3rd PP endoderm had 
inherited the thymic fate, even though thymic definitive markers (for instance, Foxn1) 
were not yet switched on. 
 
1.2.2 Specification and differentiation of thymic epithelial cells in 
the embryonic thymus 
Although the molecular mechanisms that establish TEPC fate in the 3rd PP endoderm 
are not yet fully defined, previous studies have suggested that early patterning of the 
thymic epithelium can be influenced by Paired Box 3 (PAX3) and Sonic Hedgehog 
(SHH) (Griffith et al., 2009; Moore-Scott and Manley, 2005).  Formation of a thymic 
rudiment in mice lacking the nude product demonstrated that TEC specification is 
independent from expression of the nude gene, nevertheless, subsequent 
differentiation of TECs, including assembly of the complex TEC architecture and T-
cell precursor recruitment and differentiation, are essentially dependent on its 
expression  (Bleul et al., 2006; Corbeaux et al., 2010; Vaidya et al., 2016).  The nude 
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mutant phenotype (Flanagan, 1966) is characterised by a developmental arrest in early 
thymus organogenesis and absence of thymopoiesis (Cordier and Haumont, 1980; 
Pantelouris, 1968; Pantelouris and Hair, 1970).  Further experiments, including 
positional cloning and targeted gene disruption identified FOXN1 as the protein 
encoded by the nude gene product and the nu mutation to be a single nucleotide 
deletion located in the third exon (exon3) of  the Foxn1 locus (Nehls et al., 1994, 1996).   
Moreover, thymus – bone marrow cross-transplantation studies between nude and wild 
type mice confirmed that stromal rather than haematopoietic defects caused the thymic 
phenotype (Wortis et al., 1971).  Further, analysis of nude – wild type chimeras 
identified nude TECs incorporated into the thymic epithelium of normal mice to be 
still expressing immature markers, indicating that FOXN1 promotes TEC 
differentiation in a cell-autonomous way (Blackburn et al., 1996).  Significantly, TECs 
that lack FOXN1 expression maintain a progenitor potency that allows them to form 
again a patterned and functional thymus, as demonstrated by quasi-clonal activation 
of Foxn1 in these cells postnatally (Bleul et al., 2006). 
A number of other genes, namely Homeobox A3 (Hoxa3), Eyes Absent (EYA) 
Transcriptional Coactivator And Phosphatase 1 (Eya1), SIX Homeobox 1 (Six1), 
Paired Box 1 (Pax1), Paired Box 9 (Pax9) and T-Box 1 (Tbx1), which act prior to 
FOXN1 expression, have also been found to cause abnormalities in thymus 
development (for example, hyperplasia, athymia, faulty lobe migration).  However, 
these defective phenotypes may also be due to the absence of these genes from the 
other germ layers or earlier developmental points (Conway et al., 1997; Dietrich and 
Gruss, 1995; Hetzer-Egger et al., 2002; Jerome and Papaioannou, 2001; Laclef et al., 
2003; Peters et al., 1998; Su and Manley, 2000; Su et al., 2001; Wallin et al., 1996; Xu 
et al., 2002; Zou et al., 2006).  This group of genes collectively suggests that there is 
a genetic regulatory network that acts upstream of TEC specification; their role is 
extensively described in the next section. 
 
1.2.2.1 A genetic regulatory network acting prior to TEC specification 
To better understand this early-acting genetic regulatory network, the role of the genes 
expressed prior to Foxn1 is discussed further here.  Hoxa3 is evident in both the 
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endoderm and surrounding mesenchyme of the pharyngeal region – foregut, while 
newborn mice lacking this gene are missing the thymus, parathyroid and part of the 
thyroid gland (Manley and Capecchi, 1995).  Foxn1 expression was delayed (but still 
initiated) in Hoxa3-/- mice, suggesting that Hoxa3 alone cannot lead specification of 
the thymic epithelium (Chojnowski et al., 2014).  Nonetheless, the lack of thymus 
could be explained by increased apoptosis in those mice.  Specific deletion of Hoxa3 
in the endoderm caused a more severe phenotype compared to deletion in the 
mesenchyme due to Bmp4 endoderm-specific dependence on Hoxa3 (Chojnowski et 
al., 2014). 
PAX1 and PAX9 are highly homologous transcription factors (Blake and Ziman, 
2014) that are commonly expressed in the 3rd PP at E10.5, however, their knockout 
phenotypes differ substantially (Peters et al., 1998; Wallin et al., 1996).  Pax9-/- mice 
display severe 3rd – 4th PP growth defects at E11.5 and their thymic tissue remains 
stuck in the neck region (absence of migration), however they still express Foxn1 and 
initiate thymocyte colonization that lasts only up to E16.5 due to pervasive apoptosis 
(Hetzer-Egger et al., 2002).  Pax1-/- mice display normal migration, with a mild delay 
in growth and thymocyte transition (Wallin et al., 1996).  The maintenance of Pax1 
expression is dependent on Hoxa3 expression (Manley and Capecchi, 1995); however, 
Hoxa3 expression is not affected in Pax1 Pax9 double knockouts (Zou et al., 2006), 
which suggests an upstream regulatory role for Hoxa3 compared to the above PAX 
genes.  Additionally, loss of one Hoxa3 allele (Hoxa3+/-) in combination with a Pax1 
mutant (Pax1-/-) leads to more severe aberrations, indicating a HOXA3-PAX1 partially 
regulating thymus organogenesis (Su and Manley, 2000; Su et al., 2001). 
Expression of Eya1 and Six1 is evident in the pharyngeal pouch and afterwards in the 
fetal thymus (Xu et al., 2002; Zou et al., 2006).  Eya1-/- mice demonstrate a complete 
lack of the thymus-parathyroid primordium, while Six1-/- mice (or Six1-/- Six4-/- double 
knockout) initially form a 3rd PP rudiment, which rapidly degenerates via apoptosis 
(Zou et al., 2006).  Eya1-/- Six1-/- double mutants also exhibit a more severe phenotype 
than Eya1-/- alone (Xu et al., 2002; Zou et al., 2006).  However, since EYA1 cannot 
bind DNA (Rebay et al., 2005), it is possible that EYA1 regulation of SIX1 may be 
through an alternative mechanism (for instance via EYA1’s phosphatase activity). 
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DiGeorge syndrome (DGS) is caused by the deletion of the 22q11.2 chromosomal 
region and among other symptoms, the immune system of the patients is compromised 
because of thymus hypoplasia or aplasia (Holländer et al., 2006).  In mice, knockout 
of the Tbx1 locus causes a very similar phenotype to DGS, verifying that deletion of 
Tbx1 is largely responsible for aberrations (Jerome and Papaioannou, 2001; Lindsay 
et al., 2001).  Expression of Tbx1 is apparent in the pharyngeal region (endoderm of 
the PP and arch mesenchyme; Lindsay et al., 2001), and dynamic regulation of TBX1 
is necessary to succeed normal thymus organogenesis since both Tbx1 knockout 
(Arnold et al., 2006) and gain-of-function mutants (Vitelli et al., 2009) led to aplasia 
and hypoplasia respectively.  TBX1 was shown to specifically repress Foxn1, as 
demonstrated from constitutive expression of Tbx1 under the control of the Foxn1 
promoter (Foxn1Cre), thus TEC differentiation can only proceed by Tbx1 down-
regulation (Reeh et al., 2014).  Overall, the above studies suggest a temporary role for 
Tbx1 in PP patterning and morphogenesis regulation and that happens partially through 
Fgf8 and Pax9 activation (Arnold et al., 2006; Okubo et al., 2011). 
It is likely that a genetic regulatory network orchestrates patterning and morphogenesis 
of the thymic anlage and this happens through cross-interaction of this network’s 
components.  Unlike the phenotype in nude mice, in which thymic rudiments are 
formed and survive into adulthood, most of these genes knockouts (except for Pax1) 
cause degeneration of the thymic primordia through apoptosis.  Therefore, two phases 
are evident during early progression of TECs: a) an early FOXN1-independent phase, 
in which a fine-tuned network of factors drives the cells into a stable and apoptosis-
resistant state ensuring TEC specification and survival and b) a later FOXN1-
dependent phase, in which FOXN1 activation mediates TEC differentiation into the 
functionally distinct cTEC and mTEC populations and allows further proliferation of 
these cells. 
 
1.2.2.2 Bipotent and lineage-fated thymic epithelial progenitor cells 
The early thymic primordium is populated by thymic epithelial progenitor cells 
(TEPCs) that can differentiate into the functionally distinct cortical and medullary 
TEC lineages and support the development of an adequate immune system (Bennett et 
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al., 2002).  Determination of the TEPC phenotype and isolation of these cells are 
therefore of major importance.  Evidence for the existence of such a progenitor cell 
type initially emerged from studying human thymic epithelial tumours where few cells 
were able to express both cTEC and mTEC markers (Schluep et al., 1988).  A more 
definitive TEPC phenotype was determined by a study addressing the role of FOXN1 
in mice.  As described above, this study demonstrated that cell-autonomous FOXN1 
expression is required for TEPCs to differentiate towards the cortical and medullary 
TEC lineages (Blackburn et al., 1996).  In more detail, analysis of adult aggregation 
chimeras from wild type and nude cells identified few nude-like cells marked by 
MTS20 and MTS24 monoclonal antibodies (Abs), and absence of any differentiation 
markers.  MTS20 and MTS24 Abs (Depreter et al., 2008) target the Placenta-expressed 
Transcript 1 (PLET1) antibody, which has been identified by two independent 
laboratories as a fetal TEC marker capable of reconstituting a full thymus organ in 
RTOC grafts (Bennett et al., 2002; Gill et al., 2002).  EpCAM+PLET1+ TEPCs at 
E12.5 of embryonic development were all identified to be capable of generating both 
cTECs and mTECs (designated bipotent) through a single cell transplantation assay 
(Rossi et al., 2006).  Additionally, improved flow cytometry methods identified all 
E12.5 TEPCs to be PLET1+, with the PLET1+ expression to subsequently decrease in 
organogenesis (Cook, 2010). 
A later block in differentiation due to differentiation arrest of thymocytes generated 
cells that co-expressed K8 and K5 markers which normally reside in the CMJ, while 
transplantation of these cells to mice with a later block showed their conversion into 
K8+K5- cells, suggesting their role as cTEC progenitors (Klug et al., 1998).  Also 
recently, a self-renewing subpopulation of embryonic TECs that expresses high levels 
of Claudin 3 (Cldn3), Cldn4 and stage-specific embryonic antigen (SSEA1) was able 
to generate mTECs in the long-term and this subset of TECs has been characterised as 
mTEC stem cells (Sekai et al., 2014).  Importantly, cells identified in the nude 
primordium express a similar set of markers (Baik et al., 2016), which suggests that 
FOXN1 is indispensable for TEC fate selection (Nowell et al., 2011).  Another 
embryonic progenitor mTEC population that is able to give rise to AIRE+ mTECs was 
shown to express RANK, a key regulator in the formation of the thymus medulla (Baik 
et al., 2016). 
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Despite current progress, the bipotent phenotype of specified TEC progenitors that 
populate the thymic anlage before the onset of FOXN1 has not yet been described in 
full to allow confident identification and purification of this bipotent TEPC population. 
 
1.2.2.3 A serial progression model into the embryonic cortical and 
medullary thymic epithelial cell lineages 
In the adult thymus, cTEC and mTEC populations are easily distinguishable based on 
the differential expression of a panel of markers (intracellular and cell surface ones) 
(Lucas et al., 2016; Ohigashi et al., 2013).  However, this is not the case in the 
embryonic thymus, where current TEC markers fail to clearly define the cTEC-mTEC 
early populations, setting a barrier in the analysis of the early cTEC and mTEC lineage 
emergence (Klug et al., 2000, 2002).  In a recent study, the cTEC-specific marker 
CD205 and the mTEC-specific marker CD40, which normally identify these 
populations in the adult thymus, were used to assess early cTEC and mTEC 
development (Shakib et al., 2009).  This study identified a CD205+CD40- population 
that was apparent around E12.0-13.0, while over time some cells progressively became 
CD205+ CD40+ and eventually CD205-CD40+.  Interestingly, a purified CD205+CD40- 
population was capable of giving rise to both cTEC and mTEC lineages through an 
RTOC transplantation assay, suggesting that mTEC lineages experience an early phase 
of cTEC markers expression (Baik et al., 2013).  In that direction, fate mapping data 
clearly demonstrated that all TECs experience expression of the cTEC marker β5t 
(Ohigashi et al., 2013). 
In particular for the mTEC lineage progression, SSEA1+ mTEC stem cells ontogenic 
appearance was examined against the key regulator of mTEC formation, RANK 
(Akiyama et al., 2008; Hikosaka et al., 2008; Rossi et al., 2007a).  The SSEA1+ mTEC 
stem cells was found to express RANK uniformly and also emerge earlier than the 
RANK- mTEC progenitor population (Baik et al., 2016).  Interestingly, SSEA1+ 
mTEC stem cells are evident in the embryonic thymus of mice which exhibit an mTEC 
developmental block (Relb-/- mice), whereas no RANK+ mTEC progenitors were 
detected (Baik et al., 2016).  Collectively, these studies agree on mTEC specification 
having already occurred by E12.0.  In brief, mTEC lineage progression generates 
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SSEA1+ mTEC stem cells in an RELB-independent way, however, RELB is required 
downstream of this stage to produce RANK+ mTEC progenitors which can also act as 
a subsequent source for mature AIRE+ mTECs generation (Akiyama et al., 2008).  The 
relationship between the mTEC stem cells and the mTEC progenitors is not yet known, 
however it seems that multiple members of the Tumour Necrosis Factor family 
(TNFR) take part in mTEC serial differentiation process. 
Collectively, the above findings are significant, as they propose that TEPCs are 
initially cTEC-fated and then progressively acquire their mTEC lineage in a stepwise 
manner, with mTEC sublineage differentiation to also proceed gradually through 
premature mTEC populations towards the mature mTEC phenotypes (see TEC 
differentiation diagram in Figure 1.2).  Nonetheless, the transition from the bipotent 









Figure 1.2: A serial progression model of TEC early progression in development.  The diagram 
depicts a summarised overview of early TEC differentiation from the bipotent progenitor stage towards 
the cortical (c) and medullary (m) TEC lineages based on current literature analysing the embryonic 
thymus.  Early undifferentiated bipotent progenitors (TEPCs) undergo a stage where they express cTEC-
like genes before proceeding towards the cTEC or mTEC distinct subpopulations.  An unknown 
mechanism determining mTEC specification results in the generation of SSEA1+ mTEC stem cells, which 
are subsequently dependent on RELB for further differentiation and seem to also involve the mTEC 
regulator RANK.  Finally, crosstalk among the RANK+ mTEC precursors sets off differentiation towards 








1.2.2.4 Cell-crosstalk dependence for TEC progression  
TEC differentiation and maturation depends on extracellular signalling from the neural 
crest (NCC)-derived mesenchyme and the developing thymocytes which migrate in 
the thymic rudiment during organogenesis (Auerbach, 1960; van Ewijk et al., 1994).  
The thymic lobes are surrounded by a NCC-derived mesenchymal population that 
stimulates proliferation of immature TECs by secretion of FGF factors (Jenkinson et 
al., 2003; Revest et al., 2001).  Around E11.5, haematopoietic progenitors begin to 
colonise the thymus (Luis et al., 2016) coinciding with the onset of FOXN1 and the 
morphological shift of thymic epithelial cells.  In transgenic mice where thymopoiesis 
is blocked (hCD3ɛ; block at DN1 stage), TECs maintain a two-dimensional (2D) 
configuration, with the predominant TEC population to be K5+ K8+, while thymi were 
hypoplastic with large cysts (van Ewijk et al., 2000; Klug et al., 1998).  It is possible 
that the presence of haematopoietic progenitors is required to maintain TEC 
organisation, since T-cell progenitors are not necessary for the initial stages of fetal 
epithelium patterning (Klug et al., 2002).  A subsequent block in T-cell development 
using Rag1-/- mutants (block at DN3 stage) gave rise to thymi with reticular cTEC 
organisation and a detectable K5-K8+ population, although bare detection of mTECs 
was apparent (Klug et al., 1998).  Indeed, presence of more mature T-cells is essential 
for mTEC sublineage elaboration (Hikosaka et al., 2008).  Together, these results 
demonstrate that TEC differentiation after the initial specification stage encompasses 
several checkpoints and necessitates cell non-autonomous interactions to progress. 
 
1.2.3 Signalling mechanisms involved in early thymus 
progression 
 
1.2.3.1 Sonic Hedgehog (SHH) 
The role of SHH signalling in early development has been investigated through Shh-/- 
embryos, in which disturbed separation of the thymus-parathyroid structures was 
observed.  In the Shh-/- mutants, the overall pouch domain was diminished due to cell 
death, while subsequent loss of the Gcm2 expression resulted in an expanded thymus 
domain marked by expanded expression of Bmp4 and Foxn1 (Moore-Scott and 
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Manley, 2005).  Additionally, in experiments where Shh was constitutively expressed 
in the 3rd PP, cells did not acquire a parathyroid fate, but instead TBX1 was further 
induced and in turn repressed Foxn1 expression in the thymic domain (Bain et al., 
2016; Reeh et al., 2014), suggesting that SHH expression acts as a control gate of the 
thymic-parathyroid fate, rather than imposing it. 
Following the initial patterning of the 3rd PP, expression of Shh is also evident during 
TEC differentiation.  Subsequent investigation of the Shh-/- mutants has been difficult 
since development for these embryos fails around E16.5 (Shah and Zuniga-Pflucker, 
2014).  Analysis of fetal culture of Shh-/- thymi or of chemically blocked SHH 
signalling demonstrated lower number of cTECs and mTECs, increased levels of MHC 
class II expression and reduced numbers of AIRE+ mTECs (Saldaña et al., 2016).  
Collectively, the above findings propose a role for SHH in TEC differentiation, 
although it is not clear if these effects are the outcome of cells acting autonomously or 
if they have been partially caused indirectly through lymphocyte crosstalk, since Shh 
also regulates thymocyte development (Barbarulo et al., 2016). 
 
1.2.3.2 Bone Morphogenic Proteins (BMPs) 
During early organogenesis of the thymus Bmp4 shows a dynamic spatiotemporal 
expression pattern, by which Bmp4 expression is restricted in the few mesenchymal 
cells of the 3rd pharyngeal arch at E9.5.  Its expression it then continues to expand at 
the ventral aspect of the 3rd PP at E10.5-E11.5, and finally its expression is evident 
throughout the primordium and the mesenchymal capsule (Patel et al., 2006).  
Therefore, it is possible that Bmp4 is involved in the specification of the thymic 
epithelium starting from the ventral posterior aspect of the 3rd pouch.  Some in vitro 
evidence has suggested that Foxn1 expression in TECs may be induced by Bmp4, 
Foxn1 expression in the posterior area of the 3rd pouch at E11.25 (Tsai, 2003).  In 
agreement with this, expression of the BMP inhibitor NOGGIN (normally expressed 
in a complementary pattern to that of Bmp4) under the control of Foxn1 disrupts 
thymus migration, while the existent thymus is heavily reduced (Bleul and Boehm, 
2005).  Additionally, sustained expression of NOGGIN caused partial loss of Foxn1 
in the thymic primordium which resulted in domain reversion to a cystic structure, 
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indicatory of a more immature state (Soza-Ried et al., 2008), while specific deletion 
of Bmp4 as early as E9.5 (Foxg1Cre) also resulted in a similar phenotype (Gordon et 
al., 2010).  Finally, specific deletion of Bmp4 in committed TECs and the NC-derived 
surrounding mesenchyme (using Foxn1Cre and Wnt1Cre, respectively) demonstrated 
normal migration of the structure but again reduced size, suggesting a continuous 
requirement of BMP signalling after Foxn1 initiation, a requirement no longer needed 
though for the later stages of the mesenchyme. 
In general, BMP signalling seems to up-regulate Foxn1 expression in TECs as shown 
by addition of BMP4 in FTOC medium (Tsai, 2003).  In our hands, only combinatorial 
addition of FGF8 and BMP4 in 3rd PP culture resulted in Foxn1 up-regulation (Poppis, 
Blackburn lab, unpublished).  However, neither Foxg1Cre induced Bmp4 nor deletion 
or forced Noggin expression completely abolished Foxn1 expression, although in the 
latter case Foxn1 expression was lost from part of the thymic rudiment and the 
rudiment itself exhibited a cystic structure (Bleul and Boehm, 2005; Gordon et al., 
2010; Soza-Ried et al., 2008).  Interestingly, suppression of BMP signalling by 
NOGGIN activates Bmp2 and Bmp4 in a negative feedback fashion (Bleul and Boehm, 
2005).  This feedback loop, as well as potential redundancy among BMP factors, could 
explain the small impact on Foxn1 expression in the Bmp4 deletion model using the 
Foxg1Cre (Soza-Ried et al., 2008).  In summary, these data suggest a potential role for 
the BMP signalling in Foxn1 up-regulation, although this is possibly dependent also 
on other signalling pathways acting in the region and TECs maturation status itself. 
 
1.2.3.3 Fibroblast Growth Factors (FGFs) 
FGF signalling is involved in the development of several structures in the pharyngeal 
region, with mutations disrupting the normal FGF signalling to affect normal 
organogenesis in the thymus and/or the parathyroid system.  High expression of Fgf8 
is apparent in the distal posterior presumptive thymus region around E9.5.  FGFR2-
IIIb expression is limited in the thymic epithelium and its expression is first evident at 
E13.5, while its ligands (FGF3, FGF7 and FGF10) are expressed in the mesenchymal 
tissue surrounding the developing thymus.  Aplasia or hypoplasia is observed in Fgf8 
mutants because they fail to form normal 3rd PPs (Abu-Issa et al., 2002; Frank et al., 
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2002), while reduced TEC proliferation occurs after E12.5 in FGFR2-IIIb and FGF10 
mutants (Ohuchi et al., 2000; Revest et al., 2001).  Importantly, continuous localised 
inhibition of the FGF signalling by the sprouty genes (Spry1 and Spry2) is also 
necessary for the formation of a normal-sized parathyroid (via Gcm2 induction), 
thymus-parathyroid separation (via apoptosis) and expansion of the thymic 
primordium (via cell proliferation) (Gardiner et al., 2012).  Overall, FGF signalling 
regulates early thymus organogenesis in two stages: a) rudiment patterning and 
morphogenesis through an Fgf8 negative loop and b) TEC proliferation through a 
mesenchymal-epithelial crosstalk. 
 
1.2.3.4 Wingless-type MMTV integration site family members (WNTs) 
Several WNT ligands are expressed in the thymic anlage during early organogenesis 
(around E10.5), however only WNT4 seems to persist in adult development 
(Balciunaite et al., 2002).  A critical role for WNT4 as a Foxn1 inducer has been 
identified by using cTEC-derived lines in which both co-culture with WNT4-
transfected T-cells and WNT activation by lithium chloride led to an increase in Foxn1 
expression.  In support to this finding, a later study co-cultured E15.5 thymi with 
supernatant from a WNT4-secreting cell line; analysis of isolated TECs demonstrated 
Foxn1 up-regulation as well as up-regulation of the TEC differentiation markers, Il7 
and MHC II (Kvell et al., 2014).  Furthermore, analysis of Wnt4-/- thymi by Heinonen 
et al. (2011) demonstrated decreased TEC cellularity, an effect that was stronger if the 
deletion occurred in neonatal, rather than adult mice.  In agreement with this result, 
specific knockout of Grp16 (transporter of WNT ligands to the cell surface) in TECs 
reduced thymocyte and TEC cellularity (Brunk et al., 2015).  Interestingly, elevated 
activity of WNT signalling by loss of the WNT antagonist Kremen1, gradually 
disrupted the corticomedullary compartmentalisation (Osada et al., 2006).  A more 
dramatic disruption of the thymic structure and loss of Foxn1 resulted from two 
independent studies where the WNT effector β-catenin (Swann et al., 2017; Zuklys et 
al., 2009).  In addition, up-regulation of WNT4 alone demonstrated milder effects, 
suggesting that a negative loop may be regulating WNT4 expression (Swann et al., 
2017).  Collectively, the above results highlight a potential role of WNT4 in Foxn1 
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activation/up-regulation and dynamic expression of WNT signalling is essential for 
normal thymus development. 
Understanding the genetic network and signalling mechanisms that orchestrate TEPC 
early specification and expansion in early organogenesis will enable improved 
culturing conditions for survival and proliferation of TEPCs in vitro with significant 
effects in regeneration. 
 
1.2.4 The role of FOXN1 in thymus development 
 
1.2.4.1 FOXN1-independent TEC specification  
Foxn1 expression is evident in low levels during the initial outpocketing of the 3rd PP 
(E9.5) (Nehls et al., 1994), while high levels of Foxn1 become evident from E11.25 
onwards, with this strong expression being apparent in the most ventral part of the 3rd 
PP and gradually expanding to cover the entire thymus organ (Gordon et al., 2001, 
reviewed in Vaidya et al., 2016).  As discussed above, formation of the thymic 
primordium does not require FOXN1 (established by histological analysis, Cordier and 
Haumont, 1980; Cordier and Heremans, 1975).  In agreement with this, several studies 
strongly support that FOXN1 does not determine the thymic epithelial lineage 
specification, and their findings are summarised in this paragraph.  E9.0 3rd PPs ectopic 
transplantation (prior to Foxn1 expression) is capable of giving rise to a functional 
thymus organ with evident cTEC and mTEC compartments, denoting that 3rd PP cells 
have already been specified towards the TEC fate (Gordon et al., 2004).  In addition, 
expression of genes that are specific markers of the thymic domain (such as the 
interleukin 7; Il7, and the Forkhead transcription factor g1; Foxg1) occurs 
independently of FOXN1 (Wei and Condie, 2011; Zamisch et al., 2005).  Finally, the 
developmental arrest that occurs to TEPCs with Foxn1 revertible null or subfunctional 
hypomorphic alleles can be reversed at later stages, denoting that fetal TEPCs can exist 
in a stable state in vivo (Blackburn et al., 1996; Bleul et al., 2006; Jin et al., 2014) and 
therefore  suggesting the existence of an active transcriptional network acting upstream 
of FOXN1 that establishes TEPC identity and mediates TEC specification.  Taken 
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together, the above evidence indicates that TEC lineage commitment is not dependent 
on FOXN1, but potentially relies on a yet unexplored genetic network. 
 
1.2.4.2 FOXN1-dependent TEC differentiation 
Previous literature has demonstrated that TEC differentiation (and proliferation), 
including formation of the three-dimensional (3D) TEC microarchitecture are 
critically dependent on FOXN1 expression (reviewed in Vaidya et al., 2016).  In one 
of the studies, homozygous mice for a hypomorphic Foxn1 allele  (Foxn1Δ; lacking 
the FOXN1 N-terminal domain) were generated and analysis of the resulting thymi 
demonstrated thymus hypoplasia; the cTEC and mTEC regions failed to separate, 
while additionally these abnormal thymi could only support aberrant thymopoiesis in 
adult mice (Su et al., 2003).  The above observed phenotypes indicated that TEC 
differentiation was initiated but a subsequent block occurred leading to defects in the 
adult thymus.  With the use of a different Foxn1 hypomorphic allele (Foxn1R), Nowell 
et al. (2011) investigated the impact of variable FOXN1 levels on TEC differentiation.  
Foxn1R expresses around 15% of normal Foxn1 transcript levels compared to the wild 
type (WT) Foxn1 allele and mice homozygous for Foxn1R (Foxn1R/R) were 
characterised by hypoplastic thymi and suboptimal T-cell development.  Examination 
of a Foxn1 Allelic series which was generated based on the Foxn1WT, Foxn1R and 
Foxn1− alleles revealed Foxn1 dose-dependent TEC differentiation, in summary 
showing that increasing levels of Foxn1 control both cTEC and mTEC exit from the 
TEPC stage and progression through intermediate stages to terminal differentiation in 
the fetal and adult thymus (Nowell et al., 2011).  Of note is that another study using a 
revertible Foxn1 allele (Foxn1SA2), in which Foxn1 could be reactivated in single cells 
by tamoxifen induction (Cre-ERT2 system), generated miniature thymi with well-
defined cortical and medullary compartments, containing both Cytokeratin 5-high, 
Claudin 4-high (K5hiCldn4hi), and K5−Cldn4lo/− populations (Bleul et al., 2006).  The 
outcome of this analysis, in combination with published data showing that mTEC-
restricted progenitors (mTEPCs) during thymus organogenesis are Cldn4hi (Hamazaki 
et al., 2007; Sekai et al., 2014), suggests that the appearance of the mTEC lineage may 
be independent from Foxn1 expression and therefore that the divergence of the cTEC 
22 
 
and mTEC populations may happen earlier than indicated by Nowell et al. in the lines 
above. 
In summary, several lines of evidence described above have proved the importance of 
FOXN1 in TEC progression.  Further literature has also revealed a role for FOXN1 in 
managing the attraction and differentiation of haematopoietic progenitors in the 
thymic rudiment, as well as in the regulation of neural crest cell (NCC) migration and 
maturation that will shape the thymic mesenchyme.  Altogether, these data prove 
FOXN1 high significance in the establishment of a functional thymic system. 
 
1.2.4.3 FOXN1 binding motif 
Despites FOXN1’s (product of the nude locus) indisputable role in the thymic system, 
the molecular function and the genetic network around this transcription factor have 
not yet been determined in completeness, while only recently direct targets of FOXN1 
and the FOXN1 binding motif were identified in TECs by a chromatin 
immunoprecipitation assay combined with high throughput DNA sequencing (ChIP-
seq) (Žuklys et al., 2016).  The very first prediction for a FOXN1 binding motif came 
from an in vitro selection of binding sites (SELEX), in which the oligo-bound 
sequences contained an identical tetranucleotide core subsequence, 5’-ACGC-3’ 
(Schlake et al., 1997).  Following this, a study investigating the evolution of FOX 
factors used a protein-binding microarray (PBM; Berger and Bulyk, 2009; Berger et 
al., 2006) assay to identify preferred bound sequences by the different FOX family 
members (Nakagawa et al., 2013).  This competitive study identified an almost 
identical sequence, 5’-GACGC-3’, as the strongest bound sequence by FOXN1, while 
it also suggested that FOXN1 had lost over time the ability to bind the canonical FOX 
motif (5’-AAACAA-3’).  Even though two separate studies had predicted the same 
core nucleotide sequence as the preferred FOXN1 binding motif, both of them relied 
on experiments using short oligonucleotide binding in an artificial environment.  Only 
recently, the FOXN1 binding motif was confirmed by mapping the FOXN1-DNA 
interactions in vivo on a genome scale (Žuklys et al., 2016). 
Žuklys et al. expressed a FOXN1 protein, tagged with an octapeptide, under the Foxn1 
promoter in TECs of nude mice using a bacterial artificial chromosome (BAC).  Mice 
23 
 
homozygous for the BAC (designated Foxn1wt*/wt*) demonstrated a normal coat and 
thymus architecture, as well as normal Foxn1 expression levels with a mildly reduced 
cellularity which was still capable of supporting thymocyte development.  De novo 
motif analysis of the consistently enriched FOXN1 peaks around the proximal 
transcription start site of all expressed genes (5 kilobases (kb) upstream and 3kb 
downstream of genes TSSs) predicted 5’-GACGC-3’ to be the FOXN1 binding motif, 
in full agreement with the above in vitro studies, further validating this consensus as 
the preferential FOXN1 binding sequence. 
 
1.2.4.4 FOXN1 target genes 
In terms of gene regulation in TECs, Foxn1 has been shown to be generally required 
for expression of proteins that play a vital role in promoting T-cell development 
(Bredenkamp et al., 2014a; Calderón and Boehm, 2012; Chen et al., 2009; Nowell et 
al., 2011).  For instance, the C-C Motif Chemokine Ligand 25, C-X-C Motif 
chemokine ligand 12 (CXCL12) chemokine is necessary for the attraction of thymic 
seeding progenitors in both fetal and adult thymus (Liu, 2005; Liu et al., 2006; Plotkin 
et al., 2003), while Delta like canonical NOTCH ligand 4 (DLL4) allows commitment 
of migrating hematopoietic precursors to the T-cell lineage (Hozumi et al., 2008; Koch 
et al., 2008) and  KIT Ligand (KITL) is required for T-cell survival and proliferation 
(Buono et al., 2016).  Furthermore, Proteasome subunit beta 11 (PSMB11; also known 
as β5t) and Cathepsin L (CTSL) regulate peptide production in TECs to positively 
select CD8+ and CD4+ T-cells respectively  (Honey et al., 2002; Murata et al., 2007; 
Nakagawa et al., 1998; Sasaki et al., 2015), while MHC Class II expression contributes 
in peptide selection specifically for the CD4+ T-cells.  Additionally, FOXN1 is also 
regulating genes involved in differentiation, proliferation and function of TECs, 
namely, the Paired Box 1 (Pax1), Tumor Protein P63 (Trp63), Cyclin D1 (Ccnd1), 
Cluster of differentiation 40 (CD40), Cluster of differentiation 80 (CD80), Fibroblast 
growth factor receptor 2 isoform IIIB (Fgfr2IIIb), Autoimmune regulator (Aire), as 
well as some WNT regulators (Bredenkamp et al., 2014a; Nowell et al., 2011).  Finally, 
the FOXN1-tagged ChIP-seq analysis by Žuklys et al. (2016) has identified 450 highly 
confident FOXN1 direct target candidates, while it has also experimentally verified 
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for the first time in neonatal mice that Cluster of differentiation 38 (Cd38) and Psmb11 
are directly regulated by FOXN1 in cTECs.  Suggested from previous literature 
(Nowell et al., 2011), the usual FOXN1 candidate targets (Ccl25, Dll4, Cxcl12) are 
also included in this list, strongly suggesting that they are directly regulated by 
FOXN1. 
FOXN1 is now regarded as the master regulator in the thymic system, since its 
continuous expression is required for differentiation and maintenance of the cortical 
and medullary TEC lineages as well as subsequent thymocyte maturation, processes 
indispensably linked to a functional immune system.  In 2016, a FOXN1-tagged ChIP-
seq analysis finally provided more insights into FOXN1 direct binding potency in 
TECs in vivo, further identifying highly confident FOXN1 direct target candidates, 
specifically in the thymic cortex of 1 week old mice.  The same study also proposed a 
critical role for FOXN1 in the maintenance of the antigen processing and presentation 
program in newborn cTECs based on these data.  Nevertheless, how this single 
transcription factor establishes from scratch a robust transcriptional network that 
orchestrates thymus organogenesis and function in the early residing TEPCs or (as 
recently demonstrated) in an unrelated cell type (Bredenkamp et al., 2014b) still 
remains to be elucidated.  It also remains unclear how FOXN1 initiation is regulated 
by the early genetic regulatory network that is acting in the undifferentiated thymic 
anlage. 
 
1.2.5 The role of FOXN1 in skin 
 
Expression of Foxn1 has been identified in the skin, submatrix region of the nails, 
tongue, oral cavity and nasal placode (Lee et al., 1999; Meier et al., 1999).  In the skin, 
Foxn1 expression is observed in the epidermis and hair follicles but it is limited in the 
epithelium of these cell types (Baxter and Brissette, 2002; Weiner et al., 2007).  In the 
epidermis, Foxn1 participates in the transition from the proliferative state (basal layer) 
of the keratinocytes to the differentiated state (suprabasal and rest keratinocyte layers) 
(Lee et al., 1999; Prowse et al., 1999).  FOXN1 is most prominent in the keratinocytes 
suprabasal layer when cells seem to exit their cell cycle and begin to differentiate, 
while almost all of the proliferative basal cells of the epidermis are FOXN1 negative 
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(Lee et al., 1999; Meier et al., 1999).  This intrinsic supplement of source of cells from 
stem cells dispersed in the basal layer is required to generate defensive, terminally 
differentiated layers of skin (Morasso and Tomic-Canic, 2005).  Cells positive for 
FOXN1 also express early differentiation markers (Keratin 1 and 10; K1 and K10), 
indicating that FOXN1 acts as a prodifferentiation transcription factor (reviewed in 
Grabowska and Wilanowski, 2017). 
FOXN1 expression is also evident in the hair follicles, which exhibit synchronised 
dynamic cycles of active growth, regression and quiescence (anagen, catagen and 
telogen respectively) with FOXN1 levels peaking during anagen, when multipotent 
stem cells get activated and exit their niche, while FOXN1 is absent from the telogen 
stage (reviewed in Grabowska and Wilanowski, 2017) 
The molecular mechanisms that orchestrate FOXN1 function in skin are still to be 
better understood.  Only a few genes have been identified to be FOXN1 targets and 
the exact mechanism of their regulation is poorly understood.  A microarray analysis 
in which human epidermal keratinocytes with induced human FOXN1 were compared 
to a human epidermal keratinocyte control population were compared revealed up-
regulation of gene groups linked to signalling, cytokines, growth arrest, extracellular 
matrix and metabolism, including K10 suggesting that FOXN1 induction may be 
promoting keratinocyte differentiation (Janes, 2004).  In another study, FOXN1 was 
shown to impose pleiotropic effects, with WNT signalling family genes and 
metalloproteinases to be enriched in the keratinocytes of nude mice, while BMP and 
NOTCH signalling members demonstrated the opposite effect (Kur-Piotrowska et al., 
2017).   
In hair follicles, the regulatory network surrounding FOXN1 is not clearly defined.  In 
some reports, FOXN1 has been positioned downstream of BMP and upstream of 
NOTCH canonical pathway (Cai et al., 2009), whereas in other reports it seems to exist 
downstream of the NOTCH pathway (Hu et al., 2010).  As will be discussed later 
(section 1.4), the NOTCH pathway has been involved in the fate maintenance inside 
the hair matrix.  In an initial study (Cai et al., 2009), Foxn1 and Msx2 expression has 
been shown to be required for normal expression of Notch1 in the hair follicle 
matrix.  Genetic knock-out mutants of Foxn1 and Msx2 reduced Notch1 halfway, 
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which sequentially impaired differentiation of the medulla and the inner root sheath 
(IRS) of the hair follicle.  Further experiments indicated that FOXN1 was directly 
targeting the Notch1 promoter.  Additionally, Foxn1 and Msx2 seem to be acting 
synergistically but in parallel downstream of BMP signalling, since recombinant 
human BMP4 induced Foxn1 expression in Msx2-/- hair follicles.  Despite their 
synergistic effect, Foxn1 seems to exist downstream of Msx2, as demonstrated by 
reduced Foxn1 expression in Msx2-/- mutants.  Moreover, except for regulating 
NOTCH signalling, these two factors can be independently involved in cortical and 
cuticle keratins expression.  Collectively, Foxn1 and Msx2 exist downstream of BMP 
signalling and upstream of Notch1, and together they play a pivotal role in the 
differentiation of the IRS, cortex and medulla within the hair matrix.  In the second 
study (Hu et al., 2010), inhibition of NOTCH signalling in the surrounding 
mesenchyme was shown to influence Foxn1 expression in the keratinocyte epithelial 
through Wnt5a positioning NOTCH signalling upstream of Foxn1. 
The equilibrium of the stem cell activity within the bulge stem cells can be affected by 
the BMP-WNT interplay.  Inhibition of the BMP signalling and increase of WNT 
signalling pushes the balance towards the activation of quiescent stem cells (Kandyba 
et al., 2013).  Therefore, loss or down-regulation of Foxn1 could potentially contribute 
towards stem cell activation and a more regenerative environment.  Data availability 
for BMP, WNT and NOTCH signalling pathways in the epidermis is even more limited.  
BMP seems to regulate the cell fate of amplifying cells by promoting their 
differentiation (overexpression of terminally differentiated markers; K10 and 
involucrin; IVL) (Gosselet et al., 2007).  In contrast, WNT members are secreted and 
targeting the basal proliferative layer of the epidermis (mainly consisting of committed 
progenitors), while the suprabasal and remaining layers have WNT inhibitors (Kaur, 
2006).  Taking into account that lack of FOXN1 up-regulates WNT signalling and 
down-regulates WNT inhibitors, it is possible that blockage of FOXN1 favours a 




1.3 CLASSICAL MODELS FOR STEM CELL DIFFERENTIATION AND 
MAINTENANCE 
Early studies on hematopoietic stem cell (HSC) self-renewal and differentiation have 
created a central paradigm on the mechanisms that lead maintenance and repair in 
mammalian tissues (reviewed in Morrison et al., 1995; Orkin and Zon, 2008).  In this 
well-established example, the HSCs constitute a rare population of cells that sits at the 
top of the blood lineage hierarchy and divides infrequently in an asymmetric fashion 
(Suda et al., 1984).  Upon each division, the HSC creates two cells of differing 
fates.  One of these cells is an exact copy of the pre-divided HSC, while the other 
daughter cell adopts a subsequently lineage-restricted fate.  This unique defining 
capacity of stem cells to self-renew and maintain their long term lineage is called 
multi-potency.  In this paradigm, cells flow in one direction from the HSC towards 
progenitor lineages to terminally differentiated cells which will undergo apoptosis 
eventually. 
Nevertheless, this central example cannot always explain the underlying mechanisms 
in other well-studied stem cell systems that (unlike blood which is a fluid organ) 
contain a more rigid epithelial tissue (Watt, 1999).  A main feature of the epithelial 
cells in these organs is that they attach to the basement membrane of the tissues, with 
the types of epithelial structures also variable between organs.  In the examples of lung 
and intestine, the epithelia comprise a monolayer of epithelial cells in direct contact 
with the basal layer.  In the mammary gland epithelia, two distinct cell types exist: a 
luminal population which surrounds a central lumen and myoepithelial cells which are 
located to the basal area (Visvader and Stingl, 2014).  While all myoepithelial cells 
adhere to the basement membrane, only 20% of the luminal cells are attached to it. In 
the skin epithelium, multiple layers of epithelial cells (multilayer) are apparent, where 
distance of the epithelia from the membrane determines the level differentiation per 
cell.  Additionally, it is not unusual for epithelia to contain structures with specialised 
functions (like hair follicles or glands). 
In terms of their stem cell state, solid tissues display two types of behaviour: low 
proliferative activity when in a non-excited state (like lung, pancreas and liver) with 
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exhibiting proliferation bursts upon damage, and constant self-renewing activity (like 
the intestine and testis) with daily, weekly and monthly rates of tissue 
replacement.  The latter case resembles the bone marrow self-renewal process 
(reviewed in Clevers and Watt, 2018). 
The low proliferative nature of cells has been widely used over the years as a main 
attribute to define stem cells.  Excellent examples of adult tissue stem cells exist 
(dormant satellite cells in striated muscle; reviewed in Brack and Rando, 2012, bulge 
stem cells of the hair follicle; Cotsarelis et al., 1990), nevertheless, quiescence cannot 
be used as a discriminatory feature for novel stem cell identification, since the vast 
majority of mammalian cells are non-dividing. 
Studies on the proliferative state of the intestinal crypt cells have provided an example 
where stem cells do not flow in an unidirectional way (reviewed in Clevers, 2013), 
violating the “one-way” flow rule as it has been established by the HSC main 
paradigm.  In this case, lineage-restricted daughters constitute a persistent repertoire 
of cells which is able to resettle at the bottom of the intestinal crypt cell hierarchy in 
which a short-lived multipotent population exists (Buczacki et al., 2013).  This process 
is activated upon loss of the intestinal crypt stem cell marker. 
Under a different point of view, daughter cells may exhibit plasticity: the potential to 
return to a less differentiated (stem) cell state, even though they have progressed down 
the lineage hierarchy.  This progression can range from a progenitor cell stage (see 
intestinal crypt cells) to the more extreme cases of terminally differentiated cells that 
can still revert to a stem cell state (see lung epithelium, reviewed in Tata and 
Rajagopal, 2017). 
Unlike HSCs, which are characteristically rare, quiescent, long-living and divide 
asymmetrically, stem cells in skin (Clayton et al., 2007), intestinal crypt (Lopez-Garcia 
et al., 2010; Snippert et al., 2010), oesophagus (Doupe et al., 2012), stomach glands 
(Leushacke et al., 2013) and testis (Klein et al., 2010) are abundant, cycling and divide 
symmetrically while their life span is stochastically determined.  For all the latter 
tissues, stem cell self-renewal and longevity can only be defined at the population level, 
but not at the single cell level (see Clevers and Watt, 2018). 
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Notably, tissues may also involve more than one stem cell type acting independently 
to maintain the tissue distinct lineages.  In skin, for instance, stem cell niches are liable 
to sustain the differentiation compartments that are allocated only to their local area 
(Watt and Jensen, 2009). Even though that is the case under steady state conditions, 
during tissue injury all stem cells can give rise to all the epidermal lineages (Donati 
and Watt, 2015). 
In strong contradiction to the HSC example, no stem cell population has yet been 
identified in the liver tissue over decades of studies (reviewed in Stanger, 2015), 
suggesting that the proliferative capacity of the liver lineages are sufficient to maintain 
and repair the liver tissue. 
In sum, besides the well-established paradigm of HSC-like, rare and quiescent 
professional stem cells, deeper principles may underlie maintenance and regeneration 
mechanisms of individual tissues, involving cell plasticity, population self-renewal, 
multiple tissue stem cells and regeneration led by normal tissue cells  (reviewed in 


















1.4 MODELS BY WHICH NOTCH OPERATES IN OTHER CELL 
TYPES 
NOTCH signalling is a highly conserved pathway that allows cell communication 
between neighbouring cells.  NOTCH ligands interact with their receptors which 
become activated through sequential proteolytic cleavages that lead to the release of 
the NOTCH intracellular domain.  In turn, this domain is transported inside the cell 
nucleus where it acts as a coactivator and regulates transcription of target genes in 
association with members of the CSL DNA binding transcription factor family 
(reviews by Artavanis-Tsakonas, 1999; Bray, 2006).  A wide range of cellular 
processes can be regulated by NOTCH, including specification of the cell fate, 
formation of boundaries, stem cell maintenance, cell proliferation, migration and 
apoptosis.  Despite the simple linearity regarding the mechanism of the NOTCH 
pathway itself, NOTCH signalling specifies highly complex biological outcomes 
(Artavanis-Tsakonas, 1999; Fortini, 2009; Lai, 2004) through its different modes of 
action: namely lateral inhibition, fate decisions and inductive signalling. 
Lateral inhibition characterises an event where the fate of a cell is specified while this 
cell lies among a group of equivalent cells.  One of the best characterised examples of 
lateral inhibition occurs in the embryonic neuroepithelium in Drosophila, where 
NOTCH determines if equivalent ectodermal cells will differentiate into epithelial 
cells or neuroblasts.  Initially, all cells in the neuroepithelium exhibit low levels of 
NOTCH ligand (DELTA) and its receptor (NOTCH).  However, possibly due to 
stochastic variation, some cells increase their levels of DELTA and this inceptive 
difference is magnified through a transcriptional positive feedback loop.  In contrast, 
these high-DELTA expressing cells cannot express NOTCH (because of cis-inhibitory 
interactions; Heitzler and Simpson, 1993).  Eventually, the system resolves in a salt 
and pepper pattern where the DELTA-expressing signal-sending cells differentiate 
into neuronal cells, while the NOTCH-expressing signal-receiver cells become 
epithelial cells.  The mechanism of lateral inhibition constitutes a common mechanism 
through which tissues containing identical cells are patterned during development 
(Bate and Rushton, 1993; Greenwald, 1998; Greenwald and Rubin, 1992; Roignant 
and Treisman, 2009; Rushton et al., 1995). 
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Lineage (or fate) decisions and inductive signalling within non-equivalent cells are 
also operated by NOTCH signalling.  In particular, cells are different from one another 
either because of asymmetric expression of NOTCH signalling regulators or because 
of ligand-receptor differential distribution in adjacent cells (review by Bray, 
2006).  For example, in the progeny of sensory organ progenitors, asymmetric 
segregation of the endocytic adaptor protein NUMB down-regulates NOTCH 
signalling and converts the NUMB-positive cells into NOTCH signal-senders.  On the 
contrary, expression of DELTA in vein cells during wing-vein patterning in 
Drosophila induces NOTCH signalling in the adjacent (or intervein) cells which 
blocks vein fate (Huppert et al., 1997). 
Overall, even though NOTCH signalling modality acts as a simple on/off 
switch,  multiple levels of control can ensure precise signalling in the involved cells.  
First, post-translational modifications and trafficking of the deployed ligands and 
receptors can regulate their activity.  Secondly, when the pathway is active for a 
specific period of time, oscillatory initiation/termination mechanisms are used.  This 
is possible because the NICD cofactor is short-lived but also because NOTCH target 
gene messenger RNAs and proteins are very unstable and can also inhibit their own 















1.5 MECHANISMS OF GENE REGULATION 
Gene expression in eukaryotes is controlled through a complex mechanism that 
involves a) presence of multiple RNA polymerases regulating distinct classes of genes, 
b) binding of proteins to specific regulatory sequences in order to interact and 
modulate the activity of these RNA polymerases and c) unfolding of the compact 
chromatin structure to provide a template that allows transcription to happen.  The high 
complexity of eukaryotic transcription orchestrates the unique expression patterns of 
genes that are necessary to drive development, differentiation and function of different 
cells in multicellular organisms (reviewed in Cooper and Hausman, 2009). 
Three different types of RNA polymerases exist in eukaryotic cells that modulate 
distinct classes of genes: RNA polymerase II (Pol II) for protein coding genes and 
microRNAs (Lee et al., 2004), RNA Polymerase III (Pol III) for  tRNAs (Willis, 1993),  
RNA Polymerase I (Pol I) and Pol III for rRNAs (Engel et al., 2013; Willis, 1993) and 
Pol II and Pol III for snRNAs and scRNAs (Willis, 1993). 
Part of the general mechanism through which these polymerases regulate gene 
transcription is the assembly of a pre-initiation complex formed by various proteins 
that is necessary to enable transcription initiation (Matsui et al., 1980; Orphanides et 
al., 1996).  Genes transcribed by Pol II have a characteristic TATA box and initiator 
(Inr) element in their core promoter, among other upstream and downstream binding 
sites that are specifically targeted by a group of proteins called general transcription 
factors (review by Weis and Reinberg, 1992).  Binding of these general transcription 
factors in the core promoter of genes enables Pol II recruitment and eventually 
formation of the pre-initiation complex.  A minimum of five general transcription 
factors are required to initiate transcription in in vitro systems, however, within a cell 
additional factors are necessary to stimulate transcription.  One of these factors, called 
the Mediator, is a large protein complex which can interact with both Pol II and the 
general transcription factors (Malik and Roeder, 2005).  In that way, a complex 
transcriptional machinery is formed which controls transcriptional regulation in 
eukaryotes in vivo. 
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The core promoter of genes also includes cis-regulatory regions targeted by gene-
specific transcription factors (reviewed in Maston et al., 2006).  These factors regulate 
individual gene expression.  Furthermore, many genes in mammalian cells can be 
regulated by far-acting sequences located in a significant distance from the 
transcription start site of the gene.  These particular regions, called enhancers, can 
function from a long distance and in either orientation (Dynan and Tjian, 1983).  They 
apply their regulation similarly to promoters, by regulating the RNA polymerase 
(reviewed in Maston et al., 2006).  The distant enhancers are able to interact with the 
Pol II preinitiation complex because of DNA looping (Matharu and Ahituv, 2015). 
 
1.5.1 Mechanisms of transcriptional activation and repression 
Promoter and enhancer regions contain specific binding sites through which 
transcription is regulated.  Binding sites are made of short DNA sequences that usually 
range from 6-10 base pairs.  These sequences are degenerate, denoting that regulatory 
proteins (such as TFs) will also bind to sequences deviating from the binding motif 
consensus by one or more positions.  Transcription regulators that bind to these motifs 
are divided into activators and repressors based on their function (reviewed in 
Kadonaga, 2004).  Transcription activators stimulate transcription through their 
binding to the regulatory DNA sequence (Ptashne, 1988).  These proteins are 
characterised by two domains: a DNA-binding domain that specifically binds DNA 
and an activation domain that interacts with the Mediator or other components of the 
pre-initiation complex to promote specific gene transcription.  The latter domain 
stimulates transcription by two different mechanisms.  First, by interacting with 
components of the pre-initiation complex to recruit Pol II and form the transcriptional 
complex at the promoter region.  Second, by interacting with a variety of other factors 
(namely coactivators) that modify chromatin structure to stimulate 
transcription.  Notably, transcription can also be regulated at the level of transcript 
elongation and RNA processing in which transactivators also play a role (reviewed in 
(Ma, 2011). 
Repressor proteins are also responsible for gene regulation in eukaryotic 
cells.  Similarly to the activator proteins, eukaryotic repressors bind to specific binding 
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sites to apply their effect; but in this case they cause transcription inhibition.  In some 
cases, this inhibition is mediated by interfering with the binding of the TFs to the 
regulatory region.  For instance, proximal binding of a repressor to the TSS of a gene 
can deter/prevent the interaction of general TFs or the Pol II itself with the 
promoter.  In other cases, receptors antagonize activators for binding in the same 
regulatory site.  Some repressors may exhibit the same DNA-binding unit with an 
activator but lack a stimulation domain, while others may contain a functional 
inhibitory domain that represses gene transcription by protein-protein interactions 
(active repressors).  Lastly, repressors can apply their inhibitory effect by interacting 
with corepressors, whose role is to modify the chromatin structure (reviewed in Gaston 
and Jayaraman, 2003). 
The action of both transcriptional activators and eukaryotic repressors controls the 
expression or silencing of tissue specific genes, cell proliferation and differentiation 
and responses to external stimuli (e.g. hormones and growth factors). 
 
1.5.2 Chromatin structure controlled by activators and repressors 
Both activators and repressors may control transcription not only by interacting with 
various subunits of the transcriptional machinery but also by inducing structural 
changes to the chromatin of the eukaryotic cell.  Instead of being present in a “naked” 
state, DNA in eukaryotes is wrapped around histones in the core particle of the 
nucleosome.  Packaging of the chromatin in this tight structure is directly linked to its 
availability as a substrate for permissive transcription.  Thus, gene expression is 
majorly dependent on the chromatin structure, with actively transcribed genes to be 
found in less condensed chromatin regions.  Nevertheless, these genes are still bound 
to histones and wrapped around nucleosomes, affecting the ability of both transcription 
factors and RNA polymerase to bind and transcribe DNA respectively. 
Several mechanisms are responsible for chromatin remodelling, including histone 
modifications, high mobility group (HMG) proteins-chromatin interactions and 
nucleosome rearrangement (Saha et al., 2006).  Two domains are apparent in the 
histones of the nucleosome core particle (H2A, H2B, H3 and H4): a histone-folding 
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domain, which takes part in histone-histone interactions and DNA wrapping around 
the core particle of the nucleosome, and an amino-terminal tail domain which stretches 
outside the nucleosome (Luger et al., 1997).  The extended domain contains multiple 
lysines on its tail which can be acetylated in specific positions.  Histone acetylation 
has been directly linked to transcriptional regulation through studies which showed 
associations of activators and repressors with histone acetyltransferases and 
deacetylases respectively (Brownell et al., 1996; Taunton et al., 1996).  Several other 
modifications can influence the status of histones, including methylation of arginine 
and lysine residues and phosphorylation of serine residues.  These modifications take 
place in the amino-terminal tails similar to histone acetylation and have been 
associated with alterations in transcriptional activity (Bannister and Kouzarides, 
2011).  It seems that histone modifications regulate gene expression by both 
remodelling the chromatin state and by creating accessible sites for other factors to 
bind and activate or repress transcription.  For instance, acetylation of lysines 
neutralizes their positive charge which relaxes protein structure and enables 
transcriptional activation.  Conversely, methylation of lysine residues in H3 create 
binding positions for factors that lead to a more condensed chromatin state, directly 
associating this modification with formation of heterochromatin and transcriptional 
repression. 
Apart from histone modifications, interaction of the HMG superfamily of proteins is 
able to influence the chromatin architecture by bending DNA and facilitating binding 
of regulatory factors or alternatively by inducing chromatin unfolding and maintaining 
DNA in a decondensed state (Hock et al., 2007).  Additionally,  chromatin remodelling 
factors can also alter the DNA-histone contacts by a) catalysing the sliding of the 
nucleosomes along the DNA molecule to alter the accessibility of DNA sequences to 
TFs (Workman, 2006), b)  changing the conformation of the nucleosomes to affect the 
ability of TF binding to DNA or c) ejecting histones from DNA to create a nucleosome-
free region (Henikoff, 2008). 
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1.5.3 Chromatin modifications as indicators of promoter/enhancer 
activity 
Histone modification marks are often used to distinguish promoter and enhancer 
regions in genome studies (reviewed in Andersson, 2015).  This methodology has been 
adopted based on distinguishable properties that can separate one from the other.  In 
particular, histone H3 tri-methylation at lysine residue 4 mark (H3K4me3) has been 
denoted as a specific promoter mark (as shown for instance in Barski et al., 2007), 
however, few studies have also associated this mark with regulatory active enhancers 
(as shown for instance in Koch et al., 2011 and Pekowska et al., 2011).  Furthermore, 
even though promoter and enhancer regions are usually flanked by nucleosomes 
bearing both histone H3 monomethylation at lysine residue 4 (H3K4me1) and 
H3K4me3, the H3K4me1:H3K4me3 ratio was found to be high in enhancers but low 
in promoters (Heintzman et al., 2007).  The patterns of histone post translational 
modifications (PTMs) have further been refined by subsequent studies to predict 
specific states of enhancer activity.  In short, H3K4me1 marks many enhancers, but 
on its own it cannot distinguish between active and primed (to become active) 
enhancers (Bonn et al., 2012); histone H3 acetylation at lysine residue 27 (H3K27ac) 
generally marks active enhancers (Creyghton et al., 2010) and histone H3 
trimethylation at lysine residue 27 (H3K27me3) and/or histone H3 trimethylation at 
lysine residue 9 (H3K9me3) exist at developmentally poised (silenced) enhancers, 
while they are substituted by H3K27ac when activated during early differentiation 
(Rada-Iglesias et al., 2011; Zentner et al., 2011).  Finally, other histone acetylation 
marks have been presented to have predictive power in discerning gene promoters to 
enhancers (Rajagopal et al., 2014). 
 
1.5.4 The role of pioneer factors 
Large eukaryotic genomes exist in a dual compacted chromatin state: at the level of 
the DNA wrapped around the nucleosomes (Luger et al., 1997) and at the level of inter-
nucleosome interactions (Schalch et al., 2005).  This compacted DNA state into 
chromatin restricts the amount of freely available DNA to which regulatory proteins 
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may have access to bind.  Therefore, there is an intrinsic tendency of the chromatin to 
exist in a repressive state, which reinforces a stable gene expression state and limits 
undirected cell fate commitment.  In order for the regulatory factors to gain access to 
DNA binding sites that reside within compacted chromatin (for instance silent genes) 
and control cell fate, the locally compacted chromatin must disentangle. 
Chromatin decompaction can be enabled by a subset of factors called pioneer 
factors.  The basic features that characterise a pioneer factor are the capacity to a) bind 
its cognate DNA site within “closed” chromatin (DNA is not accessible), b) instruct 
chromatin to remodel making specific DNA sequences accessible and subsequently c) 
enable binding of other TFs and lastly d) impose stable reformations in chromatin 
structure linked to epigenetic stability  (reviewed by Mayran and Drouin, 2018; Zaret 
and Mango, 2016).  However, binding of a pioneer factor can also lead to repressed 
chromatin, if the binding is alongside repressors or corepressors that cause local 
domain blanketing and impair activators access (Sekiya and Zaret, 2007; Watts et al., 
2011).  Altogether, these features suggest that when a pioneer factor “acts”, it may 
establish competence for consequent induction, establish a repressed region, or direct 
activation of a gene promoter, while its effect on chromatin is maintained. 
Nevertheless, binding of pioneer factors to chromatin is not fully unrestricted.  Certain 
chromatin domains can actively exclude pioneer factor binding through repressive 
features: in particular, the second level of compaction imposed by heterochromatin 
(regions enriched for H3K9me3 mark; Lachner et al., 2001), as first shown in a OSKM 
factor study where fibroblasts were converted into induced pluripotent stem (iPS) cells 
(Soufi et al., 2012).  Additionally, it is likely that pioneer factors will remain more 
stably bound in locations where they interact and experience cooperative binding with 
other regulatory proteins, a property which is common to both pioneer and other 
transcription factors but is not a defining feature of pioneers (reviewed by Zaret and 
Mango, 2016). 
Forkhead Box A (FOXA) constitutes the paradigm of a pioneer factor.  This was 
demonstrated by a study showing occupancy of liver-specific FoxA sites in endoderm 
prior to liver specification (Gualdi et al., 1996).  FOXA has also been shown to bind 
nucleosomal DNA (Cirillo, 1998) and unfold condensed chromatin (Cirillo et al., 
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2002).  In addition, FOXA remodelling activity and coupled nucleosome depletion 
have been shown by genome-wide studies (Iwafuchi-Doi et al., 2016; Li et al., 2011b; 
Serandour et al., 2011).  Currently, the pioneer factor label can be assigned to a 
regulatory factor by assessing the chromatin status prior to and after the factor’s 
action.  This needs to be tested in an experimental system where the cells have never 
been exposed to the pioneer factor.  Without this test, pioneer activity can only be 
























1.6 NEXT GENERATION SEQUENCING TECHNOLOGIES AND DATA 
ANALYSIS (PRÉCIS II) 
Leaps in scientific insight are closely associated with development of technology.  The 
longstanding “Holy Grail” for regulatory biology is to understand how genomes 
encode and regulate the diverse gene expression patterns that designate the type and 
state of each cell.  The fields of genomics, transcriptomics and epigenomics constitute 
the current leading elements in this type of research.  The ability to measure gene 
expression and protein-DNA interactions in a cell in a genome-wise manner plays a 
vital role in elucidation of the defining features of a cell, the instructional changes 
driving cell differentiation and the genetic regulatory networks that supervise gene 
function overall. 
 
1.6.1 A short history of DNA sequencing technologies 
“... [A] knowledge of sequences could contribute much to our understanding of living 
matter.” 
Frederick Sanger 
Since the fundamental discovery of the DNA structure (Watson and Crick, 1953), 
scientists envisioned to discover its sequence.  A major breakthrough in the field of 
DNA sequencing occurred with the development of the Sanger (Sanger et al., 1977) 
and Maxam Gilbert (Maxam and Gilbert, 1977) sequencing methods, which defined 
the first-generation of DNA sequencing technologies.  The Sanger method overruled 
the sequencing world at the time, due to its radiation-free methodology and, following 
developments in automation and parallelisation, finally led to the landmark completion 
of the first human genome sequence (Lander et al., 2001; Venter et al., 2001).  Soon 
after, genomes of the mouse and several other key model organisms were also 
sequenced (Mouse Genome Sequencing Consortium et al., 2002). 
Developed in the mid-to-late 1990s, microarray technology was the first to provide a 
highly parallel (or high-throughput) assay to measure DNA and RNA.  In principle, a 
reference set of probes (with a reference to known transcripts) is fixed in a chip and 
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the sample of interest is added (Lockhart et al., 1996; Schena et al., 1996; Southern et 
al., 1992).  The probes are then hybridised with fluorescently labelled cDNA and the 
fluorescent signal on the chip is used to infer the relative quantity of the probed 
sequences.  Microarrays became widely commercial and this significantly contributed 
to their broad application in many fields (Hughes et al., 2014; Lipshutz et al., 1999; 
Morozova et al., 2009; Stoughton, 2005).  However, microarrays face a number of 
limitations: reliance upon existing knowledge for probes does not allow de novo 
transcript identification, and the limited dynamic range of detection (because of 
background and saturation noise) cannot adequately represent the dynamic range of 
gene expression (Mortazavi et al., 2008; Wang et al., 2009). 
From the Human Genome Project onwards, the need to increase the throughput while 
reducing the cost of sequencing technologies became clear.  This was achieved with 
the development of next generation sequencing (NGS) methods.  This term is used to 
describe the technologies performing parallel sequencing of multiple DNA fragments 
to define a sequence (Rizzo and Buck, 2012).  In comparison with Sanger sequencing, 
NGS technologies produce an exponentially greater amount of DNA sequence data at 
a much higher speed, while the cost is significantly reduced (Voelkerding et al., 2009).  
Second generation sequencing methods became available from commercial 
technologies, namely Roche/454, Applied Biosystems SOLiD and Illumina Genome 
Analyser IIX (reviewed in Heather and Chain, 2016).  The NGS methodology of these 
technologies is based in common concepts.  The fragmented sample is initially 
amplified through the polymerase chain reaction (PCR), which reduces cost, time and 
species-specific bias compared to cloning.   Secondly, massive parallelisation is 
achieved via “sequencing-by-synthesis”.  Even though different technologies come 
with different detection chemistries, as a ground rule nucleotides are labelled (with 
chemiluminescence or fluorescence) and they release a chemical signal when they are 
correctly incorporated to the synthesised sequence (Margulies et al., 2005; Shendure 
et al., 2005). 
Third generation sequencing technologies are highly similar to the NGS technologies, 
however, instead of using amplified DNA for sequencing as a template, they use DNA 
molecules, thereby eliminating errors occurring in the lab at the DNA amplification 
stage (Munroe and Harris, 2010; Schadt et al., 2010).  The newest available 
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commercial technologies include Illumina HiSeq, Pacific Biosciences RS platform 
(English et al., 2012) and Oxford Nanopore (Mikheyev and Tin, 2014; Stoddart et al., 
2009).  In more detail, the PacBio platform uses zero-mode waveguides for single 
molecule real time sequencing (English et al., 2012), while Nanopore measures the 
signal change (i.e. current) when a molecule translocates through a protein nanopore 
(Stoddart et al., 2009). 
These technologies have developed side-by-side with the physical development of 
sequencing machines, the data analysis methods and the storage capabilities of the 
time.  One remaining limitation is the incapacity of these sequencing technologies to 
sequence long reads with high accuracy.  When a reference genome is available, 
computational advances can possibly overcome this issue.  However, sequencing 
novel genomes or novel transcripts remains challenging.  The PacBio platform and 
more prominently nanopore-based technologies are currently making efforts in that 
direction (English et al., 2012; Mikheyev and Tin, 2014; Stoddart et al., 2009). 
Currently, large scale sequencing can be performed for any DNA sample, whether 
from reverse-transcribed RNA, whole genome or amplified DNA by other methods.  
Integration of the generated big data enables investigation of cell regulation from many 
different aspects, such as transcription dynamics (RNA sequencing; RNA-seq), 
transcription factor binding and epigenetic modifications (Chromatin 
immunoprecipitation coupled with sequencing; ChIP-seq, DNA adenine 
methyltransferase identification assay coupled with sequencing; DamID-seq, Assay 
for Transposase-Accessible Chromatin using sequencing; ATAC-seq) and genome 
variations in a population (whole-genome sequencing and assembly).  All the above 
applications have mostly been facilitated by improvements focusing on the library 
preparation and sensitivity, while newer applications are now focusing on the single 
cell level.  Single cell RNA-seq (scRNA-seq) is perhaps the most prominent technique 
nowadays for the investigation of population heterogeneity that cannot be denoted 
from the average population profile of the RNA-seq (Grün and van Oudenaarden, 
2015; Kolodziejczyk et al., 2015; Liu and Trapnell, 2016; Saliba et al., 2014).  For the 




1.6.2 RNA-seq data processing for novel biological insight 
RNA-seq typically produces millions of sequenced reads that represent the average 
transcriptome profile of a cell population.  These data must be analysed in order for 
useful biological insights to be extracted.  A major challenge with analysis of the RNA-
seq data comes with assembling the millions of short reads into a map of non-
contiguous sequences on a genome-wide scale.  Two approaches can be recruited to 
reconstruct the transcriptome from RNA-seq data.  Transcribed sequenced reads can 
be mapped to a reference genome and overlapping alignments can be used to merge 
these sequences; or reads can be assembled as continuous transcripts de novo without 
the use of a reference genome. 
Read mapping using a reference genome has traditionally been the most common 
method to reconstruct the transcriptome.  This method increases sensitivity of the 
assembly, since lowly expressed genes may have very low coverage, making them 
insufficient for de novo assembly.  One of the hardest computational tasks in RNA-
seq read alignment is sequence non-contiguity due to introns (the non-coding sections 
of the RNA transcript) intersections.  A number of sequence aligning tools, namely 
Tophat (Trapnell et al., 2009), STAR (Dobin et al., 2013) and HISAT (Kim et al., 
2015) have introduced memory efficient and considerably fast ways to incorporate 
splice junctions allowing reliable merging of non-continuous reads.  As a next step, 
overlapping aligned reads are merged into putative transcripts and quantified.  For this 
quantification, regions that constitute a gene need to be inferred and ambiguously 
aligned reads or different isoforms have to be dealt with.  Various quantification 
methods have been proposed, ranging from simple counting of reads that overlap using 
prior information of annotated gene regions to more complex modelling of transcript 
isoforms abundances.  A few tools have been developed to perform “simple” counting, 
such as featureCounts (Liao et al., 2014) and HTSeq-count (Anders et al., 2015).  More 
recent methods have aimed at quantifying individual transcripts abundances, namely, 
Cufflinks (Trapnell et al., 2012) , RSEM (Li and Dewey, 2011), BitSeq (Glaus et al., 
2012), kallisto (Bray et al., 2016) and Salmon (Patro et al., 2016).  These approaches 
offer higher resolution compared to simple counting, while by skipping the 
computationally costly read mapping step, some (notably, kallisto and Salmon) 
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achieve very high execution speed.  However, calculating abundance of gene isoforms 
can be a lot more challenging and complex due to the high extent of overlap among 
transcripts.  Therefore, so far there is no agreement in the optimal resolution (or 
approach) for quantification of gene levels and downstream analysis. 
Mapping reads against a reference genome may result in potential information loss due 
to genetic diversity that may be apparent in a species and which cannot be represented 
in a linear reference genome.  Thus, de novo assembly constitutes an important 
alternative method to use, importantly when significant differences are apparent 
between the reference and the individual transcriptome.  Such variations may be splice 
isoforms, point mutations, indels (insertions or deletions) or significant alterations of 
the genome/transcriptome in e.g. cancer studies.  However, the main limitation of the 
de novo assembly method is that poor quality reads can result in accuracy loss of the 
transcriptomic output.  The computational hurdle of transcriptome alignment has been 
overcome by breaking down the long sequenced reads into substrings of length k (k-
mers) and then constructing graphs (called de Bruijn graphs), in which k-mers are 
represented by nodes and transcripts can be defined by following any route defined by 
the edges which constitute immediately overlapping k-mers (k-1 bases) (Compeau et 
al., 2011; Grabherr et al., 2011).  Reads are then mapped to compatible transcripts 
creating a pseudo-alignment (in which exact coordinates of the match are not kept), 
and their quantification happens through expectation maximisation procedures (see 
kallisto; Bray et al., 2016). 
The next step after transcript reconstitution and quantification is to gain useful insight 
from the experiment, by comparing gene expression profiles and selecting the genes 
that present significant changes in association with a specific condition for further 
analysis.  To discern significant from non-significant changes (often caused by 
technical variation in the measurements), a statistical model needs to be incorporated 
to best fit the nature of the RNA-seq data.  This model should account for the discrete 
nature of the RNA-seq data, differences in variance across the expression mean and 
expression intensity levels that are contingent on expression levels of other genes.  The 
Poisson model can appropriately model RNA-seq data, by describing read sampling 
from a fixed pool of genes.  A drawback of this model is that it considers an equal 
mean and variance for the data, which is not representative of RNA-seq data.  The 
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variation instead tends to be larger than the mean and also dependent on the mean 
(Marioni et al., 2008; Nagalakshmi et al., 2008; Rapaport et al., 2013).  Therefore, 
tools such as DESeq and EdgeR use a negative binomial distribution that incorporates 
a dispersion factor and estimate dispersion based on mean expression intensity from 
other genes in the samples because of the generally low number of sample replicates 
(Anders and Huber, 2010; Robinson et al., 2010).  Unlike the aforementioned tool, the 
voom function from limma represents expression intensity as a continuous variable 
and estimates the variance of expression intensity by applying non-parametric 
regression and incorporates it into a linear model (Law et al., 2014). 
At present, none of the above tools (or models) have demonstrated a major advantage 
in terms of accuracy or sensitivity of the differential expression analysis over the 
others,  and all of them are commonly used for RNA-seq analysis (Rapaport et al., 
2013; Seyednasrollah et al., 2015). 
 
1.6.3 ChIP-seq data processing for novel biological insight 
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) produces 
millions of sequenced reads that represent the average binding profile of a protein 
(transcription factor; TF, histone modification mark; HMM, DNA-binding enzyme, 
chaperone or nucleosome) in a population of cells (Barski et al., 2007; Johnson et al., 
2007; Mikkelsen et al., 2007; Robertson et al., 2007).  Main advantages of the NGS 
technologies are relatively high mapping resolution, low noise and adequate genomic 
coverage, in comparison to ChIP coupled with microarray hybridization (ChIP-chip) 
assays.  For all the above reasons, ChIP-seq is currently the most widely used method 
for locating protein-DNA interactions in genome-wide assays (Furey, 2012) and 
locating histone modification positions in epigenetics research. 
A major challenge with the analysis of ChIP-seq data is that sufficient coverage needs 
to be provided by the sequenced reads (depth of sequencing) for the data analysis to 
be meaningful.  The two main factors that influence sequencing depth are the number 
and size of the protein binding sites and the size of the genome.  For transcription 
factors (TFs) present in mammals and chromatin modifications associated with gene 
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promoters that mark narrow sites at specific locations, 20 million reads may be 
adequate (with a much lower number of reads required for worm and fly TFs) (Landt 
et al., 2012).  However, for factors with more binding sites (e.g. RNA Pol II), including 
most of the histone marks, more reads will be required, up to 60 million reads for 
mammalian genomes (Chen et al., 2012).  Importantly, to ensure sufficient coverage 
of the genome, control samples should be sequenced in higher depth than the factor 
under investigation. 
Read mapping of ChIP-seq data to a reference genome is highly similar to RNA-seq, 
however, detection of indels is not a prerequisite for most ChIP-seq experiments.  
Popular ChIP-seq aligners include Bowtie2 (Urban, 2014), BWA (Li and Durbin, 
2009), SOAP (Li et al., 2008b) and MAQ (Li et al., 2008a), which use heuristics to 
improve mapping speed and reduce the memory footprint of the alignment.  For ChIP-
seq analysis, it is important to examine the percentage of the uniquely mapped reads 
(reads that map in only one location in the genome) reported by the aligner.  A low 
percentage of uniquely mapped reads can be indicatory of technical bias, such as 
excessive PCR amplification, inadequate read length, sequencing platform-specific 
issues.  A potential cause of a high percentage of “multi-mapping” reads (reads that 
confidently map in more than one locations in the same genome) for some ChIPed 
proteins is due to biological reasons (e.g. binding in repetitive DNA).  In this latter 
case, mapping ambiguity can be improved using paired-end sequencing.  As a ground 
rule, most peak-calling algorithms will discard multi-mapping reads for increased 
sensitivity although they can often lead to the discovery of new binding sites (Wang 
et al., 2013), while duplicated reads (reads map in the exact same location) also need 
to be removed prior to peak calling to improve specificity. 
A pivotal component of the ChIP-seq analysis is to identify the ChIPed regions that 
are significantly enriched (peaks) above background.  A fine balance needs to be 
achieved between specificity and sensitivity when choosing a peak-calling algorithm 
based on the type of protein that is ChIPed, with signal smoothing and background 
modelling to be the main focus areas for several peak calling tools.  For point-source 
factors (such as most TFs), which are the most abundant type of available ChIP-seq 
data, peak callers have been fine-tuned to fit the nature of them.  Peak callers, such as 
SPP (Kharchenko et al., 2008) and MACS (Zhang et al., 2008), calculate the footprint 
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of the ChIPed protein from the mapped reads in the minus and the plus strand of the 
bound region.  By making sure that the footprint differs from the read size selection 
during library preparation, they can improve accuracy of the prediction.  After signal 
smoothing, background models remove noise either directly using a control sample, or 
indirectly based on features of the genomic landscape, such as mappability and GC 
content (Cheung et al., 2011).  A user-defined threshold is set to finally call peaks.  
Multiple statistical models have been designed to fit the nature of the ChIP-seq data, 
namely, negative binomial (CisGenome Ji et al., 2008), inflated negative binomial 
(ZINBA; Rashid et al., 2011),  Poisson (CSAR; Muiño et al., 2011), local Poisson 
(MACS), and more sophisticated machine learning modelling techniques (Qin et al., 
2010; Spyrou et al., 2009).  Additionally, a few peak callers, such as PeakSplitter 
(Salmon-Divon et al., 2010) and GPS (Guo et al., 2010) use the peak shape as a clue 
to improve the spatial resolution of the binding and avoid erroneous merging of 
neighbouring peaks from peak callers that use window-based approaches.  For broadly 
enriched factors (such as histone modification marks), several peak calling tools have 
been adjusted to identify broadly enriched regions, including SICER (Zang et al., 
2009),  CCAT (Xu et al., 2010), RSEG (Song and Smith, 2011) and ZINBA.  Few of 
the narrow peak callers such as SPP, MACS version 2 (MACS2), and PeakRanger 
(Feng et al., 2011) can also be used to call broad peaks by adjusting their bandwidth 
(longer regions) and peak “cut-off” (more relaxed thresholds), while MACS2 and 
Scripture (Guttman et al., 2010) allow for the option of identifying an enriched narrow 
peak inside an already enriched broad peak identifying a more hierarchical pattern of 
peaks.  Lastly, for factors that bind to DNA regions with bigger variation (such as 
RNA Pol II) some tools (see SPP, MACS2 and ZINBA) offer both narrow and broad 
peak calling choices based on the question that needs to be addressed.  However, with 
careful parameter adjustments, any algorithm that identifies broad peaks could be used 
in this case. 
User-settable parameters among the different peak callers can greatly influence the 
number and the quality of the enriched peaks.  One of the most important parameters, 
the enrichment metric of the peak calling algorithm, such as the p-value or the false 
discovery rate (FDR), can be greatly influenced by the statistical model that each 
tool/algorithm uses.  Therefore, using the same enrichment metric thresholds does not 
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lead to comparable results (number of peaks) among different peak callers (Szalkowski 
and Schmid, 2011).  Instead, a more consistent approach of filtering significant peaks 
from non-significant ones, is to threshold the irreproducible discovery rate (IDR; Li et 
al., 2011a).  This method assesses the rank consistency of enriched peaks among 
replicates and peaks consistent above a user-specified IDR threshold are considered 
consistently enriched and more likely to constitute true ChIPed peaks.  It has been 
reported that the numbers of peaks declared using a reproducibility threshold (e.g. 
IDR) metric rather than an enrichment-based one (e.g. p-value or FDR) are more 
comparable across experiments (Landt et al., 2012).  Importantly, at least two 
biological replicates are recommended in such ChIP-seq experiments (Landt et al., 
2012) to ensure reproducibility of the identified peaks. 
 
1.6.4 NGS and data storing 
 
A major advantage in studies involving next generation sequencing datasets has been 
the standardisation of procedures for storing and sharing data.  Genome browsers, such 
as UCSC (Kent et al., 2002) and Ensembl  (Yates et al., 2016), make feasible the 
exploration of newly generated genomic, transcriptomic, epigenomic and proteomic 
datasets.  These datasets can be mapped onto whole-genome coordinates that exist as 
centralised repositories, the genome assemblies, providing a lot of useful insight to any 
researcher.  Continuous updates of these annotation packages make sure that the 
information keeps up-to-date.  In 2012, the Encyclopaedia of DNA Elements 
(ENCODE) project (Dunham et al., 2012) was released, providing a significant update 
in respect to the function of 80% of the genome. 
Since the information generated from a high-throughput experiment reaches beyond 
the detailed questions dealt in publications, these large scale sequencing data are stored 
in standardised repositories, such as NCBI’s Gene Expression Omnibus (Barrett et al., 
2013) and ArrayExpress (Kolesnikov et al., 2015) to support reproducible research.  
The benefits of data storage and public availability can become more obvious when it 
is put in the context of other data in future research. 
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In summary, an extraordinary leap has been produced in the last 10-15 years in the 
capacity to sequence, store and share insight from sequencing experiments.  Although 
some challenges still remain to achieve optimal experiment standardisation, including 
downstream information processing and storage, the next generation sequencing field 
is an ever growing resource with an extremely powerful reserve to the scientific 
community. 
 
1.6.5 Understanding gene regulatory mechanisms through RNA-
seq and ChIP-seq data integration 
The collection of genome-wide data from various samples, such as cells, tissues or 
model organisms has been made easier and cheaper with the use of high-throughput 
technologies.  Transcriptomics, genomics, epigenomics and proteomics data each 
provide an insightful, yet singular point of view.  Therefore, integrative analysis of 
these datasets can provide a more unified, global view of gene function (discussed in 
Angelini and Costa, 2014).   This section will briefly discuss how the interplay between 
gene expression and transcription factor binding/epigenetic markers presence can help 
to elucidate gene regulatory mechanisms. 
RNA-seq data provide a clear picture of the gene expressional profile in an average 
cell population.  However, sole nucleotide sequences of expressed genes cannot 
explain their function, nor their regulation.  Genes DNA structure and accessibility to 
available transcription factors and the basal transcription machinery specifies their 
transcription.  Transcription factors, chromatin-modifying enzymes and other 
accessory proteins physically interact with DNA to modulate gene expression 
dynamics and define the cell fate (Atkinson and Halfon, 2014).  Recent studies 
demonstrate that TF and histone modification binding can predict expression of genes 
in vitro, cells’ differentiation state and other epigenetic factors (Cheng et al., 2011, 
2012; Creyghton et al., 2010; Karlić et al., 2010; McLeay et al., 2012; Ouyang et al., 
2009).  Similarly, changes in gene expression have been correlated to TF binding and 
chromatin mark modifications (Althammer et al., 2012; Klein et al., 2014).  In terms 
of the potential impact on cell state, global (and local) chromatin changes accompany 
cell differentiation, leading to silencing of pluripotency genes and activation of 
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lineage-specific ones (Chen and Dent, 2014).  In this respect, multi-omic integrated 
data can be used to explore the heterogeneity of cell populations and explain or even 
potentially control differentiation of cells during development (Comes et al., 2013; 
Macaulay and Voet, 2014). 
Prediction of gene expression is possible using a limited number of samples (with 
replicates), however this is not the case for large gene regulatory networks.  To infer 
these networks, several high-throughput datasets need to be integrated together (shown 
by  Gerstein et al., 2012).  Nevertheless, less complicated networks that rely only on 
few factors and interactions can be predicted using fewer datasets.  For instance, a 
minimal set of components was sufficient to describe self-renewal of embryonic stem 
cells (Dunn et al., 2014). 
Two different approaches can be used to achieve data integration: unsupervised and 
supervised.  The unsupervised approach excels at generating hypotheses without any 
prior knowledge through discovery of patterns using different types of clustering.  
These novel patterns can be used to make and test predictions with further datasets or 
experiments.  This is where the supervised integration can become most informative, 
relying on a few dimensions of the different datasets to apply testable hypotheses of 
the question posed.  Therefore, the more predictive the hypothesis, the more insightful 
the biological result.  Collectively, data integration itself does not constitute the final 
step in an analysis: it aims to generate novel hypotheses and assist in their testing. 
Overall, next generation sequencing technologies have evolved over the years and they 
now offer quick and in depth investigation of cells transcription profile, binding 
occupancy and accessibility landscape at a reduced cost.  Integration of the above 
datasets together can lead to more predictive hypotheses and more biological insights 
that are necessary to formulate testable experimental models for validation and to drive 





1.7 PROJECT AIMS AND THESIS STRUCTURE 
This thesis aims to improve the current understanding of the transcriptional, regulatory 
and signalling mechanisms in fetal thymic epithelial cell (TEC) progression during 
thymus organogenesis in the mouse embryo, by dint of bioinformatics analysis.  The 
objectives of this thesis and the structure of the chapters are laid out here, to provide a 
roadmap of the main points that are addressed in Chapters 3-7. 
One of the main challenges in the thymus field is to decipher how thymic epithelial 
progenitor cells (TEPCs) differentiate towards the cortical and medullary TEC 
lineages (cTECs and mTECs) during thymus organogenesis in mouse.  The current 
model (see outline in Takahama et al., 2017) of TEC differentiation describes a 
homogeneous bipotent progenitor population at E12.5 (when Foxn1 expression has 
already been established), which differentiates in a serial fashion towards the cTEC 
and mTEC lineages, after going through a preliminary stage, in which all cells express 
cTEC-like markers.  In Chapter 3, I use transcriptional datasets, representative of fetal 
TEPC and newborn TEC populations, to: a) explore the impact of different Foxn1 
levels on the progression of TEPCs, b) identify which developmental stage better 
resembles the bipotent TEPCs found in Foxn1-depleted samples, c) investigate a 
potential repressive role for FOXN1 in early fetal differentiation and d) predict a gene 
signature representative of the early bipotent progenitors.  These bioinformatics 
findings are used in combination with experimental evidence (provided by members 
of the Blackburn lab) to inform an improved version of the current TEPC progression 
model. 
TEPC exploration is currently limited by the small amounts of in vivo material that 
can be obtained from the developing thymus of mouse embryos.  To achieve expansion 
of the bipotent TEPC population in vitro, the experimental conditions in which these 
cells are kept (when in culture) would have to be fine-tuned and optimised, for cells to 
survive and expand in a more efficient way.  Thus, in Chapter 4, I use comparative 
transcriptomic analysis in conjunction with pathway enrichment analysis to predict the 
intrinsic and extrinsic signalling cues that act on the early undifferentiated TEPC state 
in vivo.  Among the predicted pathways, NOTCH signalling is identified as 
dynamically regulated in early fetal TEPCs.  In the same chapter, further experimental 
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(Dong Liu) and bioinformatics exploration of NOTCH signalling is performed, to 
explore its role in early TEPC development. 
FOXN1 comprises the central regulator of the thymic system, with its expression to be 
indispensable for the development of a functional thymus.  However, until recently,   
direct evidence for its immediate targets was lacking.  In Chapter 5, I am using 
integrative analysis of transcriptomic, genomic and epigenomic datasets to investigate 
the regulatory network, through which FOXN1 establishes the transcriptional 
programme that underpins thymic epithelial cell identity and function.  In this analysis, 
I will a) compare the chromatin accessibility landscape of fetal TEPCs with the binding 
events of FOXN1 in newborn TECs to identify a list of a high confident FOXN1 
candidate direct targets in fetal TEPCs, b) anticipate regulation of active signalling 
pathways in TEPCs via the FOXN1 predicted targets, c) explore how FOXN1 and 
NOTCH signalling may interact during fetal thymus development and d) discuss a  
potential role for FOXN1 to act as a pioneer factor and thus have the ability to impose 
TEC identity. 
The amount of high-throughput sequencing datasets of the various stromal 
subpopulations, which reside in the thymus, are currently limited and thus, field 
research could be set back due to insufficient expressional or regulatory insight in these 
populations.  For this cause, in Chapter 6, I introduce the development of ThymiBase, 
an interactive thymic-specific database that provides a platform for easy access, 
analysis and integration of curated bioinformatics datasets focussed on the thymic 
epithelium. 
To end, Chapter 7 presents a summarised overview of Chapters 3-6.  Additionally, 
it integrates together the FOXN1-NOTCH interplay (Chapters 4 and 5) with the 
revised version of the TEPC progression model in the fetal TEPCs (Chapter 3), to 
propose potential mechanisms through which TEPC specification in the cTEC and 



































Materials and methods 
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Chapter 2  
 





The first part of Chapter 2 (Data Repository) describes the biological designs and 
technical specifications of the different high-throughput sequencing datasets (provided 
by others) that I have computationally analysed for the purposes of this thesis.  The 
second part of Chapter 2 (Bioinformatics Analysis) presents in detail the RNA-seq 
and ChIP-seq pipelines that I have built to analyse the above data, as well as the post-
processing normalisation steps that I have followed to fully refine these data and 












2.2 DATA REPOSITORY 
The first part of Chapter 2 is a detailed record of the experimental designs for all the 
next generation sequencing (NGS; Behjati and Tarpey, 2013) datasets presented in this 
thesis.  Three main types of NGS data have been available for this project: 
transcriptomic, genomic and epigenomic data, which have been categorised and are 
described extensively below. 
 
2.2.1 Collection of transcriptomic datasets in mouse (RNA-seq) 
For the purposes of this project, RNA-seq datasets from thymic epithelial progenitor 
cells (TEPCs) and thymic epithelial cells (TECs) from fetal, newborn and adult mice 
have been generated by other members of the Blackburn lab or have been collected 
through public repositories.  A descriptive listing of all the RNA-seq samples 
(grouped in various series of experiments), their experimental designs and 
specifications is provided below. 
 
2.2.1.1 A Developmental series of fetal TEPC data 
RNA was obtained from EpCAM+PLET1+ TECs from fetal mice at days E10.5, E11.5 
and E12.5 of embryonic development (biological triplicates per day) by Harsh 
Vaidya, Blackburn lab (unpublished) and samples were sent for sequencing.  
EpCAM+PLET1+ mark the early developmental stages of the thymic epithelium and 
have been linked to progenitor activity of TECs (Depreter et al., 2008; Farr and 
Anderson, 1985). 
 
2.2.1.2 A Foxn1 Allelic series of fetal TEPC data 
RNA was obtained from EpCAM+PLET1+ TECs from fetal mice of different 
genotypes at day E12.5 of embryonic development (one biological replicate per 
genotype) by Stephanie Tetelin, Blackburn lab (unpublished) and samples were sent 
for sequencing.  In short, the mice genotypes contain variants of a Foxn1 normal allele 
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(Foxn1WT) and a Foxn1 revertible hypomorphic allele (Foxn1R).  For the generation of 
the Foxn1R allele, a LoxP flanked cassette was inserted into intron 1b of the Foxn1 
locus through homologous recombination in embryonic stem (ES) cells (see right 
panel in Figure 2.1) and this ES line was used to generate the Foxn1R mouse strain 
(see Nowell et al., 2011 for more details).  Precisely, five allelic combinations of the 
Foxn1WT and Foxn1R alleles resulted, Foxn1+/+ (WT), Foxn1R/+ (R/+), Foxn1+/- (Het), 
Foxn1R/R (R/R), Foxn1R/- (R/-).  Additionally, E12.5 TECs were also obtained from 
Foxn1nu/nu (Nude) mice, in which a targeted disruption of the Foxn1 locus has been 
used (Nehls et al., 1996).  RNA obtained from TECs isolated from Nude mice 
represent the transcriptional profile of these cells in the complete absence of Foxn1.  
Relative levels of expression for the WT, R/+, R/R, R/- and Nude samples are shown 
in Figure 2.1 (left panel). 
 
2.2.1.3 An RBPJ-mutant series of fetal TEPC data 
Foxn1Cre mice were crossed with an Rbpj conditional knockout (cKO) line (Dong Liu, 
Blackburn lab), creating a mouse model line (Foxn1CreRbpjFl/Fl mice), where RBPJ 
was absent from all TECs (Rbpj exon deletion is under the control of Foxn1 promoter).  
RNA was obtained from EpCAM+PLET1+ wild type (WT) and Foxn1CreRbpjFl/Fl 
(RBPJ cKO; loss-of-function; LOF) TEPC at E12.5 (3 biological replicates per 
dataset) and PLET1+ and PLET1- TEPC at E14.5 (3 biological replicates per 
dataset) by Dong Liu; Blackburn lab (Liu et al., 2017, submitted) and samples were 
sent for sequencing.  EpCAM+PLET1+ mark the early developmental stages of the 
thymic epithelium and have been linked to progenitor activity of TECs.  The cell 
populations analysed were chosen since, at E12.5, although the PLET1+ TEPC 
population is already heterogeneous, and will contain cortical TEC (cTEC)-fated cells 
along with common TEPCs and potentially medullary TEC (mTEC)-restricted 
progenitors, it cannot be split on the basis of known cell surface markers.  At E14.5 
prospective mTECs appear to be contained within the PLET1+ population, while 




2.2.1.4 TEC subpopulations from newborn and adult mice  
Raw RNA-seq data for cortical (sorted for CD45-EpCAM+Ly51+UEA1-) and 
medullary (sorted for CD45-EpCAM+Ly51-UEA1+) TEC populations from newborn 
(7 days old) mice (one biological replicate per population) were obtained from the 
GEO public repository (Barrett et al., 2013), under the GEO accession number: 
GSE44945 (generated by St-Pierre et al., 2013).  To isolate these populations, thymic 
stromal cells were stained for antibodies (Abs) against CD45, EpCAM and Ly51 and 
for the plant lectin ulex europeus agglutinin-1 (UEA-1).  CD45 is a hematopoietic pan-
epithelial marker expressed by both hematopoietic stromal cells and thymocytes.  
Unlike thymocytes, TECs that are not of hematopoietic origin do not express this 
marker (Rodewald, 2008).  Ly51 Ab recognizes a glutamyl-aminopeptidase that is 
solely evident in cTECs, while mTECs uniquely bind the plant lectin UEA1 (Gray et 
al., 2002).  Additionally, raw RNA-seq data for similarly sorted cTEC and mTEC 
populations (biological duplicates per population) from newborn (7 days old) mice 
were also obtained from the GEO public repository, under the GEO accession number: 
GSE53110 (generated by Sansom et al., 2014).  These cells, however, were also 
sorted for the MHCII marker; MHCII can be used to mark specifically mature TECs 
(Jenkinson et al., 1981).  In respect to this, Yang et al. (2006) demonstrated that the 
majority of 1 week old cTECs and  mTECs express MHCII markers.  Thus, these data 
were used as biological replicates of the St-Pierre generated datasets and combined 
together for further analysis.  Under the same GEO accession number (GSE53110, 
generated by Sansom et al., 2014), RNA-seq data from immature (CD45-
EpCAM+MHCIIloLy51-UEA1+), mature (CD45-EpCAM+MHCIIhiLy51-UEA1+), 
mature AIRE+, mature AIRE- and mature AIRE knock-out from 4 week old mice 
(biological duplicates per population) were also retrieved.  AIRE has been found to 
lead promiscuous gene expression of tissue-related antigens (TRAs) in mTECs, which 
essential for T-cell maturation and it is used here as a marker to further subdivide 




2.2.2 Collection of regulatory datasets in mouse (ChIP-seq) 
For the purposes of this project, ChIP-seq datasets of TECs from newborn mice were 
obtained from public repositories. 
 
2.2.2.1 A FOXN1-flagged peptide protein dataset in adult TECs 
Raw ChIP-seq data for the FOXN1 protein tagged with an octapeptide (biological 
duplicates) were obtained from the GEO public repository, under the GEO accession 
number: GSE75219 (generated by Žuklys et al., 2016).  In more detail, the FOXN1-
tagged protein was expressed under the control of the Foxn1 promoter in TECs of nude 
mice (Foxn1nu/nu) using a bacterial artificial chromosome (BAC).  The genotype of 
homozygous mice expressing the fused FOXN1 protein is represented as Foxn1wt*/wt* 
(details of the targeting strategy are shown in Figure 2.2).  Chromatin 
immunoprecipitation was performed with the M2 anti-FLAG antibody (F1804; Sigma) 
against the FOXN1-flagged peptide in sonicated DNA obtained from enriched TECs 
(using magnetic beads) from digested thymic lobes from 1 week old Foxn1wt*/wt* (see 
Chapter 1, section 1.2.5.3 for mice phenotypic details), and input samples were 












Figure 2.1: Relative levels of expression for the Foxn1WT and Foxn1R variants and schematic 
representation of the Foxn1R design.  (Left) QRT-PCR analysis was used to determine the relative 
levels of Foxn1 expression on E12.5 with the Sybr-Green method in 5 different samples: Foxn1+/+ (WT), 
Foxn1R/+ (R/+), Foxn1R/R (R/R), Foxn1R/- (R/-) and Foxn1nu/nu (Nude) and a no RT control.  The geometric 
mean of three housekeeping genes was used to normalise for the Foxn1 expression levels.  (Right) 
Foxn1R hypomorphic allele design: Making use of ES cells and homologous recombination, a LoxP 
flanked cassette was inserted into intron 1b at the Foxn1 locus.  These cells were used to create a 
Foxn1R mouse strain (reproduced from Nowell et al., 2011). 
 
 
Figure 2.2: Schematic representation of the FOXN1-tagged protein design construct.  A cDNA 
encoding Foxn1 fused with three Flag sequences at its C-terminus, designated Foxn1-Flag was placed 
in exon 2 of the normal Foxn1 locus through homologous recombination of a bacterial artificial 









2.2.3 Collection of accessibility datasets in mouse (ChIP-seq) 
For the purposes of this project, ChIP-seq datasets of TEPCs from fetal mice were 
generated in the lab. 
 
2.2.3.1 Histone modification data from fetal TEPCs 
Chromatin immunoprecipitation was performed with antibodies specific for tri-
methylation of lysine 4 on histone H3 (H3K4me3) and acetylation of lysine 27 on 
histone H3 (H3K27ac) and core histone H3 (panH3; used as control) in sonicated DNA 
obtained from EpCAM+PLET1+ TECs from mice at day E12.5 of embryonic 
development (biological duplicates per histone modification) by Harsh Vaidya, 
Blackburn lab (unpublished) and samples were sent for sequencing.  Histone 
modifications are covalent post-translational modifications that occur in histones and 
can influence the higher order of chromatin structure.  Specific modifications lead 
genome compartmentalisation into distinct domains, such as transcriptionally active 
euchromatin or transcriptionally silent heterochromatin (summarised by Martin and 
Zhang, 2005).  Therefore, histone modification marks can be used to assess gene 
expression and transcription factor occupancy.  All above marks are related to open 
chromatin configuration and are thus characteristic of euchromatin regions.  In 
particular, H3K4me3 marks are present in active promoters (Heintzman et al., 2007), 
while H3K4me1 and H3K27ac marks are often used in combination to provide a robust 
readout of active enhancers in the genome (Creyghton et al., 2010; Heintzman et al., 
2009; Rada-Iglesias et al., 2011; Zentner et al., 2011).  PanH3 marks all H3 histones 
in the genome, offering a uniform background to identify enrichment of histone 
modification marks.  EpCAM+PLET1+ mark the early developmental stages of the 
thymic epithelium and have been linked to progenitor activity of TECs (Depreter et 







2.3 BIOINFORMATICS ANALYSIS AND WORKFLOWS 
This section presents the generic bioinformatics pipelines that have been put together 
to pre-analyse the RNA-seq and ChIP-seq datasets provided, as well as the core 
processing analysis steps that have been undertaken in order to remove sources of 
technical bias in the aforementioned datasets.  Representative graphs of the RNA-seq 
and ChIP-seq pre-analysis and core analysis pipelines are provided at the end of each 
section. 
 
2.3.1 A common pre-analysis step in the RNA-seq and ChIP-seq 
analysis pipelines 
 
2.3.1.1 Raw reads quality control 
The FastQC tool (version 0.11.5, Andrews, 2010) was used to inspect the raw read 
files (saved in FASTQ format, Cock et al., 2010) of all the datasets described in section 
2.2  to decide if the sequenced reads require further trimming before aligning them to 
the genome.  FastQC is a commonly used tool that assesses the sequences quality and 
GC content of the reads, as well as, the presence of adapters and overrepresented k-
mers.  Quality control by FastQC suggested few low-quality reads and a small amount 
of adapter contamination in most of the samples, so low quality reads had to be 
removed and the remaining reads had to be trimmed of adapter sequences with 
Trimmomatic using default parameters (version 0.32, Bolger et al., 2014).  For single-
end (SE) or paired-end (PE) reads, the SE/PE parameter was selected accordingly.  
Also, when adapter contamination from a specific technology was detected, the pre-
set adapters were used to trim the reads; in the case that the adapter’s origin was not 
identified, reads were trimmed for the over-represented sequence detected.  Post-
trimmed reads were assessed by FastQC once again to verify that adapters and low-
quality reads had been removed properly and that trimming did not introduce any bias 
itself (for a representative diagram see upper section in Figure 2.3 or Figure 2.6). 
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2.3.2 RNA-seq pre-analysis pipeline 
 
2.3.2.1 Mapping reads to genome 
Trimmed reads that passed QC (section 2.3.1.1)  were aligned against the GRCm38.p5 
(mm10) Mouse assembly (downloaded from GENCODE – release M12) with STAR 
Aligner (version 2.5.1a, Dobin et al., 2013).  STAR is a splice aware read aligner that 
uses a RAM-intensive approach which significantly increases its mapping speed, 
allowing this tool to perform equally well or better than newer aligners such as 
HISAT2 (Kim et al., 2015), while it has also outperformed all tools of its time 
(reviewed in Baruzzo et al., 2016).  In the same review, STAR also managed to identify 
the highest percentage of correctly aligned reads using its default parameters, an 
important feature that an aligner need to possess, since there is no clear way for 
parameters optimisation in real data.  STAR ran with default parameters except for the 
--runThreadN parameter, which was set to 32 (the maximum number of double 
precision tasks that our computer facility can run in parallel; 8 processors x 4 cores 
each) to increase execution speed even more.  The comprehensive ENCODE 
annotation file for the GRCm38.p5 assembly which contains gene annotation on the 
reference chromosomes in a general transfer format (GTF) was downloaded from 
GENCODE (Harrow et al., 2006, release M12) and incorporated in the run, in order to 
extract splice junctions of the genome and improve the accuracy of the mapping. 
 
2.3.2.2 Quantification of gene counts 
The featureCounts program (version 1.5.1, Liao et al., 2014) was used to quantify the 
gene expression levels from the STAR-aligned files by counting the number of mapped 
reads per gene based on a GTF file (the same one used in section 2.3.2.1) that includes 
the gene coordinates for the GRCm38.p5 assembly.  featureCounts was executed with 
default parameters. 






Figure 2.3: Overview plot of the RNA-seq pre-analysis pipeline.  In this pipeline, each step shows 
the type of analysis performed and the specific tool that was selected when the workflow was executed.  
Raw reads are assessed with FastQC (Andrews, 2010) for different types of bias (shown in red), namely, 
high sequence quality, organism specific GC content, absence of adapters, absence of overrepresented 
k-mers and normal duplication rate.  Reads which fail to qualify for any of the quality control (QC) criteria 
above are removed with Trimmomatic (Bolger et al., 2014).  After read trimming with Trimmomatic, reads 
which passed QC are reassessed with FastQC to ensure no bias has been introduced (see section 
2.3.1.1 in the main text).  Reads which passed QC are then mapped to the provided genome assembly 
(GRCm38) with STAR aligner (Dobin et al., 2013; see section 2.3.2.1 in the main text) and gene counts 
are quantified with featureCounts (Liao et al., 2014; see section 2.3.2.2 in the main text) before raw 






2.3.3 RNA-seq core analysis pipeline 
 
2.3.3.1 Low gene counts 
The gene count tables per data series (for details see section 2.2.1) calculated with 
featureCounts (section 2.3.2.2) were imported into R and were converted into 
DGEList objects (edgeR package, Robinson et al., 2010) for further processing.  The 
majority of these genes were not expressed at a biologically meaningful extent across 
all samples (per dataset) and had to be removed prior to downstream analysis to reduce 
the number of genes that would be investigated, as well as the number of tests that 
would be performed.  To define the cut-off value under which genes would be 
discarded, the distribution of the log2-transformed counts per million (CPM) values 
for each of the transcriptomic datasets was inspected with the density function in R.  
Inspection of the resulting density plots showed that a large proportion of genes were 
unexpressed or very lowly expressed (see example plot in the left panel of Figure 2.4).  
The CPM threshold for each dataset was chosen based on each dataset’s density plot 
to sensibly separate non-expressed or lowly expressed genes from genes which are 
expressed.  A threshold of 1 was selected for all data series; this is also the suggested 
threshold in the RNA-seq Bioconductor tutorial for limma, Glimma and edgeR (Law 







Figure 2.4: Density plots of the log2-transformed CPM values from example datasets.  Density 
plots depict distribution of gene counts before (A) and after (B) filtering of the data based on a given 
expression (log2-CPM) threshold.  This threshold is chosen on the grounds of removing unexpressed or 
very lowly expressed genes across all samples, while maintaining genes that are expressed in at least 
in one of the samples, or in at least one of the sample groups if replicates are available (reproduced from 












2.3.3.2 Data normalisation and differential expression analysis 
Prior to gene-wise comparisons, normalisation across the samples is required to bring 
all distributions to the same scale in order for the future comparisons to be meaningful.  
The TMM normalisation (normalisation by trimmed mean of M values) was applied 
via the calcNormFactors function (edgeR package) in R to calculate the normalisation 
factors which represent the scaling factors per library.  These scaling factors are 
included in the DGEList object alongside the raw counts.  The voom function from the 
limma package (Ritchie et al., 2015) converts the raw count data into log2-transformed 
CPM values by extracting both the library sizes and the scaling factors from the 
DGEList object.  The voom function also weights the gene counts based on their mean-
variance relationship and it is preferred to limma-trend [or simply the cpm function 
(McCarthy et al., 2012; Robinson and Smyth, 2007) from EdgeR (Robinson et al., 
2010)] because its performance is more robust when library sizes vary among samples.  
The resulting voom object includes among others, a column with the normalised log-
CPM counts that can be also used for visualisation purposes. 
 
2.3.3.3 Data inspection and visualisation 
Hierarchical clustering and Principal Component Analysis (PCA) were used to 
visualise and inspect the structure of the sample data.  Both methods are unsupervised 
(i.e. no information of the samples relationships is provided prior to the clustering) and 
are therefore suitable for exploratory analysis of sample associations.  Samples 
groupings need to be representative of the biological design of the experiment to 
proceed with any comparative analysis between groups, and generate results that are 
meaningful and reliable.  Hierarchical clustering divides samples into homogeneous 
groups by maximising their distances based on a provided distance measure.  This 
method can be used for inspection of datasets with a simple biological design.  PCA 
identifies more complex sample relationships by representing multiple patterns 
characteristic of high levels of variance across the samples.  This method is used here 
to inspect the relationships between more complex datasets (e.g. merged data series).  
Hierarchical clustering was performed using the hclust function (Müllner, 2013) in R 
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using average dissimilarity of samples based on Pearson correlation (Pearson, 1895) 
to define groups.  PCA was performed with the prcomp function in R while the 
resulting principal components were coupled with the Analysis of Variance (ANOVA) 
method to identify strong associations of any of these principal components with class 
variables (edited code for the PrincipalComponentANOVA function is available in the 
thesis electronic supplement; initial code has been provided by Jonathan Manning; 
inspired from http://rnbeads.mpi-inf.mpg.de/index.php).  Class variables may be 
representative of the experiment’s biological design as well as of potential extraneous 
or technical effects; association of principal components with the class variables can 
inform of potential batch effects in the inspected dataset. 
 
2.3.3.4 Batch effect correction 
Batch effect correction across samples was performed with the Combat function from 
the sva package (Leek et al., 2016) in R to remove technical sources of bias.  Batch 
effect correction was only possible when technical effects present among the samples 
of a specific dataset were not confounded by the biological design of the experiment.  
After batch effect correction, datasets were replotted (see visualisation methods in 
section 2.3.3.3) to confirm that the extraneous effects had been removed while no new 
type of bias had been introduced to the data. 
 
2.3.3.5 Differential expression analysis 
Comparative analysis between groups of samples was performed using functions from 
the limma package (Ritchie et al., 2015).  For the differential expression analysis, the 
TMM-normalised CPM values (see section 2.3.3.1) were provided to the lmFit 
function to calculate a linear model which has the optimal fit to the provided gene 
expression matrix.  When batch effects were present across the samples, they were 
included in the design of the linear model to be considered for the model fitting.  The 
lmFit-generated model was then provided to the eBayes function from the same 
package to perform statistical analysis between the groups of interest and calculate 
gene fold changes between groups (in a log2-transformed scale) and a measure of 
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assigning confidence to each gene comparison.  Genes were considered as 
differentially expressed when their adjusted p-value (calculated by the BH method, as 
known as false discovery method; FDR method, Benjamini and Hochberg, 1995) was 
equal to or less than 0.05 and their |FC| ≥ 1.5 (or 0.585 in log2 format).  By selecting 
this threshold, 5% of the differentially expressed genes could constitute false positives.  
The generated gene lists with the FC values per gene were also used for pathway 
enrichment analysis when appropriate. 
 
2.3.3.6 Pathway enrichment analysis 
The Gene Set Enrichment Analysis (GSEA, Subramanian et al., 2005) software was 
used to predict signalling pathways which were enriched between groups of interest.  
The GSEA’s ‘Run GSEAPreranked’ module was used to search for enriched pathways 
provided a differential expression gene list (generated using the limma package in R) 
as the ranked list of features and an “edited” version of the ConsensusPathDB database 
(Kamburov et al., 2011) as the pathways database to search against, while the 
remaining parameters were set as default (number of permutations: 1000, collapse 
datasets to gene symbols: false).  The ‘Run GSEAPreranked’ function allows numeric 
measurements to be incorporated into the statistical analysis, as a way to quantify the 
contribution of particular genes to pathway enrichment scores, in this case, by 
considering the fold change per gene.  The ConsensusPathDB was selected on the basis 
that it offers an up-to-date repository of biological pathways that have been collected 
and integrated from multiple known databases and it included in total 2,140 mouse-
specific pathways (2,140 was the number of pathways at the time of this analysis; the 
actual number has increased since, reaching 2,173 pathways that are mouse specific).  
Because FOXN1 consists one of the central regulators of the thymic system, an extra 
pathway was added to the ConsensusPathDB (“edited”) to incorporate the 450 FOXN1 
high confidence target genes in cortical thymic epithelial cells that have been published 
recently (Žuklys et al., 2016) to assist towards this direction.  The resulted pathways 
were filtered for an FDR value ≤ 0.25 (default parameters of GSEA), which suggests 
that there is 25% probability the gene set (or pathway) that is found enriched to be a 
false positive result.  
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Figure 2.5: Overview plot of the RNA-seq core analysis pipeline.  Each step shows the type of 
analysis performed and the specific function/tool that was selected in each case.  After the gene counts 
per data series have been imported in R (see Figure 2.3), lowly or unexpressed genes are removed 
using the rowSums function from the edgeR package (Robinson et al., 2010; see section 2.3.3.1 in the 
main text).  Gene counts across samples are then normalised for their library size with the 
calcNormFactors and voom functions from the limma package (Ritchie et al., 2015) to make samples 
equal in terms of their statistical properties and allow meaningful comparisons between samples (see 
section 2.3.3.2 in the main text).  Hierarchical clustering and PCA plots were used to visually inspect the 
data (see section 2.3.3.3 in the main text).  If batch effects were apparent in the samples, the Combat 
function was used to remove the detected batch effect and the data were replotted (as before) to examine 
whether the artificial effect has been removed.  Differential expression analysis was then performed using 
the lmFit and eBayes functions from the limma package (see section 2.3.3.5 in the main text).  The 
differentially expressed gene tables were used for integration with the ChIP-seq data (see section 
2.3.5.3 and pipeline in Figure 2.7).  The same differentially expressed gene lists with the log2 fold change 





2.3.4 ChIP-seq pre-analysis pipeline 
 
2.3.4.1 Mapping reads to genome 
Trimmed reads which passed QC were aligned against the GRCm38.p5 (mm10) 
Mouse assembly (downloaded from Gencode – release M12) with Bowtie2 (version 
2.3.0, Langmead and Salzberg, 2012).  Bowtie (Langmead et al., 2009) uses full-text 
minute indexing to produce ultra-fast and memory-efficient alignment of reads against 
any genome assembly.  Bowtie2 extends Bowtie’s flexible indexing with the 
capabilities of dynamic programming algorithms to allow alignment of longer reads 
against relatively long genome assemblies (e.g. mammalian) with high accuracy and 
sensitivity without impacting on the alignment’s speed.  These attributes of Bowtie2 
fit the nature of the provided ChIP-seq data (see section 2.2.2 and 2.2.3) that are 
characterised by long sequences (50-70 base pairs) which will then be aligned against 
the mouse genome.  Parameters for Bowtie2 were kept as default with both reads to be 
provided (-1 read1 -2 read2) when the datasets were of paired-end design, while the -
U parameter was selected when reads were of single-end design.  To increase 
sensitivity of the analysis, multi-mapping reads (reads that confidently map in more 
than one location in the genome) were excluded based on Bowtie’s mapping quality 
(MAPQ) score; only uniquely aligned reads were considered for downstream analysis.  
A MAPQ score of ≥ 2 would exclude all true multi-mapping reads and also uniquely 
aligned reads with ≥ 4 mismatches (see proof from Urban, 2014).  After multi-mapping 
reads were removed, to avoid PCR amplification bias in our results the 
MarkDuplicates function from Picard (version 1.141-1, Picard tools, 2016) was used 
to further remove duplicated reads (reads that map to the exact same location more 
than once). 
 
2.3.4.2 Peak calling 
MACS2 (version 2.1.0.20150731, Zhang et al., 2008) was used for peak calling 
provided the non-redundant uniquely aligned reads as the treatment file (-t) and their 
respective background as the control one (-c).  MACS2 can be used to identify two 
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types of enrichment: a) sharp (or narrow) domains, these are domains marked by 
transcription factors or histone modifications which mark only short genomic regions 
(e.g. gene promoters) and b) broad domains, these are domains marked by histone 
modifications that expand in longer stretches of the genome (e.g. full gene bodies).  
For sharp peaks (e.g. the FOXN1-tagged and the H3K4me3 ChIP-seq data) the p-value 
cut-off to call significant peaks was set to a more lenient threshold than the default (-
p 1e-3) and the Irreproducible Discovery Rate (IDR) pipeline (available at 
https://github.com/nboley/idr) was then used to identify peaks consistent among 
replicates (for details over the specific thresholds and the IDR pipeline see section 
2.3.5.1).  For broad peaks (e.g. the H3K27ac ChIP-seq data), MACS2 was used with 
the --broad parameter on (IDR pipeline not applicable yet for broad peaks), a --broad-
cutoff of 0.1 for the broader enriched regions and a -q-value cut-off of 0.05 for any 
significant narrow peaks included in that broader enriched region.  For the histone 
modification datasets that have low sequencing depth, the MACS2 --nomodel 
parameter was selected for MACS2 not to build a shifting model when it calculates 
the fragment length.  Instead, the fragment length was provided in the --extsize 
parameter equal to 147 nucleotides long which is representative of the DNA length 
that spreads across a nucleosome since the histone modification data have an 
underlying characteristic 147bp resolution. 









Figure 2.6: Overview plot of the ChIP-seq pre-analysis pipeline.  In this pipeline, each step shows 
the type of analysis performed and the specific tool that was selected when the workflow was executed.  
Raw reads are inspected with FastQC (Andrews, 2010) for different types of bias (shown in red), namely, 
high sequence quality, organism specific GC content, absence of adapters, absence of overrepresented 
k-mers and normal duplication rate.  Reads which fail to qualify for any of the quality control (QC) criteria 
above are removed with Trimmomatic (Bolger et al., 2014).  After read trimming with Trimmomatic, reads 
that passed QC are reinspected with FastQC to make sure no bias has been introduced (see section 
2.3.1.1 in the main text).  Reads which passed QC are then mapped to the provided genome assembly 
(GRCm38) with Bowtie2 (Langmead and Salzberg, 2012; see section 2.3.4.1 in the main text) and peaks 
are called from the generated aligned files with MACS2 (Zhang et al., 2008); see section 2.3.4.2 in the 
main text).  Mapped read files can be further inspected in the genome browser with IGV (Thorvaldsdottir 







2.3.5 ChIP-seq core analysis pipeline 
 
2.3.5.1 Significant peaks 
When calling narrow peaks from samples with replicates, the IDR pipeline 
(https://sites.google.com/site/anshulkundaje/projects/idr) was used to draw a line 
between consistent and non-consistent peaks, based on peaks reproducibility among 
replicates.  In order to assess peaks consistency based on the IDR value, non-consistent 
findings (peaks) need to be included in the called peaks list and this is why the p-value 
cut-off for MACS2 was set to 1e-3; a more relaxed threshold for peak calling.  After 
running the batch-consistency-analysis.r script, included in the IDR pipeline, only 
consistent peaks with an IDR value of ≤ 0.05 were considered significant as suggested 
from the pipeline.  In the case of broad peak datasets, the broad peaks q-value (--broad-
cutoff) was used to assess if peaks were significantly enriched over background and it 
was set to 0.1 (default by MACS2 for broad peaks). 
 
2.3.5.2 Data inspection 
Mapped read files were loaded to IGV (version 2.3.72, Robinson et al., 2011; 
Thorvaldsdottir et al., 2013) for visual inspection of the aligned reads enrichment over 
the control samples (or input DNA). 
 
2.3.5.3 Peaks to genes 
The ChIPseeker package (Yu et al., 2015) in R was used to match peaks to proximal 
genes based on genomic distance.  Genes were assigned to peaks if the peak was 5,000 
(-5kb) base pairs (bp) upstream or 3,000 (+3kb) bp downstream (arbitrary threshold) 




2.3.5.4 Motif analysis 
De novo motif discovery analysis was performed with the web interfaces of MEME-
ChIP (Machanick and Bailey, 2011) and RSAT peak-motifs (Thomas-Chollier et al., 
2011) tools with default parameters to identify enriched binding patterns under a 
provided set of identified binding peaks.  Motif discovery tools rely on different 
underlying algorithms and set of parameters to identify enriched motifs in a provided 
set of sequences, therefore results can often vary a lot among them and a combination 
of tools should be used to allow better coverage of existing motifs, as was suggested 
by Tompa et al. (2005).  Additionally, a survey of web tools for motif discovery 
suggested that enriched motifs that were consistent among different tools are more 
reliable (Tran and Huang, 2014).  Commonly identified motifs by MEME-ChIP and 
RSAT were considered as more significant compared to motifs only identified by one 
of the two tools. 














Figure 2.7: Overview plot of the ChIP-seq core analysis pipeline.  Each step shows the type of 
analysis performed and the specific function/tool that was selected in each case.  To call confident peaks, 
the q-value provided by MACS2 was used as a threshold when replicates were not available, while the 
IDR pipeline and an IDR threshold was used for peaks when replicates were available.  Enriched peaks 
were further inspected in the genome browser with IGV (Thorvaldsdottir et al., 2013; see section 2.3.5.2 
in the main text).  For integration of the ChIP-seq data with the RNA-seq data (described in section 2.2.1 
and analysed based on pipelines in Figure 2.3 and Figure 2.5), peaks were mapped to genes based on 
peaks proximity to the transcriptional start site (TSS) of selected genes (-5 kb, + 3 kb from genes TSS).  
Peaks were also converted into DNA sequences (area under the peak) and motif discovery analysis was 
performed with MEME-ChIP and RSAT peak-motifs for a given a set of sequences to identify enriched 














































Modelling the developmental 




Chapter 3  
 
Modelling the developmental progression of early 





Thymic epithelial cells (TECs) constitute essential elements of the thymic 
microenvironment that orchestrate T lymphocyte (T-cell) differentiation and repertoire 
selection (Takahama, 2006) and therefore are requisite for development of a functional 
immune system.  TECs derive from a thymic epithelial progenitor cell (TEPC) that has 
the capacity -bipotent- to differentiate into the functionally distinct cortical (c) and 
medullary (m) TEC sublineages under the control of FOXN1 (Bennett et al., 2002).  
Increasing levels of Foxn1 determine phenotypically the status progression of TECs’ 
differentiation (low Foxn1 levels allow exit from the TEPC state and initiation of TEC 
differentiation, intermediate/high Foxn1 levels allow more specialised TEC 
functions), while TECs lineage specification and the regulation of cell fate choice 
between cTEC/mTEC divergence take place even in the absence of Foxn1 (Nowell et 
al., 2011).  Despite the vital role of TECs in the establishment of a functionally 
adequate thymic system, the precise mechanisms through which TEC differentiation, 
and divergence of the cTEC and mTEC sublineages occur are not yet fully decrypted. 
Therefore, with the work in Chapter 3 I aim to answer a series of questions in 
relevance to the early TEPC status and progression upon Foxn1 expression in early 
mouse development. 
Question 1: What is the impact of differing Foxn1 expression levels on the early 
developmental progression of TEPCs at the molecular level? 
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Question 2: The transcription profile of which normal TEPC developmental stage 
better resembles the experimentally competent bipotent TEPCs that exist in the thymic 
rudiments of mice lacking Foxn1 expression? 
Question 3: Is there evidence of Foxn1 acting as a repressor in the thymic epithelium? 
Question 4: Can we predict a gene expression signature capable of identifying bipotent 
TEPCs that can be used to better isolate putative TEPC populations in the early, 
newborn and adult thymus? 
Question 5: Do the above findings revisit the current model of TEPC differentiation 





















3.2.1 Pseudo-timing of a Foxn1 Allelic series dataset represents 
normal developmental progression of TEPCs 
Foxn1 expression levels comprise a definitive factor in determining thymic epithelial 
cell expansion and differentiation during the early, T-cell independent, fetal 
developmental stages and this effect has been demonstrated by phenotypic analysis of 
mouse thymi obtained from a Foxn1 Allelic series (Nowell et al., 2011), in which 
Foxn1 expression levels are progressively reduced due to the presence (in some 
variants) of the Foxn1R allele, which expresses around 20% of wild type (WT) Foxn1 
mRNA levels.  In the same paper, phenotypic analysis demonstrated a developmental 
block in TEPC differentiation that was more profound in the null or low-Foxn1 
variants compared to their allelic variants that expressed intermediate or high levels of 
Foxn1 (Figure 3.1; image edited from (Nowell et al., 2011)). 
To explore whether the phenotypes caused by impaired Foxn1 levels during early 
thymus development mimic normal developmental progression of TECs, I will 
compare the transcriptional profiles of the E12.5 PLET1+ TEPCs isolated from the 
Foxn1 Allelic series (RNA-seq data from singular biological samples provided by 
Stephanie Tetelin, Blackburn lab; see also Chapter 2, section 2.2.1) with the 
transcriptional profile of E10.5, E11.5 and E12.5 PLET1+ TEPCs from a TEPC 
Developmental series (RNA-seq data from biological triplicates per stage provided 
by Harsh Vaidya, Blackburn lab; see also Chapter 2, section 2.2.1). 
In short, there are six allelic combinations in the Foxn1 variants [Foxn1+/+ (WT), 
Foxn1R/+ (R/+), Foxn1+/- (Het), Foxn1R/R (R/R), Foxn1R/- (R/-), Foxn1nu/nu (Nude)], 
with the WT and Nude samples defining the highest (normal) expression and complete 
absence of Foxn1 respectively (see Figure 3.1 for R allele design and relative protein 
levels of Foxn1; image edited from (Nowell et al., 2011)).  The transcriptome 
information contained in the TEPC Developmental series represents gene expression 
changes that characterise overall TEPC differentiation during this time frame. The 
TEPC Developmental series may include FOXN1-dependent and FOXN1-
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independent elements, while the E12.5 Foxn1 Allelic series dataset can reveal the 
unique impact of Foxn1 expression levels on TEPCs (i.e. FOXN1-dependent 
elements) independently of their progression state since all samples were obtained at 
E12.5.  A graphical representation of how these RNA-seq series relate to each other is 



















Figure 3.1: The Foxn1R hypomorphic allele.  Making use of ES cells and homologous recombination, 
a LoxP flanked cassette was inserted into intron 1b of the Foxn1 locus.  These cells were used to create 
a Foxn1R mouse strain (top).  QRT-PCR analysis was used to determine the relative levels of Foxn1 
expression on E12.5 with the Sybr-Green method in 5 different samples.  The geometric mean of three 
housekeeping genes was used to normalise for the Foxn1 expression levels (bottom left).  Sizes of 























Figure 3.2: Graphical representation of the TEPC Developmental and the Foxn1 Allelic series.  
The image depicts the number of samples and biological replicates per data series, as well as the 
developmental stage at which the samples were obtained.  The Foxn1 Allelic series is linked to the TEPC 
Developmental series through a common developmental point that they both share.  This point is day 
E12.5; it represents the oldest developmental point in the Developmental series, and is the timepoint at 










For the analysis of the RNA-seq datasets in this thesis, I have put together a generic 
RNA-seq pre-analysis and core-analysis pipeline (described in Chapter 2, section 
2.3.1 and 2.3.2) that I am using to retrieve the expression profiles (normalised gene 
counts) of the average cell populations in the different datasets, including the TEPC 
Developmental series and the Foxn1 Allelic series datasets.  Hierarchical clustering 
was applied to the top 1,000 most variable genes (dominant gene expression profile) 
per series, to examine if samples followed the biological design of each experiment.  
The resulting dendrogram for the TEPC Developmental series (Figure 3.3, left panel), 
shows that triplicates of each developmental stage did not cluster in their own 
subgroups; sample E10.5 (C) clustered with E12.5 (A) while sample E11.5 (C) 
clustered with the rest of the E12.5 replicates.  This indicated a potential batch effect 
caused by samples sequenced in different lanes (different lanes marked with “#” and 
“*” symbols, Figure 3.3).  Therefore, the Combat function from the sva package in 
Bioconductor (Leek et al., 2016) was used to correct for this technical effect (Chapter 
2, section 2.3.3.4) and the balanced lane–subgroup design of the TEPC Developmental 
series allowed removal of lane effects without introducing other bias to the expression 
values.  Batch (or lane) effect corrected data (Figure 3.3, right panel) clustered as 
expected, based on biological age. 
The resulting dendrogram for the Foxn1 Allelic series dataset (top 1,000 most variable 
genes) revealed a sequential clustering of the samples that in general terms followed 
the biological design of graded drops in Foxn1 mRNA expression levels.  The lack of 
replicates in the Foxn1 Allelic series made it difficult to assess extraneous effects on 
the data.  Based on the phenotype of the generated mice, E12.5 R/- and E12.5 Nude 
samples would be expected to cluster separately to the rest of the samples, since only 
these Foxn1 variants exhibit a complete/near complete block in TEPC differentiation 
and hence functional athymia.  The R/R mutant generates instead a hypoplastic 
thymus.  Furthermore, the E12.5 WT TEPC samples were expected to cluster more 
closely with the E12.5 R/+ rather than the E12.5 Het TEPC sample, as it expresses 
slightly higher levels of Foxn1, although all three samples generate a fully functional 
thymus.  Despite the lack of replicates, similar phenotype samples were sequenced in 
different lanes creating a balanced experimental design to remove technical effects.  
The Combat function (sva package) was used again to remove the lane effect among 
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samples (see Figure 3.4, right hand panel).  The Combat-corrected data did not vary 
greatly from the original clustering, however, they were more consistent with known 
phenotypes of each allelic variant and the Foxn1 relative expression levels (Figure 


















Figure 3.3: Cluster dendrogram of the E10.5, E11.5 and E12.5 sample triplicates from the TEPC 
Developmental series dataset.  Triplicates did not cluster into subgroups based on the developmental 
stage they have been obtained (left panel), suggesting a potential lane effect among samples (lanes 
represented with “#” and “*” symbols).  The post batch effect correction dendrogram is shown in the panel 





Figure 3.4: Cluster dendrogram of the Foxn1 variant samples from the Foxn1 Allelic series 
dataset.  Dendrogram before batch effect correction (left panel) broadly reflects decreasing levels of 
Foxn1 expression.  Clustering of the samples after lane effect correction (right panel) better represents 
the biological design of the Foxn1 Allelic series and the relative Foxn1 expression levels as quantified 

























To compare the expression profiles of samples from the TEPC Developmental series 
with those from the Foxn1 Allelic series, I further merged the two lane-effect-corrected 
series.  Sample similarity among two experiments can be masked by technical factors 
that are specific to each experiment (e.g. vastly different library sizes), therefore, 
association of class variables (such as experiment, developmental stage and Foxn1 
levels) for the top 5,000 most variable genes from the merged dataset was plotted 
against the first ten principal components (code provided by Jonathan Manning, 
inspired from http://rnbeads.mpi-inf.mpg.de/index.php; edited code available in thesis 
electronic supplement), to assess if technical differences among the two different series 
were masking biological differences.  The above ANOVA analysis suggested that 
PC1, accounting for 20.9% of the variance (Figure 3.5), is highly associated with the 
data series variable and therefore may be masking biologically relevant differences 
due to, for instance, Foxn1 expression levels.  Since neither of the two biological 
variables (Developmental stage and Foxn1 levels) were confounded by the data series 
class and since E12.5 WT, Het and R/+ samples from the Foxn1 Allelic series were 
almost identical to the E12.5 triplicates from the TEPC Developmental series, I 
concluded that batch effect correction would remove the technical effect caused by 
different data series being integrated together, without introducing any bias. 
ANOVA analysis on the batch effect corrected merged dataset indicated that the data 
series effect had been removed.  PC1 and PC3 (accounting for 17.8% and 10.4% of 
variation respectively) were now highly associated with the developmental stage and 
Foxn1 level variables respectively (depicted in the covariate matrix, Figure 3.6) 
representing differences among samples due to biological factors and not extraneous 
effects. 
Gene distances in PC1 were plotted against gene distances in PC3, to observe sample 
clustering in the integrated dataset (Figure 3.7).  Since samples from the Foxn1 Allelic 
series were all collected at E12.5, they might be expected to group together with the 
E12.5 triplicates from the Developmental series.  However, if cell identity is 
significantly influenced by Foxn1 mRNA expression levels, the samples should cluster 
based on the extent to which their average global expression profile has been impacted 





Figure 3.5: PCA/variable associations among the TEPC Developmental series and Foxn1 Allelic 
series integrated dataset before batch effect correction.  Heatmap of the association levels (p-value 
calculated by ANOVA function in R, original code provided by Jonathan Manning and edited version 
available in thesis electronic supplement) of class variables (data series, developmental stage and Foxn1 
levels) among the first ten principal components for the top 5,000 most variable genes indicates an 




Figure 3.6: PCA/variable associations among the TEPC Developmental series and Foxn1 Allelic 
series integrated dataset after batch effect correction.  Heatmap of the association levels (p-value 
calculated by ANOVA function in R, original code provided by Jonathan Manning and edited version 
available in thesis electronic supplement) of class variables (data series, developmental stage and Foxn1 
levels) among the first ten principal components for the top 5,000 most variable genes, indicating that 
variation within the data reflects the biological design of the data. 
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In Figure 3.7, the Foxn1 null/low expression thymic primordium (samples E12.5 
Nude and E12.5 R/-), which comprises TEPCs in a developmentally arrested state that 
can function as stem cells (TESCs, see Jin et al., 2014), clusters together with the 
undifferentiated wild type TEPCs at E10.5 (grey circle).  Sample E12.5 R/-, that 
expresses very low levels of Foxn1 mRNA, groups together with samples E10.5 (C) 
and E11.5 (A) (Figure 3.7, pink circle).  This is consistent with the fact that in sample 
E10.5 (C), Foxn1 expression is just above the detection level, while sample E11.5 (A) 
contains the lowest detected levels of Foxn1 among the E11.5 group.  Sample E12.5 
R/R, which expresses intermediate levels of Foxn1, clusters together with the two other 
E11.5 replicates (Figure 3.7, blue circle) whose profiles reflect further developmental 
progression than samples from the E10.5 developmental stage but less than those from 
E12.5.  Samples E12.5 WT – Het – R/+ group clusters with the rest of the E12.5 
triplicates (Figure 3.7, yellow circle) which agrees with the normal thymus phenotype 
generated by mice carrying the heterozygous and wild type genotypes. 
The above groupings thus demonstrate that the E12.5 Nude and E12.5 R/- samples 
represent on average a very immature TEPC population, despite being isolated on the 
later E12.5 developmental stage.  This also indicates that the average E10.5 TEPC 
population would be able to generate a full functional thymus if isolated and exposed 
to the right levels of Foxn1, consistent with previous findings (Gordon et al., 2004).  
The E12.5 developmental stage represents the latest TEPC age analysed.  At this stage, 
TEPC are actively differentiating.  Overall, Figure 3.7 illustrates that data clustering 
faithfully follows the Foxn1 expression levels design, showing a clear effect of Foxn1 






Figure 3.7: Principal component analysis of the TEPC Developmental series and Foxn1 Allelic 
series integrated dataset.  The PCA plot shows samples clustering from two different data series that 
have been integrated together.  Samples from the TEPC Developmental series are represented with 
triangles, while samples from the Foxn1 Allelic series are represented with circles.  Colour gradient inside 
both triangles and circles illustrates Foxn1 expression levels in each sample.  PC1 (x-axis) accounts for 
17.8% of samples variance, while PC3 (y-axis) describes 10.4% of samples variance.  Both axes 
represent samples differences that, in the Allelic series dataset, is due primarily to the Foxn1 level effect, 
while for the TEPC Developmental series is due to both the Foxn1 levels and the developmental stage 









To further establish that batch effect correction of the integrated datasets did not bias 
our data and to also examine if groups’ clustering (in Figure 3.7) is representative of 
genes expression profiles across samples (expressing similar Foxn1 levels) and did not 
result because of samples’ average clustering, gene expression patterns for TEPC and 
TEC lineage-specific markers (reviewed in Takahama et al., 2017) and for Foxn1 
target genes (Nowell et al., 2011; Žuklys et al., 2016) were observed across samples 
in each series and samples per series were clustered (see heatmaps in Figure 3.8) based 
on these markers.  Even though these markers consist a very small percentage of the 
total number of expressed genes in TEPCs, their level of expression is able to define 
major subpopulations of the thymic epithelium and therefore they can be used when 
inspecting samples identity and expressional profiles. 
Gene patterns across samples of varying Foxn1 levels were majorly similar for the 
selected markers.  Furthermore, the TEPC Developmental series dataset demonstrated 
a clear separation of samples E10.5 (A) and E10.5 (B) (similar to the PCA plot; Figure 
3.7) from rest of the samples, with samples E10.5 (C) and E11.5 (A) grouped and 
slightly separated from the E11.5 (B) and E11.5 (C) ones, while the E12.5 triplicates 
formed their own group with most genes showing a clear expression pattern among 
them.  The Foxn1 Allelic series also indicated a clear separation of the Nude and R/- 
from rest of the samples, which show a linear trend of separation based on increasing 
Foxn1 levels.  Overall, heatmap clustering of the individual series supports the 
observed clustering in PCA (Figure 3.7) and suggests that gene patterns across 
samples are highly similar. 
In summary, integration of the TEPC Developmental series with the Foxn1 Allelic 
series demonstrated that variation in Foxn1 expression level within an allelic series 
results in changes in gene expression that closely mimic those observed in the normal 
temporal development of TEPCs during fetal thymus development.  This analysis 
further highlighted the importance of a single transcription factor, FOXN1, in defining 
cell identity in TEPCs.  These datasets will consist the basic platform used to track 
differences between undifferentiated and differentiated TEPC genes, and FOXN1-
dependent genes, in this thesis, and will also be used in combination with more datasets 




































Figure 3.8: Lineage-specific gene heatmaps for the TEPC Developmental series and the Foxn1 
Allelic series datasets before data integration. Both heatmaps depict samples clustering per series, 
based on a selected list of markers (Takahama et al., 2017) which are representative of different TEPC 
and TEC sublineages present in the embryonic and postnatal thymus. Column annotations (DevStage) 
on top side of the heatmaps represent the developmental day on which samples have been collected 
(E10.5-E12.5), while row annotations (Class) describes the TEPC/TEC subpopulation that is defined 
according to high expression levels of the specific gene. FOXN1 target genes, including Kitl, (under the 
cTEC class) have been additionally annotated with an “*” symbol. 
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3.2.2 Projection of differentiating TEPC genes onto representative 
populations of the TEC sublineages indicates TEPC heterogeneity 
among the E12.5 TEPCs 
To interrogate how the cTEC and mTEC sublineages are generated during TEC 
differentiation, genes that are differentially expressed between the E10.5 
(undifferentiated progenitors) and E12.5 (differentiating TEPCs) timepoints from the 
TEPC Developmental series were projected on representative populations of the cTEC 
and mTEC sublineages (see next paragraphs for details).  The data that I have used for 
this projection were embryonic E14.5 PLET1- and E14.5 PLET1+ TECs (RNA-seq 
data from biological triplicates per population provided by Dong Liu, Blackburn 
lab; the majority of these cells will become cTECs and mTECs respectively) and 1 
week old cTECs and mTECs [merged RNA-seq data from similarly sorted individual 
and biological duplicates obtained and reanalysed from GEO public repository: GEO 
accession codes GSE44945 (St-Pierre et al., 2013) and GSE53110 (Sansom et al., 
2014); for details see Chapter 2, section 2.2.1.4]. 
To identify groups of genes that change consistently between the E10.5 and E12.5 
triplicates from the TEPC Developmental series, differential expression analysis was 
performed using the limma voom function (see Chapter 2, section 2.3.3.2) and I 
assigned statistical significance to the gene changes using the false discovery rate 
(FDR).  The Foxn1 expression levels across all samples are shown in Figure 3.9, 
suggesting higher variance among the E10.5 samples than the ones at E11.5 or E12.5 
timepoints.  An FDR threshold of ≤ 0.2 and an absolute fold change (|FC|) value ≥ 1.5 
was chosen to define statistically significant genes.  A total of 1,650 genes passed the 
FDR threshold and were considered for further analysis. 
To explore how changes in the expression profile of early TEPC development is 
represented in later developmental points (such as E13.5 and older samples), when the 
cTEC and mTEC sublineages have emerged (or are starting to emerge), I further 
divided the 1,650 differentially expressed genes (E12.5 versus E10.5) in up and down-
regulated gene groups (980 versus 670 genes respectively) and then plotted them 
according to the representative expression values they have acquired in the E14.5 and 


















Figure 3.9: Representative levels of Foxn1 in the TEPC Developmental series dataset. A scatterplot 
of Foxn1 levels among the early TEPC developmental points (replicates per point distinguished by A-B-
C lettering) demonstrates higher variability among the E10.5 triplicates, compared to the rest of the 
samples. The high variance may be explained by high biological variance at this very immature stage. 
E10.5 may comprise a high interchangeable TEPC state, where Foxn1 levels may increase very rapidly 
after detection of its expression at ~E10.25 timepoint. Also, only small numbers of cells were used to 




The scatterplots shown in Figure 3.10 show a bias for up-regulated genes at E12.5 vs 
E10.5 to be more highly expressed in E14.5 PLET1- TECs than in E14.5 PLET1+ TEC, 
a pattern that was even stronger when looking at the same genes in 1 week old cTECs 
versus 1 week old mTECs.  The opposite pattern was apparent for the genes down-
regulated in the E12.5 vs E10.5 comparison, which were more highly expressed in the 
E14.5 PLET1+ and 1 week old mTECs than in the E14.5 PLET1- and 1 week old 
cTECs.  Of note is that most of the up-regulated genes from the E10.5 to E12.5 
developmental stage were also expressed in E14.5 PLET1-/1 week old mTEC 
populations, albeit at lower levels than those in the E14.5 PLET1+/1 week old cTEC 
populations.  In contrast, a high portion of the down-regulated genes were fully absent 
from E14.5 PLET1-/1 week old cTEC (Figure 3.10, bottom right panel – genes below 
0 in y-axis). 
To investigate if these differing patterns of expression were driven by FOXN1, 
samples from the Foxn1 Allelic series were used to filter the 1,650 differentially 
expressed genes (E12.5 vs E10.5; TEPC Developmental series) for genes dependent 
on FOXN1.  Lack of sample replicates in the Foxn1 Allelic series dataset made it 
difficult to confidently compare samples to one another.  However, based on the 
phenotypic and functional characteristics that the Foxn1 Allelic series samples share, 
they could be categorised in three groups.  Samples E12.5 WT, E12.5 Het and E12.5 
R/+ (or Group 1) represent TEPC populations that express high levels of Foxn1 and 
can give rise to a normal (or hyperplastic) fully functional thymus, sample E12.5 R/R 
(or Group 2) expresses intermediate levels of Foxn1 and generates a suboptimally 
functional, hypoplastic thymus, while samples E12.5 Nude and E12.5 R/- (or Group 
3) are representative of a TEPC arrested population that leads to athymia. 
Pairwise comparison analysis was performed between the two phenotypically most 
distinct groups (Group 1: WT – Het – R/+ versus Group 3: Nude – R/-) to identify 
genes that are highly dependent on FOXN1.  In this analysis, up-regulated genes from 
E10.5 to E12.5 would be considered FOXN1-dependent if two out of three samples in 
Group 1 expressed these genes more highly than both samples in Group 3, and vice 
versa in the case of down-regulated genes.  The pairwise comparison identified a total 
of 850 FOXN1-dependent genes, which were used to assess the influence of FOXN1 










Figure 3.10: Projection of TEPC differentially expressed genes on E14.5 and 1w TEC 
subpopulations. The plot depicts a clear trend of the E12.5 vs E10.5 up-regulated genes to be more 
highly expressed in the representative cTEC compartment (E14.5 PLET1- and 1w cTECs; see circles 
coloured in red shades), while the down-regulated genes from the same comparison are more highly 
expressed in the representative mTEC compartment (E14.5 PLET1+ and 1w mTECs; see circles 
coloured in blue shades) with some of the genes completely missing from 1w cTECs (bottom right plot, 
blue circles below -1 in y-axis). Values in both axes are shown in log2-transformed RPKM format, size 
of the spot is scaled so that more highly expressed genes (either in x or y-axis) are represented with 
bigger circles, while colour scale (red or blue) represent spots density (darkers shades of red or blue – 
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Figure 3.11: Projection of FOXN1-dependent, differentially expressed TEPC genes on E14.5 and 
1w TEC subpopulations. The plot depicts a clear trend of the FOXN1-dependent up-regulated genes 
to be found higher expressed in the representative cTEC compartmnet (E14.5 PLET1- and 1w cTECs; 
see circles coloured in red shades), while the FOXN1-dependent down-regulated genes to be found 
higher expressed in the representative mTEC compartment (E14.5 PLET1+ and 1w mTECs; see circles 
coloured in blue shades) with some of the genes completely missing from 1w cTECs (bottom right plot, 
blue circles below -1 in y-axis). Values in both axes are shown in log2-transformed RPKM format, size 
of the spot is scaled so that more highly expressed genes (either in x or y-axis) are represented with 
bigger circles, while colour scale (red or blue) represent spots density (darkers shades of red or blue – 
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Figure 3.11 illustrates the expression profiles of the 850 FOXN1-dependent genes 
[586 up-regulated (60% of DE up-regulated genes) and 264 down-regulated (40% of 
DE down-regulated genes)] that are mapped to the later developmental E14.5 PLET1-
/1 week old cTEC and E14.5 PLET1+/1 week old mTEC populations.  The patterns 
observed in Figure 3.10 for the up- and down-regulated genes are preserved in the 
FOXN1-dependent genes in Figure 3.11 suggesting that this pattern reflects FOXN1 
up-regulation.  FOXN1-dependent genes whose expression increases with FOXN1 up-
regulation (from E10.5 to E12.5) show higher levels of expression in representative 
populations of the cTEC than the mTEC lineage.  This difference is in agreement with 
the higher level of Foxn1 expression in cTECs versus mTECs (Rode et al., 2015;  
O’Neill et al., 2016) and it suggest the role of FOXN1 as a potential activator (also 
denoted by Žuklys et al., 2016).  Most of the FOXN1-dependent up-regulated genes 
remain expressed still in the mTEC compartment, although not as highly as in cTECs. 
The opposite trend is observed for genes that down-regulate from E10.5 towards 
E12.5.  These genes down-regulate when cells progress from an early developmental 
point to a latter one when Foxn1 expression increases and they are also found to be 
more highly expressed in the mTEC compartment (which has lower Foxn1 levels 
compared to the cTEC compartment), with some of the genes to be completely absent 
from the cTEC compartment (genes below -1 in y-axis; Figure 3.11).  All the above 
suggest a repressive role for FOXN1 in regulation of these genes.  This repression 
could happen either by direct binding of FOXN1 on gene promoters, or through 
indirect control of other regulatory factors that can then bind and affect downstream 
genes.  In both cases, these down-regulated genes may be expressed in a heterogeneous 
population of differentiating TECs (at E12.5), in which cells average profile shows an 
expressional decrease of these genes, however, this average expression profile (which 
at E12.5 better resembles a cTEC early phenotype) could be masking a few cells that 
would still be expressing these genes higher (less differentiated/expressing lower 
levels of Foxn1).  These genes may never reach as high levels of Foxn1 and could 
form the mTEC compartment by maintaining expression of these genes.  To examine 
the above scenario and to better envision how the differentiation of TEPCs occurs, 
gene expression values of the 264 down-regulated genes at E10.5 and E12.5 were 
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compared to the expression values of these genes in 1week old cTEC and mTEC 
(Figure 3.12). 
Gene expression values at E12.5 for particular genes in the down-regulated gene set 
were almost identical with those in 1 week old cTECs (Figure 3.12, top right panel, 
genes between 150 and 264 on x-axis), while the same genes were expressed much 
more highly in 1 week old mTECs (Figure 3.12, bottom right panel, genes between 
150 and 264 on x-axis).  On the other hand, the same group of genes at E10.5 TEPCs 
demonstrate similar expression levels to the same group of genes in 1w mTECs 
(Figure 3.12, bottom left panel, genes between 150 and 264 on x-axis).  The high 
similarity of the E10.5 TEPC gene expression profiles with the profiles in 1w mTECs 
could suggest a relation between these two populations.  However, if only a few cells 
maintain an E10.5 TEPC expressional profile (potentially less differentiated) when 
reaching the E12.5 developmental stage, gene expression values of these cells would 
be masked by the average E12.5 population gene profile which would represent on 
average a more cTEC-like phenotype. 
From this, I conclude that FOXN1 rapidly represses, either directly or indirectly, a 
number of genes on its induction in TEPCs.  These genes remain repressed in cTECs, 
and the repression is complete by E12.5.  However, since I observed a trend for these 
down-regulated genes to be expressed in mTECs, the possibility that a rare 
subpopulation of TEPCs at E12.5 continues to express these genes, and that these cells 
then generate the mTEC lineage, cannot be excluded.  This could be tested by 







Figure 3.12: Expression levels of the FOXN1-dependent, down-regulated genes (E12.5 versus 
E10.5) in E10.5 TEPCs, E12.5 TEPCs, 1w old cTECs and 1w old mTECs.  Expression levels of the 
FOXN1-dependent E12.5 versus E10.5 down-regulated genes are shown in pairwise comparisons of 
E10.5 TEPCs-1w cTECs (top left panel), E12.5 TEPCs-1w cTECs (top right panel), E10.5 TEPCs-1w 
mTECs (bottom left panel) and E12.5 TEPCs-1w mTECs (bottom right panel) to compare the 
expressional profiles of these genes between these populations.  Genes (represented in the x-axis) are 
sorted by increasing fold change (in absolute value), with stronger changes to be shown towards the end 










3.2.3 Foxn1 heterogeneity among E12.5 bipotent TEPCs 
To address the issue of Foxn1 heterogeneity among the E12.5 TEPCs (see section 
3.2.2), Foxn1 levels should be determined on a per cell resolution.  Foxn1 expression 
has already been established in TECs during prenatal development (Rode et al., 2015; 
O’Neill et al., 2016).  In particular, analysis of thymi from a Foxn1-eGFP reporter 
mouse line has demonstrated a graded expression of Foxn1 between cTECs (marked 
by the CD205 cTEC-specific marker) and mTECs (marked by the UEA1 mTEC-
specific marker) at E17.5 in mouse development (when mTEC numbers become 
appreciable) with the mTEC population to be expressing lower levels of Foxn1 
(O’Neill et al., 2016).  In earlier timepoints, there is no distinct separation among the 
cTEC and mTEC lineages but only a separation between the MHCIIhi and MHCIIlo 
cell populations (E13.5 TECs, see O’Neill et al., 2016), with the MHCIIlo TECs to be 
expressing lower levels of Foxn1.  The above published data come in support of a 
possible Foxn1 heterogeneity in E12.5 TEPCs, while they more specifically suggest 
the existence of a two-level graded Foxn1 expression pattern which would agree with 
the presence of a rare TEC progenitor among rest of the differentiating TECs at E12.5. 
If the E12.5 TEPCs are dynamically regulated based on Foxn1 levels, it would also be 
interesting to examine if cells of the same stage with higher Foxn1 level would 
demonstrate lower levels of the PLET1 marker whose expression has been linked to 
progenitor capacity of fetal TEPCs (Depreter et al., 2008; Ulyanchenko et al., 2016).  
Approximately 99% of E12.5 TEPCs are PLET1 positive (example FACS plot from 
Liu et al., 2017, submitted).  PLET1 was significantly down-regulated between the 
E10.5 and E12.5 timepoints, with its down-regulation being FOXN1-dependent (see 
section 3.2.2).  To determine how strongly PLET1 down-regulation depended on 
Foxn1 expression level, I observed the expression profile of Plet1 in relation to Foxn1 
levels in 31 thymic epithelia samples, comprising the TEPC samples from the TEPC 
Developmental series and Foxn1 Allelic series integrated dataset, the 1 week old cTEC 
and mTEC samples and the 4 week old mTEC subpopulations (St-Pierre et al., 2013; 
Sansom et al., 2014) consisting of immature, Aire knock-out, Aire negative, Aire 
positive and mature mTECs (see Chapter 2, section 2.2.1.4 for sample details). 
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To estimate the level of correlation between Plet1 and Foxn1 expression, I calculated 
gene-to-gene correlation across the aforementioned 31 datasets (replicates treated 
separately) using the Spearman method (non-parametric data) in combination with a 
statistics test to evaluate the confidence of the correlation.  Foxn1 expression was 
significantly anti-correlated to Plet1 (rho ≃  -0.85, p-value  ≃ 5 x 10-7), as shown in 
Figure 3.13, with strong dependence of Plet1 down-regulation on Foxn1.  Moreover, 
association of the Plet1/Foxn1 ratio with the differentiation status of the sample 
suggested a more immature/anti-differentiated phenotype in samples expressing more 
Plet1 and less Foxn1 (TEPCs and immature mTECs, Figure 3.13), and a more 


















Figure 3.13: Scatterplot of Plet1 versus Foxn1 among various TEC samples.  Correlation analysis 
of Plet1 and Foxn1 among the TEPC Developmental series and Foxn1 Allelic series integrated dataset, 
E14.5 PLET1- and PLET1+ TEC populations (Dong Liu, submitted), 1 week old cTECs and mTECs and 
4 week old immature, Aire knock-out, AIRE negative, AIRE positive and mature mTECs.  Level and 
statistical significance of the correlation between the two factors are shown under Spearman’s rank 
correlation, while sample labels are provided in the box on the right-hand side of the plot.  The null 
hypothesis (H0) of the test would consider that samples are not correlated.  H0 was rejected (p-value ≤ 














3.2.4  A well-defined TEP/SC gene signature from scRNA-seq data 
To investigate in depth the heterogeneity of Foxn1 expression in E12.5 TEPCs, and to 
determine the existence of a rare subpopulation of cells that expresses lower levels of 
Foxn1 and possibly mTEC-associated genes among the E12.5 TEPCs, single cell (sc) 
RNA-seq data from the E12.5 TEPC population needs to be generated.  Identification 
of a rare Foxn1low subpopulation of cells from the E12.5 TEPC scRNA-seq data would 
likely allow better characterisation of this population by a unique gene signature which 
could then be used to potentially identify the same population or its derivatives in other 
stages during thymus development.  Characterising the expressional profile of this 
population would also clarify if these cells are bipotent TEPCs or they better resemble 
mTEPCs not previously identified before.  Howbeit, if this population of (m)TEPCs is 
very rare, a larger number of E12.5 progenitors would be required to be sequenced to 
capture it. 
 
3.2.5 Alternative markers to use in combination with PLET1 and 
EpCAM to identify a homogeneous population of bipotent 
TEP/SCs 
PLET1 is able to identify and purify all TEPCs at E12.5 in prenatal mouse 
development (Bennett et al., 2002; Gill et al., 2002).  PLET1 has also been shown to 
mark medulla epithelia stem/progenitor cells in early thymus ontogeny that further 
generate medullary islets (Rodewald et al., 2001) and a rare cTEC specific population 
in the adult thymus (Ulyanchenko et al., 2016) that is able to generate both thymic 
epithelial lineages; it has, therefore, been associated with progenitor potential.  
However, after E12.5, appearance of PLET1- TECs demonstrated an equal capacity to 
generate a fully functional thymus.  This potency of both PLET1+ and PLET1- 
populations continues until E18.5 when the PLET1+ subpopulation becomes a 
minority (Swann and Boehm, 2007; Rossi et al., 2007b).  Thus, PLET1 alone becomes 
an insufficient marker to isolate TEPCs that are bipotent. 
In the absence of scRNA-seq data, it would be preferable to use an earlier timepoint to 
identify markers to use in combination with (or instead of) PLET1 for isolating 
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bipotent TEPCs or TESCs.  As discussed before, from the Foxn1 pseudo-timing 
analysis (section 3.2.1), and the Foxn1-Plet1 correlation analysis (section 3.2.3), 
E10.5 samples were shown to resemble on average a more undifferentiated TEP/SC 
population.  Therefore, representative markers of that population would be more likely 
to identify a premature state of the TEP/SCs. 
To generate a list of alternative markers to be used in combination with PLET1 for 
bipotent TEP/SC isolation, the integrated dataset of the TEPC Developmental series 
and Foxn1 Allelic series was scanned and genes were considered as candidate markers 
only if they met certain criteria.  The expression level of candidate TEP/SC markers 
should diminish from E10.5 to E12.5; thus, a more stringent FDR threshold (FDR <= 
0.05) was used to identify high confidence genes in the candidate down-regulated gene 
list.  To bias the identification of candidate TEP/SC markers that could be used for cell 
sorting, genes that were expressed at higher levels than Plet1 at the early E10.5 
undifferentiated progenitor stage (based on their average expression values across the 
E10.5 replicates from the TEPC Developmental series) and that could also bind to 
cell’s surface (transmembrane proteins) were selected.  The resulting list of the 




























Figure 3.14: Candidate marker list to be used in combination with PLET1 for TEP/SC isolation.   
The screening process for the candidate markers selected genes that were more highly expressed at 
E10.5 compared to Plet1, their expression decreased with Foxn1 increase and they could bind to the cell 
surface.  A list of these TEP/SC markers with their mean expression levels noted by a horizontal line 

































Multiple lines of evidence have demonstrated the importance of Foxn1 in respect to 
the thymic system, with Foxn1 to be indispensable for TEPC differentiation in each 
derived sublineage (Chen et al., 2009; Cheng et al., 2010; Corbeaux et al., 2010; 
Nowell et al., 2011; Su et al., 2003).  In one of these studies (Nowell et al., 2011), 
phenotypic analysis of thymi from an allelic series of mice expressing different levels 
of Foxn1 suggested that available levels of Foxn1 can determine both the size and the 
functionality of the thymi produced (either directly or indirectly through lack of 
regulatory signals between differentiating TECs and maturing T-cells).  In this chapter, 
I have made a list of observations based on bioinformatics analysis of RNA-seq series 
from early developmental stages of fetal TEPCs and newborn TECs to predict a 
potential TEPC differentiation model during thymus ontogeny.  
Observation 1:  The TEPC samples from the Foxn1 Allelic series, sorted for Foxn1 
increasing levels, correspond to wild type E10.5, E11.5 and E12.5 TEPCs from the 
TEPC Developmental series (see Figure 3.7), and thus the developmental steps that 
can be achieved in each of the allelic variants resemble a natural progression step of 
the fetal thymic epithelium.  Therefore, imposition of different maximum Foxn1 levels 
effectively corresponds to ‘pseudo-timing’ of early TEPC differentiation, with 
progression at each stage representing a natural progression step of TEPCs.  {this 
paragraph addresses Question 1 in section 3.1}  
Observation 2:  The average transcriptional profiles of the E10.5 TEPC samples (see 
groupings in Figure 3.7) and gene expression patterns of important TEPC and TEC 
lineage-specific markers (depicted in Figure 3.8) have indicated that the E10.5 TEPCs 
better resemble the E12.5 R/- and E12.5 Nude samples from the TEPC Developmental 
series, in which Foxn1 expression is majorly blocked.  The latter ones have been shown 
to be able to survive in vivo indefinitely and produce all thymic lineages upon Foxn1 
reactivation (Jin et al., 2014).  Additionally, these early E10.5 TEPCs are characterised 
by the highest levels of Plet1 (early thymic progenitor marker) compared to the rest of 
the TEPC developmental points, as shown by the differential expression analysis 
between the E10.5 and E12.5 sample triplicates, in which Plet1 was found to be down-
regulated with statistical significance in the E12.5 TEPCs (see section 3.2.1).  Plet1 
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expression was also found strongly anti-correlated (rho = -0.85, p-value ≤ 0.05) to that 
of Foxn1 (thymic pro-differentiation marker) in a correlation analysis performed 
among 31 TEC datasets (see section 3.2.3).  Together, these findings suggest that 
E10.5 TEPCs are more likely to consist a homogeneous TESC population (or bipotent 
TEPC population) that can give rise to all cTEC and mTEC sublineages and under the 
right conditions they could be maintained and expanded in vitro.  {this paragraph 
addresses Question 2 in section 3.1} 
Observation 3:  FOXN1-dependent genes that were differentially expressed between 
the E12.5 and E10.5 timepoints showed divergent patterns of expression among the 
cTEC and mTEC populations with up-regulated genes at E12.5 (vs E10.5) to exhibit 
higher expression in cTECs (vs mTECs) and down-regulated genes at E12.5 (vs E10.5) 
to exhibit lower expression in cTECs (vs mTECs) (see section 3.2.2, Figure 3.11 and 
Figure 3.12).  These patterns mainly represent the dynamic role of FOXN1 which 
appears to be acting both as an activator and a repressor for different groups of genes, 
resulting in divergent expression patterns maintained in the postnatal cTECs and 
mTECs (TEC populations that express Foxn1 in different levels).  Therefore, cTEC 
and mTEC fated cells could already be present among the E12.5 TEPCs, when Foxn1 
expression has been well established.  {this and the next paragraph address Question 
3 in section 3.1}   
A repressive role for FOXN1 has not been demonstrated before, thus here I discuss 
potential mechanisms by which FOXN1 could achieve gene repression in TEPCs.  In 
order to repress transcription of a particular gene, FOXN1 would have to bind to 
specific DNA sites and cause transcriptional inhibition.  Repression could be imposed 
by FOXN1 blocking or antagonising (lack of a stimulation domain or active inhibition 
through protein-protein interactions) for the binding site of a regulatory factor 
(transcription factor or member from the transcription initiation complex), or it could 
repress a certain group of genes by interacting with corepressors whose role is to 
modify the chromatin structure (reviewed in Gaston and Jayaraman, 2003).  
Nonetheless, FOXN1 ChIP-seq data will be vital to confidently demonstrate whether 




Observation 4:  Even though PLET1 has been linked to progenitor activity of TECs 
before (Bennett et al., 2002; Gill et al., 2002; Rodewald et al., 2001; Ulyanchenko et 
al., 2016), using solely PLET1 as a TEC early marker does not allow pure isolation of 
bipotent progenitors from the thymus in different embryonic stages of mouse 
development.  Therefore, in Chapter 3, I have used the E10.5 TEPCs (which better 
represent bipotent progenitors [see Observation 2]), in a comparative analysis versus 
the more progressed E12.5 TEPCs to identify a list of gene candidates which we could 
use in combination with PLET1 for better isolation of the early bipotent TEC 
population.  Subsequent filtering criteria used for the markers selection include equal 
or higher expression of these marker candidates at E10.5 compared to PLET1 
expression at the same stage and ability of these markers to bind the cell surface for 
more efficient cell isolation.  {this paragraph addresses Question 4, section 3.1} 
 
3.3.1 A potential TEP/SC differentiation model 
The in-silico observations from Chapter 3 inform a TEPC differentiation model {this 
section addresses Question 5 in section 3.1} in which E10.5 TEPCs represent (on 
average) an undifferentiated bipotent TEPC population (or TESCs) characterised by 
the highest Plet1 levels (in agreement with the progenitor capacity of these cells) 
[Observation 2], while from the onset of Foxn1 expression, E11.5 and E12.5 TEPCs 
comprise increasing proportions of differentiating TECs (lineage fated) whose 
progression is dependent on the Foxn1 level [Observation 1], with the possibility of 
distinctive expression profiles of cells to already exist among the E12.5 TEPCs that 
are then maintained in the differentiated cTEC and mTEC lineages [Observation 3]. 
Previous analysis of the Foxn1 levels on a per cell resolution in prenatal mouse 
development (O’Neill et al., 2016) has already proposed the existence of two 
populations with differing Foxn1 levels as early as E13.5 in mouse development that 
supports the prediction of a heterogeneous (or bimodal) expression pattern for Foxn1 
among the E12.5 TEPCs.  The subpopulation of cells that expresses Foxn1 in a lesser 
degree could comprise: a) less differentiated progenitor cells (more similar to the ones 
at the E10.5 or the E11.5 developmental stage) that will eventually increase their 
Foxn1 level and choose between a cTEC or an mTEC fate or b) mTEC fated 
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progenitors (mTEPCs) that will maintain moderate levels of Foxn1 and progressively 
become mTECs. 
E12.5 TEPC heterogeneity comes in opposition to the clonal analysis of TEPCs by 
Rossi et al. (2006) that demonstrated a capacity for the E12 TEPCs to differentiate into 
both cortical and medullary TECs.  However, unpublished data from Alison M. Farley 
(Blackburn lab, 2006) that repeated the clonal analysis for the E11.5 and E12.5 TEPC 
populations failed to reproduce the above results (injected cells would acquire only a 
cTEC phenotype).  As noted from correspondence with the authors, the only difference 
between the two protocols was due to cells laying in an overnight culture before 
injected in the aged matched developing thymus.  Apparently, keeping TEPCs in 
culture, reduces average levels of Foxn1 in the population.  It is then possible that the 
majority of the TEPCs in culture return to a more immature state and become again 
TEP/SCs.  If that is the case, Rossi et al. has really demonstrated that TEPCs at E12.5 
still exist in a transient state and are still capable of returning to a more immature state 
through adjustment of the Foxn1 levels, while Farley demonstrated that the majority 
of E12.5 TEPCs lack bipotency and are most probably cTEC fated progenitors.   
Collectively, the bioinformatics observations in conjunction with experimental 
evidence (denoted when necessary in the paragraphs above) can inform of a TEPC 
progression model, in which the E10.5 TEPCs comprise undifferentiated bipotent 
progenitors, while the TEPCs in later developmental stages (E11.5 and E12.5) are 
characterised by cell heterogeneity, which takes place after increase in Foxn1 
expression.  Three different versions of heterogeneity can be assumed based on the 
available data:  Version 1 describes the E11.5 and E12.5 TEPCs to consist of (more 
immature) bipotent TEPCs and cTEC fated progenitors (cTEPCs), version 2 envisions 
that the E11.5 and E12.5 TEPCs constitute mTEC fated progenitors (mTEPCs) and 
cTEPCs, while version 3 proposes the possibility of all three populations (TEPCs, 
mTEPCs and cTEPCs) to be apparent within the E11.5 and E12.5 TEPCs in different 
proportions.  The predicted TEPC progression model with the alternative 
heterogeneity versions of the E11.5 and E12.5 TEPC populations are illustrated 





Figure 3.15: Schematic representation of a potential TEPC differentiation model towards the TEC 
sublineages.  In this model, E10.5 TEPCs (light magenta colour) represent (on average) an 
undifferentiated TEPC population (or a TESC population, see section 3.2.1), while from the onset of 
Foxn1 expression, cells progressively comprise increasing populations of TEPC-fated cells (red/magenta 
and magenta/blue shades, see discussion in section 3.3.1); these TEPC-fated cells shall give rise to the 
cTEC (red colour) and mTEC (blue colour) main lineages.  The predicted TEPC heterogeneity, which is 
depicted in the E11.5 and E12.5 developmental stages of this model, could be resolved by alternative 
versions of existing populations:  In version 1, only bipotent TEPCs and cTEC-fated progenitors 
(cTEPCs) are present in the E11.5 and E12.5 TEPCs.  In version 2, only mTEC-fated progenitors 
(mTEPCs) and cTEPCs exist within the above populations, and in version 3, TEPCs, cTEPCs and 
mTEPCs altogether form the above populations.  The TEPC and the mTEPC populations are illustrated 
with a dashed line at the developmental timepoints E11.5 and E12.5, to represent the alternative versions 
of heterogeneity within the proposed model, because in version 1 and in version 2, mTEPCs and TEPCs 
respectively are absent from the E11.5 and E12.5 timepoints.  Notably, the E11.5 and E12.5 cTEPCs or 
mTEPCs are able to return to a less immature or bipotent state upon Foxn1 reduction (Farley 2006; 







The model in Figure 3.15 agrees with the serial progression model of TEC 
differentiation reviewed in Takahama et al. (2017) that describes together the current 
understanding around “TEPCs towards TECs” differentiation based on existing 
literature.  Briefly, starting from a bipotent progenitor stage, TEPCs have to go through 
a cTEC-like TEPC stage [expressing Ly75 (Cd205), β5t (Psmb11) and Il7] from which 
a Claudinhi SSEA1+ mTEC stem cell population derives through an unknown 
mechanism and further differentiates into the mTEC lineage, while cells not expressing 
these latter markers will further differentiate into cTECs (see Chapter 1, Figure 1.2).  
Our model, in comparison to the one reviewed by Takahama et al., additionally 
suggests the existence of a (m)TEPC population among the cTEC-like TEPCs 
(E11.5/E12.5 TEPCs, see Figure 3.15) that would eventually consist some mTEC 
population, or act like a bipotent progenitor.  If existent, this population could consist 
part of the unknown mechanism that gives rise to the Claudinhi SSEA1+ mTEC stem 
cells, since E10.5-E12.5 TEPCs do not express the SSEA1 marker just yet.  Lastly, 
since all mTECs seem to have experienced expression of Ly75 (CD205), β5t 
(PSMB11) and Il7 in early ontogeny (Ohigashi et al., 2013), I would expect this 
population to also express (momentarily or continuously in a low level) these genes 
among other genes that are found highly expressed in E10.5 TEPCs and newborn 
mTECs. 
To examine the prospect of a heterogeneous expression of Foxn1 in E12.5 TEPCs and 
the existence of a rare TEPC and/or mTEPC subpopulation, scRNA-seq data for the 
E12.5 TEPCs will be required.  scRNA-seq data will verify current predictions/ 
findings presented here.  If enough cells express Foxn1 at a low level, the scRNA-seq 
data will also be able to generate a gene signature to allow isolation of this particular 
population of cells (even from later developmental stages) for expansion and 
functional characterisation.  Because these data are not yet available, uniquely 
expressed genes in E10.5 TEPCs that are expressed higher than Plet1 and are also able 







RNA-seq data integration in conjunction with comparative bioinformatics analysis 
was used in Chapter 3 to investigate the early state of TEPCs in conjunction to Foxn1 
expression and to also develop a potential model of TEPCs differentiation towards the 
cTEC and mTEC sublineages.  In Chapter 3, I have shown that precise expression 
levels of Foxn1 play a vital role in regulating TEPCs identity, with different maximum 
Foxn1 levels to effectively correspond to ‘pseudo-timing’ of TEPCs natural 
progression in the fetal thymic epithelium.  Furthermore, it is the first time that a 
repressive role for FOXN1 has been indicated, with additional analysis to be required 
to confirm whether the repressive effect is due to direct binding of FOXN1 on DNA 
regulatory regions or due to indirect regulation of other transcription factors.  In 
Chapter 3, I also propose a new in silico TEPC differentiation model which 
encompasses the existence of a common bipotent progenitor (at E10.5) and appearance 
of lineage-specific progenitors (from E11.5 onwards).  Therefore, based on these 
findings and a clonal analysis of the E12.5 TEPCs by Farley (Blackburn lab), the 
current bipotent E12.5 TEPCs suggested by Rossi et al. (2005) is revisited.  Our data, 
in combination with the Rossi et al. paper, suggest that E12.5 cTEPCs and mTEPCs 
could exist in a transient state where lineage restriction can be amended through Foxn1 
expression reduction.  Markers to use in combination with (or without) PLET1 for the 


















































An in silico model of the signalling 
requirements for the survival and 
expansion of bipotent fetal TEPCs 
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Chapter 4  
 
An in silico model of the signalling requirements for 





The thymic primordium is believed to contain bipotent thymic epithelial progenitor 
cells (TEPCs) from the time of its formation at least until the onset of expression of 
FOXN1, the transcription factor (TF) whose continuous expression is necessary for 
development and maintenance of a functional thymus.  These undifferentiated TEPCs 
present in the early fetal thymus can reconstitute all known thymic epithelial cell 
lineages and direct the formation of a complete, fully functional thymus (Gordon et 
al., 2004).  Differentiation arrest of TEPCs occurs in nude mice, which lack functional 
Foxn1 due to a null mutation (Nehls et al., 1996).  Recently, it has also been shown 
that when FOXN1 expression is blocked, at least some TEPCs are retained in a 
bipotent state, and these remain present in vivo apparently indefinitely (Jin et al., 
2014).  This indicates that the cell state upstream of FOXN1 initiation is inherently 
stable, and suggests that these cells effectively function as thymic epithelial stem cells 
(TESCs).  Expanding this population of cells in vitro could assist significantly in 
minimising the cost and time in thymus research.  
During fetal thymus development, early patterning of the 3rd pharyngeal pouch into 
the thymus and the parathyroid specific structures occurs in a neighbouring cell – 
independent way (Griffith et al., 2009), while domain spreading of both organs and 
separation from the pharynx are dependent on the existence of a supporting 
mesenchymal population around both primordia (Franz, 1989).  Interactions between 
the thymic epithelium that resides in the expanding primordium and the surrounding 
mesenchyme enables proliferation and differentiation of the undifferentiated TEPCs 
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towards cortical and medullary lineages independently of further lympho-epithelia 
crosstalk (Klug et al., 2002).  Previous research has indicated the WNT (Balciunaite 
et al., 2002), FGF (Frank et al., 2002), SHH (Moore-Scott and Manley, 2005) and 
BMP (Bleul and Boehm, 2005; Patel et al., 2006; Tsai, 2003) signalling pathways as 
regulators of the early TEPC state through endocrine signalling or provision of soluble 
growth factors, since diminished or enhanced activity of these pathways can lead to 
athymia or thymic hyperplasia.  Additionally, it has been proposed that FOXN1 
expression may be regulated by WNT and BMP signalling pathways (Balciunaite et 
al., 2002; Soza-Ried et al., 2008).  Despite this progress, a comprehensive model that 
describes dynamic regulation of signalling activity during the transition from 
undifferentiated TEPCs into differentiating TEPCs has not yet been described.  
To achieve the expansion of TEPCs in vitro, understanding of the intrinsic and 
extrinsic regulation of this upstream cell state and of FOXN1 initiation is needed, as 
expansion of TEPCs in vitro will require imposition of a reversible early block in 
differentiation and also fine-tuned experimental conditions for these cells to survive 
and grow.  Thus, in Chapter 4, I aimed to generate an unbiased in silico model of 
signalling pathways activity during fetal thymus development that could be used to 
assist with TEP/SC maintenance and proliferation in vitro.  Additionally, to support 
the integrity of this in silico model, throughout section 4.2.3 of Chapter 4 I have 













4.2.1 Pathways reshaped at the onset of Foxn1 expression in 
TEP/SCs: pathways switching off 
To predict signalling pathways that reshape on the onset of FOXN1 expression, when 
early undifferentiated TEPCs start to differentiate, I extended the differential 
expression analysis (described in Chapter 3, section 3.2.1) that was performed 
between the E10.5 and E12.5 samples from the TEPC Developmental series (RNA-
seq data from biological triplicates per stage provided by Harsh Vaidya, Blackburn 
lab; see also Chapter 2, section 2.2.1) using pathway enrichment analysis. 
For the pathway enrichment analysis, the fold change values of the total 15,321 
differentially expressed genes from the comparative analysis of RNA-seq data from 
PLET1+ TEPCs isolated at E10.5 and E12.5 were provided as a ‘Pre-Ranked Gene 
List’ in GSEA (Subramanian et al., 2005) and analysed against the edited 
ConsensusPathDB database (Kamburov et al., 2011, details in Chapter 2, section 
2.3.3.6).   This approach should predict signalling pathways that alter between these 
two developmental stages. 
The GSEA output indicated two groups.  The first is pathways demonstrating increased 
intracellular signalling activity while TEPCs proceed from E10.5 to E12.5; these are 
referred to as up-regulated pathways.  The second group is pathways that demonstrate 
decreased or complete loss of intracellular signalling activity while TEPCs proceed 
from E10.5 to E12.5; these are referred to as down-regulated pathways.  Since the 
purpose of this analysis is to identify pathways implicated in regulation of the 
proliferation and survival of early undifferentiated TEPCs, I focused my analysis on 
pathways that exhibit more activity at the early E10.5 developmental stage and whose 
activity is found to decrease over time (down-regulated list of pathways).  From these 
down-regulated pathways, only those that had an FDR ≤ 0.25 (enriched with statistical 
significance) and were related to signalling were considered for further investigation.  




Table 4.1: List of enriched signalling pathways with decreased activity in TEPCs between E10.5 and E12.5 timepoints.  In sequence, the columns show the name 
of each enriched pathway (GS follow link to MSigDB), the number of Pre-Ranked genes identified per pathway (size), the enrichment score of each pathway (ES), the 
enrichment score of each pathway normalised for the size of the pathway (NES), the nominal p-value (NOM p-val) that is not adjusted for the pathways size or multiple 
hypothesis testing and the FDR q-val (see Chapter 2, section 2.3.3.6). 
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Pathway enrichment analysis can often be limited by the complexity of the database 
used to predict enrichment for a particular gene set.  By complexity we refer to the size 
(number of pathways) and coverage (number of organisms and cell types represented) 
of the database in relation to the system under investigation.  Database curation, based 
on the current literature, defines pathways and assigns genes to them accordingly. 
Thus, de novo pathway analysis can only identify known pathways.  However, current 
annotation is far from perfect, with signalling pathways to also often have different 
function in different cell types, thus relying on pathways names to identify the 
pathways involved in regulation of a new cell type can be misleading.  Additionally, 
when a pathway is represented by a large number of genes, random accumulation of 
some genes may indicate that the pathway is enriched (or active) in that cell type, even 
though the main signalling molecules of the pathway (such as ligands, intermediate 
signalling molecules and receptors) may be missing. 
To further analyse the resulting pathways in Table 4.1, pathways that shared a large 
number of genes contributing to their enrichment were grouped together (see Figure 
4.1).  Additionally, individual genes that contribute to each pathway’s core enrichment 
were manually inspected and when appropriate the related pathway was renamed to 
better fit the contained genes (for detailed listing of genes see sections below).  For 
complicity, non-differentially expressed genes were also considered (if expressed) per 
pathway if they consisted essential molecules for the pathway’s function.  In the case 
of NEURAL CREST DIFFERENTIATION and HEDGEHOG SIGNALING 
PATHWAY pathways (#37 and #38 in Table 4.1, genes contributing to their core 
enrichment could be assigned to more than one major signalling pathways, thus all 
related pathways were included in the renaming of the #37 and #38 pathways (Table 
4.1) respectively (see Figure 4.1).  From these further analyses, six main pathways 
have been identified from the data presented in Table 4.1: the Fibroblast Growth 
Factor (FGF) signalling pathway, the NOTCH signalling pathway, the canonical and 
non-canonical Wingless Integration-1 (WNT) signalling pathways, the Sonic 
Hedgehog (SHH) signalling pathway and the Insulin-like Growth Factor (IGF) 






Figure 4.1: Grouped overview of the down-regulated signalling pathways based on core 
enrichment genes overlap.  High overlap of core enrichment genes among pathways allowed grouping 
of the statistically significant signalling pathways (listed in Table 4.1) in broader categories with names 
that better represent their underlying signalling mechanism/process (colour coded pathways per 
category).   In addition, the core enrichment genes of the NEURAL CREST DIFFERENTIATION (#37) 
and the HEDGEHOG SIGNALING PATHWAY (#38) pathways could be assigned to more than one major 
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The above analysis is informative about the intracellular signalling mechanisms that 
are active in early undifferentiated TEPCs, but it can also identify signalling pathways 
activated in response to ligands provided by neighbouring cells (e.g. mesenchymal 
cells or migrating haematopoietic progenitors) by assessing the expression of effector 
genes known to be activated in response to specific signalling. 
In sections 4.2.1.1 to 4.2.1.4, I consider in detail the curated categories outlined in 
Figure 4.1, discussing the details of each category, including the expression levels of 
the relevant ligands, intracellular molecules and receptors, and core enrichment genes 
per pathway, and outlining which of these genes are differentially expressed with 
statistical significance (FDR ≤ 0.2, see Chapter 3, section 3.2.2 for threshold 
selection) between the E12.5 and E10.5 from the TEPC Developmental series to 
represent more confident changes between the two timepoints.  Representative graphs 
combining all resulting pathways in groups of two follow at the end of this section 
(Figure 4.6). 
 
4.2.1.1 FGF signalling pathway 
Three curated pathways, namely, the SHC-MEDIATED CASCADE (#4), FRS2-
MEDIATED CASCADE (#14) and NEGATIVE REGULATION OF FGFR 
SIGNALING (#20) (Table 4.1), were found to share the same core genes contributing 
to their enrichment score (see Figure 4.1 for overlap and Figure 4.2 for the list of core 
enrichment genes).  These were therefore grouped together under the category FGF 
signalling, since the enriched genes constitute the main ligands and receptors of the 
FGF signalling pathway (for detailed references to the FGF signalling pathway and its 
role in thymus development see Chapter 1, section 1.2.4.3).  The top ranked core 
















Figure 4.2: GSEA Enrichment plot for the SHC-MEDIATED CASCADE pathway and gene list of 
core enrichment.  Enrichment score on the GSEA plot (top y-axis) indicates the degree of over-
representation (in absolute value) for the provided pre-ranked gene set (differentially expressed genes – 
E12.5 versus E10.5) and the direction of their regulation (negative sign/down-regulated genes).  The Pre-
Ranked list metric (GSEA plot, bottom y-axis) provides information over the numeric ranking used to 
weight genes (in this case log fold change), while the barcode bars (GSEA plot, middle part) represent 
all gene hits in the particular pathway with genes contributing to core enrichment of the pathway listed in 
the table next to the Enrichment plot. Differentially expressed genes for an FDR ≤ 0.2 are colour-coded 
in blue (* FDR ≤ 0.05, ** FDR ≤ 0.01). 
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Based on the expression data from the TEPC Developmental serie, Fgf8 was strongly 
expressed in the undifferentiated TEPCs at E10.5, but was not expressed in E11.5 or 
E12.5 TEPCs.  Fgf10 was moderately expressed in E10.5 TEPCs and was also absent 
at E11.5 and E12.5.  Fgf3, despite its apparent down-regulation in terms of fold-
change, exhibited very low level expression at all three TEPC developmental stages.  
Fgfr1 was expressed in E10.5 TEPCs, albeit at lower levels than Fgf8, with its 
expression progressively to decrease at E11.5 while it is fully absent in the E12.5 
TEPCs.  Notably, Fgf10, Fgf7 and Fgf3 comprise the main ligands of the Fgfr2-IIIb 
receptor, and therefore expression levels of Fgfr2-IIIb are also noted in the collective 
pathways representation (Figure 4.6). 
 
4.2.1.2 NOTCH, BMP and canonical WNT signalling pathways 
Inspection of the NEURAL CREST DIFFERENTIATION (#37) pathway indicated 
that its core enrichment genes (see top right panel in Figure 4.3) mainly comprised 
regulators of the NOTCH signalling pathway. 
Of NOTCH pathway genes, the receptor Notch3, ligands Dll1, and Dll3, effector Rbpj 
and target Msx2 contributed significantly to the enrichment of the NEURAL CREST 
DIFFERENTIATION pathway.  These genes demonstrate a continuous down-
regulation from E10.5 to E12.5 stage in TEPCs, indicating a gradual decrease in 
pathway activity.  However, NOTCH signalling seems to exhibit more complex 
regulation in the early development of the thymic epithelium since one of its main 
ligands, Dll4, is targeted by FOXN1 and reaches high levels of expression at E12.5, in 
contrast to the above trend.  In agreement with the Dll4 up-regulation, two of 
NOTCH’s main target genes [Hes1 (FDR ≤ 0.05) and Heyl (FDR ≤ 0.2)] also up-
regulate when cells proceed towards the E12.5 stage.  Finally, one of NOTCH’s main 
receptors (Notch1) seems to be constitutively expressed in all three timepoints, 
suggesting that the pathway could be active in all of them but its activity may be 
dynamically regulated based on provision of ligands by different groups of cells at 
distinct timepoints.  
Other genes contributing to the NEURAL CREST DIFFERENTIATION pathway 
enrichment, and also strongly down-regulated with statistical significance between 
123 
 
E10.5 and E12.5 (FDR ≤ 0.2), include Fgf8 and Fgfr1 (see section 4.2.1.1 above), 
Homeobox B1 (Hoxb1), Peripheral myelin protein 22 (Pmp22), Transcription factor 
AP-2 alpha (Tfap2a), T-Cell leukemia homeobox 2 (Tlx2), Paired like homeobox 2b 
(Phox2b), Collagen type II alpha 1 chain (Col2a1) and Protogenin (Prtg).  From the 
above, only Col2a1 and Prtg were expressed at E12.5, while only Col2a1, Prtg and 
Phox2b were expressed at E11.5.   The remaining genes were only present in E10.5 











Figure 4.3: GSEA Enrichment plot for the NEURAL CREST DIFFERENTIATION pathway and gene 
list of core enrichment.  Enrichment score on the GSEA plot (top y-axis) indicates the degree of over-
representation (in absolute value) for the provided pre-ranked gene set (differentially expressed genes 
– E12.5 versus E10.5) and the direction of their regulation (negative sign/down-regulated genes).  The 
Pre-Ranked list metric (GSEA plot, bottom y-axis) provides information over the numeric ranking used 
to weight genes (in this case log fold change), while the barcode bars (GSEA plot, middle part) represent 
all gene hits in the particular pathway with genes contributing to core enrichment of the pathway listed in 
the table next to the Enrichment plot.  Differentially expressed genes for an FDR ≤ 0.2 are colour-coded 






4.2.1.3 SHH and WNT (non-canonical) signalling pathways 
The HEDGEHOG SIGNALING PATHWAY (#38, Table 4.1) enrichment plot and 
list of genes contributing to the pathway’s core enrichment are shown in Figure 4.4.  
Patched 1 (Ptch1), Patched 2 (Ptch2), Serine/Threonine Kinase 36 (Stk36) and GLI 
Family Zinc Finger 1 (Gli1) are all major effectors of the SHH pathway.  Of these 
genes, Ptch1 (the main receptor of Shh) was down-regulated between E10.5 and E12.5 
with statistical significance (FDR ≤ 0.2), while closer inspection of the mRNA levels 
for all the above genes revealed very low level of expression at E10.5, which 
progressively became incompetent or fully absent, suggesting that this pathway is 
potentially switched off before TEPCs progress to E12.5.  Inactivation of the SHH 
signalling in TEPCs is consistent with former literature that shows SHH signalling to 
drive cells differentiation towards the parathyroid fate by restricting the expression of 
the Gcm2 main regulator of the parathyroid (Grevellec et al., 2011).  
Further overview of the core list of genes for the HEDGEHOG SIGNALING 
PATHWAY suggested that some of the genes allocated to this pathway could also 
activate the WNT non-canonical pathway.  WNT Family Member 5A (Wnt5a) and 
WNT Family Member 5B (Wnt5b) are components of the non-canonical WNT 













Figure 4.4: GSEA Enrichment plot for the HEDGEHOG SIGNALING PATHWAY and gene list of core 
enrichment.  Enrichment score on the GSEA plot (top y-axis) indicates the degree of over-representation 
(in absolute value) for the provided pre-ranked gene set (differentially expressed genes – E12.5 versus 
E10.5) and the direction of their regulation (negative sign/down-regulated genes).  The Pre-Ranked list 
metric (GSEA plot, bottom y-axis) provides information over the numeric ranking used to weight genes 
(in this case log fold change), while the barcode bars (GSEA plot, middle part) represent all gene hits in 
the particular pathway with genes contributing to core enrichment of the pathway listed in the table next 
to the Enrichment plot.  Differentially expressed genes for an FDR ≤ 0.2 are colour-coded in blue (* FDR 
≤ 0.05, ** FDR ≤ 0.01). 
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4.2.1.4 IGF signalling pathway 
The SIGNALING BY IGFR1 (#48), IGF1R SIGNALING CASCADE (#47) and IRS-
RELATED EVENTS TRIGGERED BY IGF1R (#45) pathways were also found to 
share the majority of core genes contributing to their enrichment (see Figure 4.5) and 
were grouped together under the IGF signalling category (Figure 4.1), since Insulin 
Like Growth Factor 1 (Igf1) and Insulin Like Growth Factor 2 (Igf2) are the main 
ligands of the IGF signalling pathway, while SHC Adaptor Protein 2 (Shc2), Insulin 
Receptor Substrate 1 (Irs1) and Insulin Receptor Substrate 4 (Irs4) consist part of the 
IGF signalling cascade.  The genes enriched in these categories also included all those 
that contribute to the FGF pathway core enrichment (see section 4.2.1.1). 
Both IGF ligands showed decreased expression at E12.5 compared to E10.5, with Igf1 
reaching very low levels of expression by E12.5.  To form a more complete picture of 
the IGF intracellular activity, levels of the IGF receptors (IGF1R and IGF2R), as well 
















Figure 4.5: GSEA Enrichment plot for the IGF1R SIGNALING CASCADE and gene list of core 
enrichment.  Enrichment score on the GSEA plot (top y-axis) indicates the degree of over-representation 
(in absolute value) for the provided pre-ranked gene set (differentially expressed genes – E12.5 versus 
E10.5) and the direction of their regulation (negative sign/down-regulated genes).  The Pre-Ranked list 
metric (GSEA plot, bottom y-axis) provides information over the numeric ranking used to weight genes 
(in this case log fold change), while the barcode bars (GSEA plot, middle part) represent all gene hits in 
the particular pathway with genes contributing to core enrichment of the pathway listed in the table next 
to the Enrichment plot.  Differentially expressed genes for an FDR ≤ 0.2 are colour-coded in blue (* FDR 




4.2.2 A testable model of the signalling pathways required to 
maintain and expand TEP/SCs in vivo 
From the outcomes of the pathway enrichment analysis presented in section 4.2.1 and 
its subsections, I set out to create an in silico model that collectively summarises the 
pathways that down-regulate or switch off when cells proceed towards differentiation. 
The main regulators of the signalling pathways predicted in the enrichment analysis 
above (section 4.2.1) including the ligands, transient signalling molecules and targets 
are illustrated in Figure 4.6.  The core enrichment genes exhibiting consistent changes 
(Figure 4.2-Figure 4.5, coloured in blue) between the two developmental timepoints 
were then used to guide assembly of a signalling pathways model over all pathways.  
To improve the consistency of the model, when main pathway regulators were not part 
of the core enrichment gene list, they were added to the graph, with representative 
expression values from the TEPC Developmental series dataset. 
The SHH, WNT (canonical and non-canonical), NOTCH, BMP, FGF and IGF 
signalling pathways are thus depicted in Figure 4.6, with SHH effectively absent from 
all TEPC stages, the IGF, FGF and non-canonical WNT pathways to show a 
substantial decrease in ligand-expression (note: extrinsic provision of these ligands is 
possible), while NOTCH activity exhibits more complex regulation.  Previous 
literature has already demonstrated roles for the SHH, FGF and IGF pathways in early 
fetal thymus development, partially validating the outcomes of this model.   
The nature of Wnt5a, as a secreted protein, suggests that it could affect distinct 
regulatory pathways downstream in TEPCs but also in surrounding cells.  Previous 
research has identified multiple alternative receptors (He et al., 2008; Keeble, 2006; 
Martinez et al., 2015) through which WNT5A may establish its action, as well as 
partner proteins (Matsuyama et al., 2009) that can regulate cells by interacting with 
WNT5A.  In the model illustrated in Figure 4.6, Wnt5a is expressed very highly in 
E10.5 TEPCs and it subsequently down-regulates (FDR ≤ 0.03) in the later 
developmental stages.  A list of potentially involved receptors and interactors based 
on current literature is shown in Figure 4.7, where the log2 (RPKM) normalised 
expression values from the TEPC Developmental series dataset were used to depict 
the expression levels of these genes during early TEPC development.  Even though 
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both Ryk and Sfrp1 genes are expressed in a high enough level to allow signal 
transduction, the only gene that mimics Wnt5a pattern of expression and down-
regulates with statistical significance (FDR ≤ 0.05) towards the E12.5 timepoint is 
WNT5A potential interactor, Sfrp2.  Based on this, we can speculate that WNT5A-
SFRP2 (and/or SFRP1) protein interaction, as well as binding of WNT5A to the RYK 
receptor could control signalling processes in early undifferentiated TEPCs. 
It is apparent in Figure 4.6 that NOTCH signalling activity (as represented from the 
early TEPC samples) cannot describe a definitive trend of action.  The NOTCH ligand 
genes Dll1 and Dll3, receptor gene Notch3 and intermediate molecule Rbpj are clearly 
“switching off” by E12.5, when the NOTCH ligand Dll4, and target genes Hes1 and 
Heyl exhibit their highest expression level, with the NOTCH receptor Notch2 to be 
constitutively highly expressed in all three developmental stages.  It is possible that 
different levels of activity and involved molecules take part in distinct developmental 
stages.  Throughout these stages, the undifferentiated TEPCs have evolved towards 
more fated progenitors, now possibly constituting a more progressed cell type in the 
thymic lineage which may require NOTCH signalling for different purposes.  It is also 
likely that NOTCH may affect cells in a non-equal manner, since a number of cells 
that exhibit NOTCH signalling need to be the signal senders, while their neighbouring 
cells should be receiving the signal through cell-to-cell interactions.  It is evident that 
the role of NOTCH in early TEPCs requires further exploration to generate a more 
definitive picture of its action. 
Notably, Msx2 has been linked to the NOTCH, BMP and WNT pathways during 
differentiation of other cell types other than the thymic epithelium.  In the most 
relevant example, Msx2 together with Foxn1 have been shown to act upstream of the 
NOTCH pathway and promote hair shaft differentiation (Cai et al., 2009).  
Furthermore, in multipotent mesenchymal progenitors, BMP signalling has been 
shown to up-regulate Msx2 which in turn promotes differentiation of the osteogenic 
lineage that contributes into calcification of the vasculature (Cheng et al., 2003).  
Additionally, BMP-Msx2 signalling has been demonstrated to up-regulate the 
canonical WNT signalling through up-regulation of the WNT ligands in artery 
calcification (Shao et al., 2007).  Lastly, during osteogenic differentiation of vascular 
smooth muscle cells, Msx2 is regulated through NOTCH signalling in an independent 
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manner of that of the BMP signalling (Shimizu et al., 2009).  In short, Msx2 consists 
a common target or regulator of BMP, NOTCH and WNT signalling pathways and its 
expression is highly related to the cells differentiation state. 
In summary, in Figure 4.6, I provide a collective in silico model of signalling activity 
for the early undifferentiated TEPCs that can assist in better understanding TEPC 
differentiation in vivo.  Detailed interpretation of this model in combination with the 












































Figure 4.6: Schematic 
representation of the 
down-regulated 
signalling pathways 
activity model in the 
early TEPCs to assist 
TEPCs expansion in 
vitro.  Assembled graph 
depicts TEPCs 
differentiation over E10.5, 
E11.5 and E12.5, with 
darker shades of purple 
shading cells that express 
higher levels of Foxn1. 
Expression levels of main 
ligands, intermediate 
transducers and receptors 
per pathway are explained 
by colour-coding, while 
when multiple alternative 
regulators exist, they are 
shown in black colour and 
the “?” symbol to  
denominate unknown 
regulation and are further 

























Figure 4.7: Expression profiles of Wnt5a receptors and interactors in TEPCs.  Average log2 RPKM 
expression values of the WNT5A receptors and interactor genes (including Wnt5a itself) over the E10.5, E11.5 
and E12.5 timepoints (sample triplicates) from the TEPC Developmental series.  Statistical significance 
calculated from the differential expression analysis between the E10.5 and E12.5 timepoints using the limma 




























4.2.3 Exploring NOTCH signalling in the thymic epithelium: 
regulation of the medullary thymic epithelial cell lineage via 
specification of medullary progenitor cells. 
NOTCH signalling has a crucial role in thymocyte development (Shah and Zuniga-
Pflucker, 2014) and its down-regulation has recently been shown to be required to 
promote the later stages of mTEC development (Goldfarb et al., 2016; Jiang et al., 
1998; Masuda et al., 2009).  However, the potential for NOTCH to regulate early 
TEPC development has not yet been studied in detail.  The pathway enrichment 
analysis in section 4.2.1 has indicated NOTCH signalling to exhibit complex 
expression in the PLET1+ TEPCs at E10.5, E11.5 and E12.5 developmental stages, 
with Rbpj (the transcriptional effector required to transduce NOTCH signals) showing 
decreased expression when proceeding towards the E12.5 stage (see 4.2.1.2), 
complementary to the decreased activity of the other NOTCH pathway genes Notch3, 
Dll1, Dll3, and  Msx2 (Figure 4.3), while the NOTCH ligand Dll4 and the NOTCH 
target genes Hes1 and Heyl demonstrate an opposite pattern of behaviour with 
significant up-regulation of their expression towards the E12.5 TEPCs.  This 
implicates NOTCH signalling as a potential regulator of the early fetal TEPC state, 
and therefore I selected this pathway for further investigation. 
 
4.2.3.1 Genetic ablation of NOTCH signalling in early TEPCs under the 
control of Foxn1 demonstrates an effect only in the mTEC compartment 
To validate and better understand the importance of NOTCH activity in early fetal 
TEPCs and differentiating TECs, NOTCH signalling had to be blocked in all TECs.  
RBPJ is the main signal transducer of NOTCH signalling and deletion of it should 
block NOTCH activity in cells that express NOTCH.  Therefore, Foxn1Cre mice were 
crossed with an Rbpj conditional knockout (cKO) line (Dong Liu, Blackburn lab), 
creating a mouse model line (Foxn1CreRbpjFl/Fl mice), where RBPJ was absent from all 
TECs (Rbpj exon deletion is under the control of Foxn1 promoter).  Analysis of 2 week 
old mice (Dong Liu, Blackburn lab) demonstrated a reduced proportion of mTECs 
among total TECs in both male and female mice, while numbers of cTECs remained 
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unaffected.  T-cell differentiation proceeded normally in the Rbpj cKO mice, with T 
regulatory cells showing no apparent differences when compared to the control mice 
suggesting that the model was specific for the TEC compartment of the developing 
thymus (Liu et al., 2017, submitted).  These data suggested a unique impact of the 
early loss of NOTCH signalling activity (loss-of-function assay) in the differentiating 
mTEC population. 
Therefore, to probe at the transcriptional level the effect of loss of RBPJ on TEPC, 
RNA-seq datasets from wild type (WT) and Foxn1CreRbpjFl/Fl (RBPJ cKO; loss-of-
function; LOF) PLET1+ TEPC at E12.5 (biological triplicates per population; see 
also Chapter 2, section 2.2.1.3), and PLET1+ and PLET1- TEPC at E14.5 (biological 
triplicates per population; see also Chapter 2, section 2.2.1.3) were used; these 
datasets were generated by Dong Liu (Blackburn lab, University of Edinburgh).  The 
cell populations analysed were chosen since, at E12.5, although the PLET1+ TEPC 
population is already heterogeneous, and will contain cTEC-fated cells along with 
common TEPCs and potentially mTEC-restricted progenitors, it cannot be split on the 
basis of known cell surface markers.  At E14.5, prospective mTECs appear to be 
contained within the PLET1+ population, while prospective cTECs have down-
regulated this marker.  NOTCH resides in both TEC compartments. 
To retrieve the normalised gene counts of the WT and RBPJ cKO (LOF) datasets, I 
ran the RNA-seq pre-analysis and core-analysis pipelines (described in Chapter 2, 
sections 2.3.2 and 2.3.3) that I have put together for the analysis of RNA-seq datasets 
in this thesis. I next used the generated log2 RPKM normalised values of the above 
datasets to observe samples similarity based on their expressional profiles and I also 
further applied differential expression analysis between selected samples (see next 
paragraphs) to identify genes that change with statistical significance. 
No obvious differences were observed from the differential expression analysis 
performed between the PLET1+ WT and PLET1+ LOF samples at E12.5.  As expected 
considering the timing of deletion of Rbpj using Foxn1Cre (approximately at E12, Liu 
et al., 2017, submitted), the time period between samples collection and Rbpj’s exon 
deletion is too little to allow any differences to become apparent.  In accordance to 
this, Principal Component Analysis (PCA) of the top 2,000 most variable genes from 
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the E14.5 RBPJ PLET1+ and PLET1- WT and LOF samples (samples collected two 
days later by Dong Liu, Blackburn lab) revealed a slight separation of the E14.5 
PLET1+ WT from the E14.5 PLET1+ LOF samples on PC2, while no differences were 
found among the PLET1- samples (Figure 4.8).   This analysis therefore verified that 
loss of RBPJ, and consequently NOTCH signalling activity, affected only the TEC 
compartment containing prospective mTECs and undifferentiated TEPCs.  
Additionally, clustering of the E14.5 PLET1+ LOF samples closer to the 
PLET1- samples (PC2), suggested that TEPC samples with an ablated NOTCH signal 
during early TEPC development (after E12) acquires a more cTEC-like phenotype 
similarly to the PLET1- samples.  In the same PCA plot, biological variability among 
samples is represented in PC1.  This effect is apparent when observing PLET1+ and 
PLET1- groupings per replicate across the x-axis (note that the PLET1+ and PLET1- 
populations were sorted from the same cell preparations).  Overall, clustering analysis 
of the E14.5 PLET1+ and PLET1- samples shows that ablation of the NOTCH 
signalling pathway in early TEPCs under the Foxn1 promoter uniquely impacts on the 
mTEC lineage with also PLET1+ LOF samples to better resemble on average PLET1- 
samples of the same day.  The specific impact of the mTEC lineage was also supported 
by flow cytometric analysis (Dong Liu, Blackburn lab), demonstrating a proportional 
and numerical decrease in mTEC numbers in E14.5 PLET1+ LOF samples (Liu et al., 
2017, submitted). 
To identify consistent expressional changes of genes between the E14.5 PLET1+ RBPJ 
cKO samples and their controls, I performed differential expression analysis between 
the E14.5 PLET1+ RBPJ cKO and the E14.5 PLET1+ WT groups using the limma 
voom function (Chapter 2, section 2.3.3.2).  This revealed very few consistent 
differences with gene names to be outlined in the text here [Desmoglein 3 (Dsg3) and 
Regulator of G protein signalling 4 (Rgs4) (FDR < 0.1), Myosin light chain 7 (Myl7) 
(FDR < 0.2)] and a clear trend of NOTCH targets to be down-regulated in the E14.5 
PLET1+ RBPJ cKO samples, though their FDR values were higher than the pre-set 
threshold of 0.2 (Table 4.2).  Down-regulation of these targets was verified by RT-
qPCR analysis (Liu et al., 2017, submitted).  From the RT-qPCR analysis it became 
apparent that Notch1, Notch2, Notch3 and Jag1 in both E14.5 PLET1+ and PLET1- 
TECs were significantly more lowly expressed in cKO thymi compared to controls 
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(data from Dong Liu).  This pattern suggested that NOTCH activation may be causing 
up-regulation of its own receptors and JAG1 ligand, in a positive feedback loop.  One 
could contemplate that this positive feedback loop may lead to a sharper 
responsiveness to further boost NOTCH signalling. Of note is that average Foxn1 and 






























E14.5 WT+ R3 
E14.5 WT+ R1 
E14.5 LOF+ R1 
E14.5 LOF- R1 
E14.5 WT- R1 
E14.5 WT- R3 
E14.5 LOF- R3 
E14.5 LOF+ R3 
E14.5 WT+ R2 
E14.5 LOF+ R2 
E14.5 WT- R2 
E14.5 LOF- R2 
Figure 4.8: PCA plot of the E14.5 RBPJ WT and LOF (RBPJ cKO) samples. Samples on PC2 
separate at a first level into PLET1+ (dark blue/light blue) and PLET1- (dark grey, light grey), while on a 
second level the E14.5 PLET1+ WT samples (dark blue) are distinct to the E14.5 PLET1- WT samples 
demonstrating the effects of RBPJ cKO specifically in the PLET1+ compartment. PC1 is representative 




Developmental stage E14.5 
PLET1 status PLET1+ PLET1- 
Genotype & sample name WT LOF WT LOF 
Gene symbol Ensembl ID Rep1 Rep2 Rep3 Rep1 Rep2 Rep3 Rep1 Rep2 Rep3 Rep1 Rep2 Rep3 
Notch1* ENSMUSG00000026923 0.19 0.06 0.58 -8.69 -1.03 -1.74 -2.39 0.01 -2.30 -1.56 -1.25 -2.05 
Notch2* ENSMUSG00000027878 4.91 3.40 4.02 6.43 3.29 3.44 4.78 3.64 3.46 5.20 3.27 3.68 
Notch3* ENSMUSG00000038146 -0.16 -0.14 0.48 -8.20 -3.79 -5.55 -1.78 -0.45 -1.72 -4.82 -1.50 -2.28 
Jag1* ENSMUSG00000027276 5.51 4.49 5.83 6.34 4.18 3.73 4.52 3.40 3.85 4.86 3.32 3.49 
Hes1* ENSMUSG00000022528 4.32 4.10 4.43 2.97 4.10 4.49 4.50 4.63 4.82 3.88 4.06 3.41 
Heyl* ENSMUSG00000032744 1.17 2.36 2.18 -5.52 0.18 -2.96 1.77 2.76 2.72 -2.39 2.03 1.25 
Ascl1 ENSMUSG00000020052 -5.37 -0.65 0.54 0.37 -0.97 -3.54 -0.32 -0.61 -6.48 -5.83 -1.83 -6.48 
Foxn1 ENSMUSG00000002057 4.89 5.95 4.94 2.64 5.51 4.58 5.06 6.30 6.58 4.42 5.82 5.52 
Plet1 ENSMUSG00000032068 3.01 3.36 3.54 2.36 3.57 4.00 -5.85 1.77 -0.54 -5.85 0.67 -2.49 
 
Table 4.2: Expression values of NOTCH targets for the E14.5 RBPK cKO (LOF) and WT samples.  Log2 RPKM values are provided for the NOTCH gene targets in 




4.2.3.2 Time-dependence of mTECs ablation during early thymus 
development 
The functional analyses conducted by Dong Liu have demonstrated that loss of 
NOTCH signalling in E12.5 TEPCs causes a numerical decrease in mTECs, and that 
NOTCH signalling is required for mTEC specification in a limited time-window prior 
to E16.5 (Liu et al., 2017, submitted).  While some mTECs are generated in the 
Foxn1Cre; RbpjFl/Fl model, this likely reflects that by the time of onset of deletion 
(around E12), some TEPCs may have already acquired an mTEC fate. 
My RNA-seq analyses of the TEPC Developmental series and the Foxn1 Allelic series 
(described in Chapter 3, section 3.2.1) shows that Rbpj expression levels are lower in 
the E11.5 and E12.5 TEPCs, with Plet1 having statistically significant (FDR ≤ 0.05) 
down-regulation between the E10.5 and E12.5 timepoints.   This suggests that the 
NOTCH signalling operation through RBPJ would normally be reduced by E11.5 and 
can partially explain the lack of more consistent differences among the E14.5 PLET1+ 
RBPJ cKO and E14.5 PLET1+ WT samples.  The lower levels of Rbpj observed at the 
later timepoints (E11.5 and E12.5) may represent a general decrease of NOTCH 
signalling in all TEPCs that express NOTCH.  However, if a few TEPCs retain high 
levels of Rbpj, this would be masked by the population analysis (results in support of 
TEPCs heterogeneity after Foxn1 expression are described in Chapter 3).  In either 
case, impacting Rbpj levels at a stage where its expression has already been limited 
should not lead to very distinguishable differences, as observed in Figure 4.8.  The 
findings presented here provide an explanation for the time-dependency of NOTCH 
function observed in experiments using pharmacological inhibition of NOTCH 
activity (Liu et al, submitted). 
Previous literature has suggested that divergence of mTEC progenitors can occur 
independently of Foxn1 expression and earlier than E12.5 (Hamazaki et al., 2007; 
Nowell et al., 2011).  To study the impact of loss of NOTCH signalling on mTECs at 
a FOXN1-independent stage when Rbpj is more highly expressed, Dong Liu cultured 
E10.5 pharyngeal pouches (PP) in control and DAPT conditions and demonstrated an   
almost complete inhibition of the mTEC lineage in the presence of DAPT (Liu et al., 
2017, submitted).  In other words, blockage of NOTCH signalling before Foxn1 
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expression fully ablated the mTEC fate and maintained the cTEC fate of TEPCs.  As 
will be demonstrated in Chapter 5, section 5.2.3, Rbpj is predicted to be a direct target 
of Foxn1 in TEPCs, a result that comes in agreement with the more severe phenotype 
caused by ablation of NOTCH signalling prior to Foxn1 expression; which would itself 
cause down-regulation of Rbpj.  Therefore, these data suggested that high NOTCH 
activity in early undifferentiated TEPCs is necessary for mTECs specification, a 
process possibly controlled by Foxn1 levels per cell.  This prediction could be further 
reinforced by the single-cell (sc) RNA-seq data of the E12.5 TEPCs. 
Collectively, the bioinformatics analyses and clustering of the PLET1+/- RBPJ cKO 
and WT samples, that I have performed in sections 4.2.3.1 and 4.2.3.2 have 
demonstrated a consistent (though not statistically significant) decrease in the 
expression of multiple genes involved in NOTCH signalling and have further 
implicated a unique role of NOTCH signalling in the mTEC compartment (see 
separation of PLET1+ LOF and WT samples on PC2, Figure 4.8).  Additionally, 
observation of Rbpj expression levels across the TEPC Development series and the 
Foxn1 Allelic series integrated dataset in conjunction with ChIP-seq analysis of a 
FOXN1-tagged protein dataset (Žuklys et al., 2016) presented and reanalysed in 
Chapter 5 have suggested a potential time-dependence of NOTCH’s signalling impact 
in the mTEC lineage, with a more severe phenotype (mTEC ablation) to be expected 
in earlier deactivation (prior to Foxn1 expression) of the NOTCH signalling.  Data 
generated by Dong Liu (Blackburn lab, University of Edinburgh) have fully validated 
and further expanded the findings from the bioinformatics analyses here, verifying the 
expressional differences in the NOTCH target genes and the unique impact on mTECs, 
as well as the suggested time dependence model, implicating NOTCH as an important 







4.2.3.3 Genetic reinforcement of NOTCH signalling in early TEPCs 
perturbs the exit from the early TEPC state 
Since loss of NOTCH signalling leads to loss of the mTEC lineage, it was interesting 
to determine whether enforced NOTCH signalling activity might convert all TEPCs 
into mTECs.  This was addressed using a TEC specific gain-of-function (GOF) model, 
in which Foxn1Cre mice were crossed with R26-LoxP-stop-LoxP-NICD-IRES-eGFP 
(NICD) mice and generated Foxn1Cre;NICD mice that would express constitutively 
active NOTCH signalling and high (but normal) levels of NICD (Dong Liu, Blackburn 
lab).  These NOTCH gain-of-function experiments led to NICD thymi with higher 
levels of PLET1 and lower levels of MHCII in comparison to the E14.5 controls, 
indicating a delay in TEC differentiation (Liu et al., 2017, submitted). 
To probe the effect of sustained NOTCH signalling activity on early TEPCs at the 
transcriptional level, I analysed the RNA-seq datasets from five E14.5 PLET1+ NICD 
TEPC samples (data provided by Dong Liu, Blackburn lab; cell numbers for E14.5 
PLET1- NICD TEPC samples were extremely low) using the RNA-seq pre-analysis 
and core-analysis pipelines that I have put together for the RNA-seq data processing 
in this thesis (described in Chapter 2, section 2.2.1.3) in order to retrieve the 
normalised gene counts for all expressed genes of these datasets.  PCA of the E12.5 
and E14.5 WT and RBPJ cKO (LOF) samples (biological triplicates per population) 
with the E14.5 NICD (GOF) samples revealed three groups (Figure 4.9); Group 1: 
E14.5 PLET1+ NICD; Group 2: E14.5 PLET1+ and PLET1- WT and LOF samples; 
and Group 3: E12.5 PLET1+ WT and LOF samples.  Comparison of these groups 
showed that Group 2 and 3 shared some similarity in PC2, while Group 1 was found 
to cluster in-between Groups 2 and Group 3 in PC1 (but closer to Group 2).  This 
suggested that the E14.5 NICD samples had undergone a block in differentiation, since 
they all remain PLET1+ (Liu et al., 2017, submitted), or that over activation of NOTCH 
signalling had inducted a rare or aberrant TEC subtype. 
Since within batch effect correction was not possible between the three groups due to 
confounded batch effect with the biological differences across groups, the profiles of 
housekeeping genes were plotted among all groups to track preferences towards any 
specific group (Figure 4.9).  No significant differences were observed among groups 
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for the housekeeping genes, allowing for across group comparisons. I additionally 
performed differential expression analysis with limma (for details see Chapter 2, 
section 2.3.3.5) between the E14.5 PLET1+ GOF and E14.5 PLET1+ WT samples 
which clearly predicted several NOTCH targets as up-regulated in the GOF samples 
with statistical significance (FDR ≤ 0.2), while again none of the housekeeping genes 
were found differentially expressed in the same comparison. 
Finally, I performed an independent signalling pathway enrichment analysis using the 
total number of differentially expressed genes between the E14.5 PLET1+ GOF versus 
the E14.5 PLET1+ WT samples and their fold changes (calculated by limma voom) as 
a ‘Pre-Ranked Gene List’ in GSEA (Subramanian et al., 2005) against the edited 
ConsensusPathDB database (Kamburov et al., 2011, details in Chapter 2, section 
2.3.3.6), which also predicted NOTCH signalling pathway as enriched between the 
GOF and the WT groups among two other signalling pathways that were identified 
(shown in Table 4.3).  The GSEA Enrichment plot and the list of genes contributing 










Notch1 Notch2 Notch3 Jag1 
Figure 4.9: Differences among RBPJ cKO, NICD and WT groups.  PCA plot (top right panel) depicts a clear separation among the E12.5 WT/RBPJ cKO (orange/brown), 
the E14.5 WT/RBPJ cKO (blues/greys) and the NICD group (green).  The top right panel shows how NOTCH genes are impacted in the aforementioned samples with 
Notch3, Hes1 and Heyl found to be statistically significant between the GOF versus the E14.5 PLET1+ WT group.  The bottom barplot shows that no strong patterns were 
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Table 4.3: Up-regulated signalling pathways in the E14.5 PLET1+ GOF versus E14.5 PLET1+ WT 
comparison.   In sequence, the table provides name of each pathway (GS follow link to MSigDB), 
number of Pre-Ranked genes identified per pathway (size), enrichment score of each pathway (ES), 
enrichment score of each pathway normalised for the size of the pathway (NES), NOM p-val and FDR 
q-val (see Chapter 2, section 2.3.3.6 for more details). 
Figure 4.10: GSEA Enrichment plot for NOTCH1 INTRACELLULAR DOMAIN REGULATES 
TRANSCRIPTION and gene list of core enrichment.  Enrichment score on the GSEA plot (top y-axis) 
indicates the degree of over-representation (in absolute value) for the provided pre-ranked gene set 
(differentially expressed genes – E14.5 PLET1+ GOF versus E14.5 PLET1+ WT) and the direction of their 
regulation (positive sign/up-regulated genes).  The Pre-Ranked list metric (GSEA plot, bottom y-axis) 
provides information over the numeric ranking used to weight genes (in this case log fold change), while 
the barcode bars (GSEA plot, middle part) represent all gene hits in the particular pathway with genes 
contributing to core enrichment of the pathway listed in the table next to the Enrichment plot. Differentially 
expressed genes for an FDR ≤ 0.2 are colour-coded in red (* FDR ≤ 0.05, ** FDR ≤ 0.01). 
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To better characterise the phenotype of the E14.5 GOF samples, I observed the 
expression levels of markers associated with the early TEPC and mature TEC state, as 
well as, the cTEC and mTEC derived sublineages across all E12.5 WT and LOF, E14.5 
WT and LOF and E14.5 GOF samples (shown in Figure 4.11).  This revealed that 
cTEC-associated genes in Group B (Figure 4.11), including Foxn1, were up-regulated 
from E12.5 to E14.5 in the WT samples, but that the E14.5 GOF samples retained 
similar levels of these markers to those observed in the E12.5 progenitors.  This 
suggested that they retained some similarity to the early TEPCs/early cTECs, and that 
expression of these differentiation markers was blocked as a result of enforced 
NOTCH signalling.  From this, I hypothesised that the lack of Foxn1 up-regulation 
might explain the lack of up-regulation of the other cTEC markers.  Relevant to this is 
that Foxn1 overexpression has previously been shown to result in down-regulation of 
NOTCH target genes in both mTEC and cTEC populations isolated from E17.5 
Foxn1Cre;iFoxn1 mice (O’Neill and Blackburn, unpublished).  These mice provide a 
model where Foxn1 overexpression can be induced under the control of Cre  
(Bredenkamp et al., 2014b) (see also Chapter 5, section 5.2.3 for more details).  
Supporting this idea, the ChIP-seq analysis of a FOXN1-tagged protein dataset 
(Žuklys et al., 2016)  that I will present in Chapter 5 of this thesis shows that FOXN1 
directly negatively regulates Rbpj, as well as a number of known NOTCH target genes 
(Fbxw7, Hey1, Hes6).  TEC differentiation may therefore be driven by a reciprocal 
inhibition between Foxn1 and Rbpj, in which increasing levels of FOXN1 drive cTEC 
differentiation by down-regulating the response to NOTCH signalling, while high 
levels of NOTCH signalling are required in some TEPCs to protect the mTEC 
phenotype and possibly down-regulate Foxn1.  The same pattern is also retained in 
one week old cTEC and mTEC populations (merged RNA-seq data from similarly 
sorted individual and biological duplicates obtained from public repositories; see 
Chapter 2, section 2.2.1.4 for details). 
Expression of genes related to both cTEC and mTEC differentiation in Group C 
(Figure 4.11) would remain high in all E14.5 samples with little variation among them, 
while they were much lower expressed in the E12.5 samples, suggesting a partial 
progression of the E14.5 PLET1+ GOF samples despite their high expression of Foxn1 
and Plet1.  Additionally, early ontogeny lineage-restricted mTEC markers (such as 
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Krt5, Cld3 and Cl4; Group A) were substantially up-regulated in the GOF samples.  
Lastly, genes in Group D (such as Fgfr2, Kitl and Pax9) showed lower expression in 











































Figure 4.11: Heatmap of TEPC and TEC-specific lineage markers for NOTCH mutant and control 
samples.  Row scaled values for a panel of TEPC and TEC markers among the E12.5 WT/LOF, E14.5 
PLET1+ WT/LOF, E14.5 PLET1- WT/LOF and E14.5 PLET1+ GOF are shown to identify clusters [A-D] 
of genes that change similarly per group.  Group A: early ontogeny lineage-restricted mTEC markers. 
Group B: FOXN1 targets/cTEC-like genes.  Group C: cTEC and mTEC lineage differentiation genes. 
Group D: early ontogeny TEPC genes. 












From these data, I have concluded that overexpression of NOTCH in TEPCs causes at 
least a partial block in cTEC lineage progression (ablation of PLET1- TECs) and 
assists but does not impose mTEC development, suggesting an additional role of 
NOTCH in TEPC maintenance. 
Overall, experimental validation of NOTCH signalling activity in fetal TEPCs has 
verified that E10.5 TEPCs experience high levels of NOTCH activity, which, at a 
population level, progressively decreases concomitant with the onset of differentiation 
such that by E12.5 NOTCH signalling activity is lower in the TEPC population.  These 
data have informed detailed functional testing of the role of NOTCH signalling in early 
TEC development by Dong Liu and Dr Kathy O’Neill in the Blackburn lab, and form 
part of a resulting manuscript (Liu et al., 2017 submitted).  From these studies, we 
conclude that NOTCH signalling is necessary for specification of the mTEC 
compartment in a defined time window, prior to E16.5.  Withal, these functional data 
are partially consistent with the model of extracellular signalling pathways regulation 
















Nude mice, in which TEC differentiation is blocked prior to the onset of TEC 
differentiation, retain at least some bipotent TEPCs into adulthood.  These cells remain 
in a stable state in vivo apparently indefinitely.  Remarkably, release of the block in 
Foxn1 expression in a single cell, is sufficient to direct formation of a fully functional 
thymus (Bleul et al., 2006; Jin et al., 2014).  To improve the culture conditions and 
acquire the ability to maintain TEPCs in vitro, I investigated the signalling 
mechanisms active in the early pre-Foxn1 state.  Pathway enrichment analysis was 
performed between the undifferentiated and more differentiated TEPCs during the 
E10.5-E12.5 time-period, to identify signalling pathways active in the thymic 
epithelium prior to Foxn1 expression.  From this analysis, I generated an in silico 
model of signalling pathways activity in TEPCs just prior to the onset of differentiation 
that provides increased understanding of the signalling mechanisms supporting cells 
before their transition.  Insights gained from this predicted signalling pathway analysis 
are discussed below. 
 
4.3.1 A clear separation of TEC and parathyroid fate 
The Sonic Hedgehog (SHH) signalling pathway is known to act as a control gate of 
the thymic-parathyroid fate, with its ablated or enforced activity to disrupt the 
patterning of the thymus-parathyroid primordium.  Explicitly, absence of SHH (the 
main ligand of the pathway) in the endoderm of the 3rd pharyngeal pouch during 
organogenesis (thymus-parathyroid domain spreading), allows extension of the 
thymus into the parathyroid compartment (as demonstrated by Moore-Scott and 
Manley, 2005) suggesting that SHH signalling must be restricted in a particular region 
at a particular time point for thymus formation to take place.  Alternatively, ectopic 
expression of SHH in early development induced TBX1 which blocked the expression 
of Foxn1 and subsequently imposing of the thymic fate without though the cells to 
acquire a parathyroid fate (Bain et al., 2016; Reeh et al., 2014). 
The clear separation from the parathyroid fate is evident in the RNA-seq dataset of the 
E10.5 and E12.5 TEPCs from the TEPC Developmental series, with the main receptors 
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of the pathway (Ptch1 and Ptch2) expressed only at a very low level in the PLET1+ 
population analysed at E10.5, and being undetected at subsequent timepoints.  This is 
consistent with silencing of the SHH intracellular or extracellular signalling in the 
early TEPCs to allow normal Foxn1 expression and progression of the thymic fate 
(Figure 4.6).  Since PLET1 is expressed throughout the parathyroid at E10.5 and 
E11.5, there is a minor possibility that few parathyroid cells are present in the RNA-
seq samples.  This seems not to be the case here though, at least by E11.5 onwards 
since none of the SHH involved genes are expressed at E11.5 or E12.5 TEPCs 
(Ptch1/2, Gli1, Tbx1).  Additionally, Shh itself is fully absent from all datasets, 
consistent with the above observation. 
 
4.3.2 Changes in TEPC identity could be reflecting changes in cell 
morphology 
The mechanisms which orchestrate the diverse morphogenetic events in the thymus 
during early mouse ontogeny are not yet fully understood.  Originating from the 
endoderm of the 3rd pharyngeal pouch at E10.5, the thymic anlage initially forms as 
essentially a polarised monolayer of columnar epithelial cells.  This monolayer transits 
through a multilayered pseudostratified epithelial structure around E11.5 (which 
maintains an apico-basal polarity around a central lumen) before it forms the highly 
orchestrated three dimensional structure of the thymus where cells are no longer 
polarised (Itoi et al., 2001).  During this transition, the thymus and the parathyroid 
primordia are clearly patterned by E11.5, while they detach sequentially from the 
pharynx by apoptotic cell death around E11.5-E11.75 (Gordon et al., 2004).  In the 
end, both organs start migrating towards their final anatomical positions at E12.5 
(summarised in Gordon and Manley, 2011). 
Cell polarity is the asymmetric division of various components of a cell (cytoskeleton, 
plasma membrane or organelles) and it is used to maintain a barrier between cells or 
help cells to find their proper position for their normal function.  The polarity of 
specialised structures can be established by morphogens.  These include members of 
the BMP, WNT and SHH signalling pathways which can work cooperatively or in 
opposition to each other (Lee et al., 2001; Marcelle et al., 1997; Zhang et al., 2002) to 
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sculpt tissues.  In particular, Bmp4, Fgf8 and Shh have been implicated with the 
patterning of the pharyngeal region, since their loss or impaired regulation results in 
hypoplastic or absent pharyngeal arches (Abu-Issa et al., 2002; Ahlgren and Bronner-
Fraser, 1999; Bachiller, 2003; Frank et al., 2002; Ohnemus et al., 2002; Revest et al., 
2001; Stottmann et al., 2001) which subsequently lead to malfunctions in the thymus 
formation due to disturbed pouch patterning or thymus-pharynx-parathyroid 
separation. 
WNT5A is a known morphogen ascribed to the non-canonical WNT signalling 
pathway.  Non-canonical WNT signalling branches include: a) the Planar Cell Polarity 
(PCP)/Convergent Extension (CE) pathway, b) the WNT/Ca2+ pathway and c) the 
WNT/FZD2-ROR2 pathway.  Primarily, Wnt5a is an important regulator of 
embryonic development since its disruption leads to prenatal death in mice 
(Yamaguchi et al., 1999).  The same study demonstrated that proximal distal 
outgrowth of several structures in vertebrate early development requires Wnt5a 
expression (cell cycling), with the outgrowing tissues of homozygous mice (at a late 
embryonic stage) to reveal gross morphological defects.  Examples of Wnt5a 
regulation of cell polarity and directional cell migration exist in various cell types.  
During the mammalian palate development, this is orchestrated by the graded 
expression of Wnt5a and its receptor Ror2 along the anteroposterior (AP) axis (He et 
al., 2008), and a potential mechanism of regulation could be by the asymmetric 
accumulation of a WNT-mediated receptor-actin-myosin polarity structure (W-
RAMP) as demonstrated in a melanoma cell line study (Witze et al., 2008).  In a more 
recent study, WNT5A expression was shown to contribute to AP polarity of epithelial 
cells through its asymmetric secretion (basolaterally) in polarised kidney epithelial 
cells in mice (Yamamoto et al., 2015).  Additionally, interaction of SFRP proteins with 
WNT5A can regulate the apicobasal polarity and oriented cell division in the gut 
epithelium during embryonic mouse development (Matsuyama et al., 2009).  Roles of 
Wnt5a in promotion of self-renewal in tissue stem cells have also been demonstrated 
in spermatogonial stem cells in mouse (Yeh et al., 2011).  Taken together, WNT5A 
demonstrates a versatile role in the regulation of various processes such as self-
renewal, differentiation, polarity and migration of the cells, while the outcome of its 
regulation depends on the provision of several receptors in the regulated cells. 
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In my analysis, Wnt5a demonstrates high expression levels at E10.5, while its 
expression gradually decreases over the E11.5 and E12.5 subsequent timepoints.  As 
discussed before (Chapter 3), E10.5 TEPCs exist in an undifferentiated TEPC state, 
in which they can survive in vitro long-term upon Foxn1 blockage.  The high levels of 
Wnt5a expression in E10.5 TEPCs may indicate a potential role in the control of cells 
self-renewal.  In that direction, Wnt5a was shown to maintain HSCs in a quiescent G0 
state which increased their repopulating ability (Nemeth et al., 2007).  
Moreover, E10.5 TEPCs and E11.5 TEPCs exhibit an apicobasal polarity while very 
few cells may be still polarised at E12.5 (Itoi et al., 2001).  The timing of Wnt5a down-
regulation after Foxn1 initiation is consistent with their differentiation and their 
morphological switch from a mono layer of polarised cells that surrounds the thymic 
lumen to an apolar, complex and well-defined structure that characterises the thymus.  
Towards this direction, the expression pattern of the Sfrp genes among the stages of 
the TEPC Developmental series (shown in Figure 4.7) resembles the expression 
pattern of Wnt5a, with Sfrp2 to down-regulate with statistical significance (FDR ≤ 
0.05) when cells proceed towards the E12.5 timepoint. Thus, similar to the example in 
the gut epithelium (Matsuyama et al., 2009), Wnt5a may be interacting with these 
proteins to orchestrate cell polarity.  In that scenario, epithelial cells would have their 
basal layer at the lumen surface and their apical layer would be extended away from 
the lumen during E11.5.  Further down-regulation of Wnt5a at E12.5 could represent 
the loss of the apicobasal polarity for the majority of TEPCs. 
Because Wnt5a comprises a secreted protein and a morphogen, existence of multiple 
available receptors (based on the bioinformatics data presented in this thesis) make it 
difficult to distinguish between the specific mechanisms that WNT5A may be 
controlling in early undifferentiated TEPCs.  Nevertheless, to test if WNT5A may 
support self-renewal of the early undifferentiated TEPCs, provision of WNT5A in cell 
culture should be able to promote TEPCs survival even in the absence of feeder cells 
(mesenchyme) and/or it could aid in the formation of a pseudostratified structure since 
TEPCs survive better in a 3D structure.  Additionally, conditional deletion of Wnt5a 
in TEPCs in conjunction with immunofluorescent analysis for tight junctions and 
adherent proteins would enable testing of the above hypothesis and establish a role for 
Wnt5a in the maintenance/control of TEPCs polarity and differentiation.  If Wnt5a is 
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related to the delayed separation of the thymus/parathyroid from each other and/or 
both from the pharynx, a migration assay could be performed to identify cell 
polarisation and movement through imagining in vitro.  Finally, it is always possible 
that the surrounding mesenchyme or the incoming hematopoietic progenitors could 
also provide the WNT5A ligand and maintain the ongoing signalling required for 
different functions of TEPCs, as discussed in the next section. 
 
4.3.3 Switching to a neighbouring cell-dependent fate 
The role of the FGF signalling pathway (FGF) has been widely investigated in the 
early undifferentiated TEPC stages and proceeding thymus development (summarised 
in Gardiner et al., 2012).  Previous research has highlighted FGF8 as necessary for 
normal thymus development, with high expression of Fgf8 apparent in the distal 
posterior presumptive thymus region before the onset of Foxn1, and null or hypoplastic 
Fgf8 mutations leading to thymic hypoplasia and athymia (Abu-Issa et al., 2002; Frank 
et al., 2002).  FGFR2-IIIb comprises another essential factor for thymus development 
since its expression is required for TEC proliferation after E12.5 (Revest et al., 2001).  
FGFR2-IIIb expression escalates after Foxn1 initiation (tested in thymic epithelium 
and skin samples) suggesting that Fgfr2IIIb is a direct target of FOXN1.  Fgfr2IIIb 
null mutation results in reduced thymus size, but normal anatomical position, T-cell 
development and Foxn1 expression (Revest et al., 2001).  FGFR2-IIIb earliest point of 
detection is E13.5, approximately the time that TEC proliferation will reach to a block 
in Fgfr2IIIb-/-lacZ.  Unlike its ligands (FGF3, FGF7 and FGF10) that are expressed in 
the mesenchymal tissue surrounding the developing thymus, FGFR2-IIIb expression 
is limited in the thymic epithelium.  Of these ligands, FGF10 is thought to be the main 
ligand required for normal thymus development, since the absence of FGF10 leads to 
athymia (Ohuchi et al., 2000). 
In agreement with the literature, my analyses revealed high expression levels of Fgf8 
and Fgfr1 in E10.5 TEPCs, with no further expression of these factors at E11.5 or 
E12.5.  Of the ligands, Fgf7 and Fgf3 were essentially absent from TEPC at all stages 
analysed.  Previous in situ hybridisation (ISH) analysis had indicated that Fgf10 was 
not expressed in TEPCs, but in the neural crest cell (NCC)-derived thymic 
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mesenchyme.  However, through the more sensitive technique of RNA-seq, the 
analyses presented herein revealed moderate expression of Fgf10 in TEPCs at E10.5 
possibly explaining the greater effect of loss of FGF10 compared to FGF7 in thymus 
development.  Potential contamination of the cell populations analysed by RNA-seq 
with surrounding neural crest cells is unlikely, since the cells were sorted using TEPC 
markers and since bona fide neural crest genes FoxD3 and Sox10 (Simoes-Costa and 
Bronner, 2015) were also not detected.  Furthermore, our RNA-seq data have 
demonstrated expression of the Fgfr2-IIIb as early as E10.5, reestablishing the earliest 
detection point for Fgfr2-IIIb to exist prior to Foxn1 initiation.  In our data, Fgfr2-
IIIb’s expression escalates in E11.5 and E12.5 agreeing with the suggested role of 
FOXN1 as a regulator of FGFR2-IIIb.  Further evidence in support of this suggestion 
comes from the ChIP-seq reanalysis of a FOXN1-tagged protein dataset (Žuklys et al., 
2016) presented in Chapter 5 that identifies Fgfr2-IIIb as a highly confident direct 
target of FOXN1.  Lastly, Spry1 and Spry2, FGF feedback antagonists, whose 
expression is required for FGF inhibition maintenance at a specific location of the 
pouch and subsequent patterning formation (Gardiner et al., 2012), were found 
expressed in similar levels across the developmental points. 
Up-regulation of FGFR2-IIIb after Foxn1 initiation potentially allows for stronger 
activation of the FGF signalling pathway in TEPCs, signifying the moment when 
TEPCs become more reactive to FGFR2-IIIb ligands.  The absence of most FGF 
ligands from TEPC at all stages analysed suggests that TEPCs depend on an 
appropriate supporting surrounding environment to provide the appropriate 
proliferation and survival signals.  Down-regulation of Fgf10, the only FGFR2-IIIb 
ligand expressed in E10.5 TEPCs, potentially marks a complete transition of 
developing TEC to dependence on neighbouring cells for FGF signalling inputs. 
IGF factors are also known to play an important role in thymus development (reviewed 
in Lee et al., 2010; Smith, 2010), with IGF1 increasing survival and differentiation of 
TECs and thymocytes by activating IGF-1R, an effect that is delivered through TECs 
(Chu et al., 2008).  My analysis has indicated that both Igf1 and Igf2 mRNA levels 
decrease significantly from E10.5 to E12.5, with Igf1 being expressed at extremely 
low levels at E12.5, suggesting decreased intracellular signalling activity.  Similar to 
FGF signalling, IGF ligands are expressed at low levels at E12.5, but the receptor is 
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still expressed at a high level, allowing activation of the pathway through ligands 
provided by neighbouring cells.  Contrary to the decrease of the FGF ligands, that were 
absent from both cTEC and mTEC populations from one week old mice, both IGF 
factors were found to be almost uniquely expressed in the one week old mTEC 
population and was almost absent in cTECs, suggesting that a loss of the IGF ligands 
could potentially impact more the mTEC compartment.  Lastly, IGF availability can 
be controlled by the presence of IGFBPs that can bind to the IGF ligands and prevent 
them from activating their receptor.  Multiple Igfbp genes seem to be expressed in the 
different timepoints of the TEPC Developmental series at variable mRNA levels, with 
no obvious trend of up-regulation or down-regulation across these developmental 
stages.  Therefore, it is difficult to evaluate their contribution in restricting pathway’s 
activation. 
In summary, investigation of the core enrichment genes involved in the FGF and IGF 
signalling pathways has suggested a switch of TEPCs from a partially cell autonomous 
system to a system depending on extracellular provision of ligands from the NCC-
derived mesenchyme and potentially haematopoietic progenitor cells.  The data 
suggest that this switch is driven by FOXN1 and permitted by the presence of FGFR2-
IIIb and IGF1R.  However, the impact of decreased IGF signalling activity in TEPCs 
may not equally influence both TEC lineages. 
 
4.3.4 Establishing the mTEC lineage from a common TEPC 
progenitor 
NOTCH regulators hold a dominant role in different stages of TEC and thymocyte 
development (Shah and Zuniga-Pflucker, 2014), however, contribution of NOTCH 
signalling during early ontogeny of the thymic epithelium has not yet been studied in 
detail.  In brief, pathway enrichment analysis in section 4.2.1 has identified NOTCH 
pathway (among other signalling pathways) as highly active in the undifferentiated 
E10.5 TEPCs but consistently down-regulated as TEPCs progress towards the E12.5 
timepoint, suggesting a potential regulatory role for NOTCH signalling during fetal 
TEPC differentiation.  Nevertheless, a closer look at NOTCH ligand Dll4 and target 
genes Hes1 and Heyl (whose expression increases when cells proceed towards the 
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E12.5 stage) made obvious that NOTCH pathway may be dynamically regulated in 
different developmental stages and possibly by different groups of cells.  Thus, 
NOTCH was put under the microscope for further exploration.     
In agreement with the decreased expression of Rbpj in E12.5 TEPCs, comparative 
bioinformatics analysis of NOTCH loss-of-function (LOF, Rbpj exon deletion under 
the control of the Foxn1 promoter around E12) samples versus stage-matched controls 
demonstrated only a few expressional differences between these groups (section 
4.2.3.1).  Though few, differences between the E14.5 PLET1+ LOF TEPCs and their 
controls were still apparent, while comparison of the E14.5 PLET1- LOF TEPCs to 
their controls did not reveal any differences (see Figure 4.8), demonstrating an effect 
(even subtle) only in the PLET1+ TEPC population.  The PLET1+ compartment of 
E14.5 TEPCs constitutes undifferentiated TEC progenitors and potentially mTEC 
specific progenitors (mTEPCs), while the PLET1- compartment comprises of mostly 
cTEC-fated progenitors (cTEPCs), suggesting that it is the TEPCs or the mTEPCs 
rather than the cTEPCs that are impacted by NOTCH ablation. 
Additionally, comparative analysis of the transcriptional profiles of the E12.5 vs E10.5 
samples from the TEPC Developmental series (RNA-seq data from biological 
triplicates per stage provided by Harsh Vaidya, Blackburn lab; see also Chapter 2, 
section 2.2.1) in conjunction with comparative analysis of high-Foxn1 and low-Foxn1 
groups from the Foxn1 Allelic series (RNA-seq data from singular biological samples 
provided by Stephanie Tetelin, Blackburn lab; see also Chapter 2, section 2.2.1) 
presented in Chapter 3 (section 3.2.2) has identified Rbpj among other genes as 
FOXN1-dependent that down-regulates with Foxn1 increase.  This finding suggested 
that Rbpj down-regulation may be regulated (directly or indirectly) by FOXN1, thus 
ablation of Rbpj expression after Foxn1 initiation would be expected to have minimum 
impact. 
Experimental evidence from Dong Liu (Blackburn lab, University of Edinburgh) 
demonstrated that inhibition of NOTCH signalling at E10.5 in TEPCs led to the 
complete loss of the mTEC lineage, in total agreement with the above predictions, and 
also verified NOTCH signalling as a potent regulator of mTECs specification.  
Conversely, overexpression of NOTCH intracellular domain in all TEPCs blocked 
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TEC lineage differentiation, evidenced by retention of PLET1 staining (Dong Liu) 
and lack of differentiation markers (Figure 4.11), but did not force the differentiation 
of mTECs (Figure 4.11), suggesting roles for NOTCH in both mTEC specification 
and TEPC maintenance. 
A potential regulatory mechanism between FOXN1 and NOTCH signalling is 
extensively described in Chapter 5 (section 5.3.3) while how this interplay fits with 
the revised TEPC differentiation model (presented in Chapter 3, section 3.3.1) is 
devised in Chapter 7 (section 7.1.4). 
In summary, the bioinformatics analysis presented herein (section 4.2.3), in 
conjunction with extensive experimental investigation and validation of the NOTCH 
signalling pathway in the Blackburn lab by Dong Liu, has concluded that “a NOTCH 
gate controls differentiation of thymic epithelial progenitors and medullary thymic 
















In this chapter, I have presented a comparative bioinformatics analysis in conjunction 
with pathway enrichment analysis of RNA-seq data obtained from TEPCs at 
timepoints just prior to, during and immediately following the initiation of the TEC 
differentiation programme.  This integrative analysis was used to determine which 
major signalling pathways are highly active in fetal TEPCs, focusing on those 
pathways whose activity is decreasing while they are transiting towards differentiation.   
The identified pathways indicate a) the separation of the thymus from the parathyroid 
fate (section 4.3.1), b) potential roles for WNT5A in cell renewal and cell polarity 
(maintenance of TEPCs and/or guidance of TEPCs into the 3D complex architecture 
of the functional thymus, section 4.3.2) and c) a shift from a TEPC autocrine niche to 
a TEPC niche dependent on neighbouring cells (section 4.3.3).  Moreover, 
computational and experimental validation of the importance of NOTCH activity in 
early TEPCs (ablation of NOTCH signalling), highlighted NOTCH as a potent 
regulator of mTEC specification and maintenance of the TEPC state in a short but 
well-defined time window.  Additionally, overexpression of NOTCH signalling 
suggested that E12.5 TEPCs may still exist in a fairly interchangeable state which 
could be fine-tuned or potentially pushed back to a less differentiated state (a concept 
also discussed in Chapter 3, section 3.3.1) by an altered signalling reciprocity 
involving (in this case) FOXN1 and NOTCH.  
Within the in silico model predicted in Chapter 4, the master thymus regulator, 
FOXN1, seems to control the signalling pathways that dictate the TEPC proliferation 
and differentiation state.  This is evidenced by FOXN1 directly targeting FGFR2-IIIb, 
that controls TEPC expansion, alongside with Rbpj and other regulators involved in 
the NOTCH pathway, that are involved in the specification of the mTEC lineage (the 
role of FOXN1 and its regulatory landscape are discussed extensively in Chapter 5).  
Overall, this analysis has improved the current picture of the signalling mechanisms 
that govern maintenance and specification of TEPCs prior to their sublineage 

















































Chapter 5  
 





FOXN1 comprises the master transcriptional regulator of TEC differentiation, with 
continuous expression of Foxn1 also being required for maintenance of the thymic 
epithelium (Chen et al., 2009; Cheng et al., 2010; Nowell et al., 2011).  Evidence for 
its significance is that absence of functional FOXN1 protein arrests differentiation of 
thymic epithelial cells (TECs), blocks initial formation of the organ, and prevents 
colonisation of thymic primordium by hematopoietic progenitors (T-cell precursors).  
This early block can be reversed by reestablishing Foxn1 expression in TECs, and this 
alone then leads to normal thymus development (Bleul et al., 2006).  In a more extreme 
example, “forced” expression of FOXN1 in a thymus-unrelated cell population, mouse 
embryonic fibroblasts (MEFs), is capable of reprogramming these cells into functional 
TECs (“induced” TECs or iTECs), further demonstrating the extraordinary potency of 
this factor (Bredenkamp et al., 2014a). 
Despite the core role that FOXN1 plays in the thymus and 20 years of research since 
FOXN1 (nude gene product) was first identified (Nehls et al., 1994, 1996), the full 
picture of the functional network around this regulator is incomplete.  In Chapter 5, I 
attempt to better understand how FOXN1 imposes its dominant role in the thymic 
system, by identifying direct FOXN1 targets in early TEPCs and investigating the 
pathways that FOXN1 controls through them, via a comparative study between fetal 







5.2.1 Prediction of candidate direct FOXN1 targets in mouse fetal 
TEPCs 
In this chapter, I will describe the integrative analysis undertaken to identify candidate 
direct FOXN1 targets in mouse fetal TEC progenitors (TEPCs).  A brief summary of 
the above analysis is provided here.  Starting from the already identified list of 
FOXN1-dependent genes from the fetal TEPC RNA-seq series (described extensively 
in Chapter 3, section 3.2.1), I will first subselect the genes which show binding 
evidence for FOXN1 in their distal promoter sites (peaks located within -5kb and +3kb 
of the gene’s transcription start site) using ChIP-seq data available from 1 week old 
(1w) TECs.  Next, I will retain only the genes that also show evidence for an active 
promoter or enhancer mark in TEPCs using histone modification ChIP-seq data from 
E12.5 TEPCs that overlap with the 1w TEC FOXN1 enriched peaks.  This final list of 
genes will define the (first-described) high-confidence candidate direct FOXN1 targets 
in fetal TEPCs. 
 
5.2.1.1 FOXN1-dependent genes in fetal TEPCs 
To identify a list of FOXN1-dependent genes, the differentially expressed genes 
between E12.5 and E10.5 timepoints (|FC| ≥ 1.5 and FDR ≤ 0.2) from the TEPC 
Developmental series (RNA-seq data from biological triplicates per stage provided 
by Harsh Vaidya, Blackburn lab; see also Chapter 2, section 2.2.1) were integrated 
with the differentially expressed genes (pairwise comparisons between Foxn1high vs 
Foxn1low phenotypic sample groups) from the Foxn1 Allelic series (RNA-seq data 
from singular biological samples provided by Stephanie Tetelin, Blackburn lab; see 
also Chapter 2, section 2.2.1) and the overlap of both differentially expressed gene 
lists was taken (details on data integration are given in Chapter 3, section 3.2.1).  As 
described previously, the TEPC Developmental series dataset depicts gene expression 
profiles of E10.5, E11.5 and E12.5 TEPCs during mouse development.  These 
timepoints relate to the developmental stages at which: Foxn1 expression is majorly 
163 
 
absent, Foxn1 expression has been initiated and Foxn1 expression has been 
established.  The gene expression changes that occur among these stages could be 
assigned to either FOXN1 expression itself or FOXN1-independent developmental 
progression.  The Foxn1 Allelic series dataset shows, specifically at the latest 
timepoint of the TEPC Developmental series (E12.5), how variation of Foxn1 levels 
alone impacts on the expressional profile of TEPCs.  Chapter 3 section 3.2.1 has 
demonstrated the dominant effect of Foxn1 dosage on cell identity, with Foxn1 
expression level influencing TEC developmental progression, suggesting that many of 
the changes occurring in the early TEPC development might be FOXN1-dependent.  
In order to focus on direct FOXN1 targets, I therefore focused the analysis on those 
genes that are dependent on FOXN1 (independently of the developmental stage) to 
limit the span of the gene inventory search. 
In particular, a total of 15,321 genes were expressed in at least in one of the E10.5 and 
E12.5 TEPC sample triplicates from the TEPC Developmental series based on a log2-
transformed counts per million (CPM) cut-off value of zero, which was selected based 
on samples’ expression density plot, as described in Chapter 2, section 2.3.3.1.  As 
described before (Chapter 3, section 3.2.1), the limma package from Bioconductor 
was used to calculate differential gene expression between E10.5 and E12.5 timepoints 
and to assign statistical significance to the gene changes.  From the 15,321 genes 
expressed in E10.5 or E12.5 TEPC samples, only 1,650 (980 up-regulated and 670 
down-regulated) were differentially expressed between the E10.5 and E12.5 triplicates 
with |FC| ≥ 1.5 and FDR ≤ 0.2.  These 1,650 genes were selected for further analysis 
(Figure 5.1, step 1).  Pairwise comparison analysis was performed between a Foxn1high 
and a Foxn1low phenotypic group, consisting of the Foxn1+/+ (wild type; WT), Foxn1+/- 
(Het) and Foxn1R/+ (R/+) samples, and the Foxn1R/- (R/-) and Foxn1nu/nu (Nude) 
samples from the Foxn1 Allelic series dataset respectively.  This comparison identified 
genes that are highly dependent on FOXN1 (for details see Chapter 3, section 3.2.1).  
The latter filtering for FOXN1-dependent genes decreased the number of differentially 
expressed genes from 1,650 to 850 genes (586 up-regulated and 264 down-regulated) 
that were fully dependent on FOXN1 (Figure 5.1, step 2).  These 850 genes change 
consistently between the pre- (E10.5) and post-FOXN1 (E12.5) TEPC developmental 
stages as defined by a |FC| ≥ 1.5 and a FDR ≤ 0.2 criteria, however, their change can 
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be most likely explained by direct dependence on FOXN1, since they also change 
consistently between the Foxn1high and a Foxn1low phenotypic groups, independently 

















Figure 5.1: Overview of the integrative analysis for identification of FOXN1 target candidates in 
TEPCs. The total number of up-regulated (in red) and down-regulated (in blue) genes between the 
E10.5 and E12.5 timepoints from the TEPC Developmental series dataset is shown in the top of this 
schema, with step 1 retaining only differentially expressed genes with FDR ≤ 0.2. In step 2, genes that 
are not dependent on FOXN1 are excluded from further analysis, while in step 3 genes are filtered on 
the basis of having a FOXN1 binding peak in their distal promoter area (-5kb to +3kb from the TSS of 
the gene). Step 4 shows how many of these genes have an accessible promoter or enhancer region 
with either an H3K4me3 or an H3K27ac mark, while step 5 shows how many of these two accessibility 
marks co-reside with the FOXN1 peaks (or simply mark alternative sites in the distal, TSS of the gene).  
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5.2.1.2 Direct binding events of FOXN1 in newborn TECs 
Until recently, lack of suitable antibodies meant that data on direct FOXN1 binding to 
the promoter/enhancer regions of expressed genes were not available.  Recently, a 
FOXN1-tag ChIP-seq dataset became available (Žuklys et al., 2016), which identified 
direct FOXN1 targets in newborn mouse cTECs. 
In their study, Žuklys et al. express a FOXN1 protein, tagged with an octapeptide (for 
details of the design see cited paper or Chapter 2, section 2.2.2.1), under the Foxn1 
promoter of nude mice (Foxn1nu/nu) using a bacterial artificial chromosome (BAC).  
Mice homozygous for the BAC (Foxn1wt*/wt*) demonstrated a normal coat and thymus 
architecture, as well as normal Foxn1 expression levels, but a mildly reduced 
cellularity which was still capable of supporting thymocyte development.  Chromatin 
immunoprecipitation (ChIP) was performed in isolated thymic lobes from 
homozygous mice and DNA samples were pooled to create two replicates that were 
sent for sequencing.  After sequencing, contaminating adapters were removed using 
Trimmomatic (Bolger et al., 2014), alignment was performed with BWA (pre-
alignment; Li and Durbin, 2009) and Stampy (Lunter and Goodson, 2011) against the 
mouse genome assembly (mm10) and MACS2 (Zhang et al., 2008) in combination 
with the IDR pipeline (https://github.com/nboley/idr) was used to call confident 
FOXN1 peaks.  9,012 peaks passed the IDR threshold, of which a third marked the 
distal upstream TSS region of genes and were enriched for H3K4me3 marks.  
Furthermore, de novo motif discovery using the aforementioned IDR-selected peaks 
predicted the canonical (5’-GACGC-3’) FOXN1 binding motif and an alternative 
motif (5’-GAAGC-3’) which were both over-represented in the DNA sequences under 
the peaks. 
 
5.2.1.3 Inferring candidate direct FOXN1 targets in fetal TEPCs from 
FOXN1 binding events in newborn TECs 
Since no other ChIP-seq datasets were available for FOXN1 in fetal TEPCs, I used the 
FOXN1-tagged ChIP-seq dataset in newborn TECs (Žuklys et al., 2016) to obtain a 
list of FOXN1 binding sites, which I then further integrated with the list of FOXN1-
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dependent genes in TEPCs (from the differential expression analyses described in 
section 5.2.1.1), to infer potential FOXN1 gene regulatory events in fetal TEPCs.  In 
more detail. I obtained the raw FASTQ files from the FOXN1-tagged ChIP-seq data 
from newborn TECs through the GEO repository (Barrett et al., 2013) and reanalysed 
them (as described in Chapter 2, section 2.3.1 and section 2.3.4) to provide a list of 
FOXN1 binding sites.  In general, the ChIP-seq reanalysis steps were similar to the 
Žuklys et al. ChIP-seq pipeline, including adapter removal with Trimmomatic, peak 
calling with MACS2 and identification of confident peaks with the IDR pipeline.  
However, I used Bowtie2 (Langmead and Salzberg, 2012) for read mapping in the 
ChIP-seq reanalysis instead of the BWA-Stampy combination that was used by  Žuklys 
et al.,  so that the same alignment tool was used for the analyses of the ChIP-seq 
datasets described in my thesis.  A total of 4,858 IDR confident peaks (IDR ≤ 0.05) 
resulted from the FOXN1-tagged protein ChIP-seq reanalysis.  As also shown by 
Žuklys et al., FOXN1 confident peaks (IDR ≤ 0.05) were found to mostly bind at the 
promoter region of genes and also at some distal intergenic regions (to a lesser extent); 
these intergenic regions could represent enhancer regions across the genome (Figure 
5.2). 
To infer candidate direct target genes for FOXN1 in the fetal TEPCs, I integrated the 
4,858 FOXN1 confident peaks (IDR ≤ 0.05) from the FOXN1 ChIP-seq reanalysis in 
newborn TECs based on their genomic location (in reference to mouse genome 
assembly; version GRCm38.p5 from GENCODE – release M12) with the FOXN1-
dependent genes in TEPCs from the TEPC Developmental series and the Foxn1 Allelic 
series RNA-seq dataset analyses (identification of these genes is described extensively 
in section 5.2.1.1, see also Figure 5.1, step 1-2).  For this integration, only TEPC 
FOXN1-dependent genes with a FOXN1 confident peak around their distal TSS site 
[5 kilobases (kb) upstream and 3kb downstream of genes TSSs] were chosen as 
potential FOXN1 direct targets in TEPCs.  A subset of 597 FOXN1-dependent genes 
demonstrated FOXN1 binding evidence at their distal promoter region (-5kb, +3kb), 
with 468 of them (~78.4%) to be up-regulated in association with increase in Foxn1 
expression (Figure 5.1, step 3), suggesting a predominant role for FOXN1 as a 
transcription activator in TEPCs.  This conclusion was consistent with findings 
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showing a prevailing role of FOXN1 in genes up-regulation in newborn cTECs 









Figure 5.2: FOXN1 ChIP-seq peaks distribution in the mouse reference genome assembly gene regions.  The 4,858 FOXN1 confident peaks (IDR ≤ 0.05) from the 
FOXN1 ChIP-seq re-analysis in newborn TECs were annotated in terms of genomic features with the peakAnno function from ChIPseeker package in R and plotted in a 
barplot format with plotAnnoBar function from the same package.  Approximately 50% of the peaks reside in the proximal promoter region (light blue section) of the 
reference genome, with the second biggest percentage of peaks to fall into distal intergenic regions (brown section). 
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5.2.1.4 Insights in the TEPC chromatin accessibility landscape based 
on promoter and enhancer histone modification marks in E12.5 TEPCs 
The FOXN1 binding landscape marked by the FOXN1-tagged ChIP-seq dataset is 
representative of a mixed TEC population in newborn mice.  When a transcription 
factor binds at a promoter or enhancer region of a gene and regulates its expression in 
a specific cell type, a fair assumption is that it will probably regulate the same gene in 
another cell type if the gene is expressed in the new cell type and the promoter or 
enhancer region of this gene is also accessible and active. 
To assess the chromatin regulatory landscape of TEPCs, histone modification data 
were generated from E12.5 fetal TEPCs [Vaidya and Blackburn (unpublished)].  These 
datasets comprise ChIP-seq for the H3K4me3 and H3K27ac chromatin modifications 
(ChIP-seq data from biological duplicates per mark provided by Harsh Vaidya, 
Blackburn lab; see also Chapter 2, section 2.2.3.1): the H3K4me3 modification 
mainly marks active promoters (Heintzman et al., 2007), while the H3K27ac 
modification marks mostly accessible and active enhancers (Creyghton et al., 2010; 
Heintzman et al., 2009; Rada-Iglesias et al., 2011; Zentner et al., 2011).  Combined, 
these histone modification marks provide a robust readout of accessible and active 
promoter and enhancer regions of TEPCs on day E12.5 in embryonic development.  
By making use of the above histone modification datasets, TEPC genes with accessible 
and active promoters or enhancers in their distal promoter regions in the E12.5 TEPC 
average population landscape can be identified. 
The average binding profile of the H3K4me3 and H3K27ac marks in TEPCs was thus 
plotted for all regions marked by the 4,858 FOXN1 confident peaks (IDR ≤ 0.05) from 
the FOXN1 ChIP-seq reanalysis in newborn TECs, to broadly assess accessibility of 
the regions located under the FOXN1 IDR peaks in TEPCs, by looking at the 
modification profiles of those regions in TEPCs (Figure 5.3).  In more detail, Figure 
5.3 depicts genomic region profiles (top section) and respective heatmaps (bottom 
section) of the FOXN1 ChIP-seq peaks in newborn TECs, and the H3K4me3 and 
H3K27ac histone modification marks in fetal TEPCs for all the regions defined by the 
FOXN1 IDR peaks in newborn TECs, centred in the middle of the FOXN1 IDR peak 
and extended by ± 2 kb from the centre of the peak.  The genomic profiles represent 
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cumulatively the peaks enrichment scores over a set of genomic regions (the FOXN1 
IDR peaks), while heatmaps show for each FOXN1 IDR peak-defined region the 
enrichment score  of selected datasets (FOXN1 peaks from newborn TECs, and 
H3K4me3 and H3K27ac from fetal TEPCs) per row (Ramírez et al., 2016).  As 
expected, distributions of the FOXN1 peaks are centred in the middle of the IDR 
FOXN1 peaks, while the histone modification marks show a binomial distribution over 
the IDR FOXN1 defined regions with a depletion in the centre of the IDR FOXN1 
peaks.  Transcription factor binding sites (TFBS) reside in the open chromatin region 
between flanking nucleosomes that carry these histone modification marks (Chai et 
al., 2013), thus this depletion signature is expected in IDR FOXN1 binding site.  
Overall, samples H3K4me3 (A) and H3K27ac (B) demonstrated the strongest signals 
(fold-enrichment versus control) around the FOXN1 peak centres, marking 
approximately two thirds of the FOXN1 IDR peaks.  This analysis therefore suggested 
that a common landscape might exist for FOXN1 targets in fetal TEPC and newborn 
TEC samples.  Because replicate samples for H3K4me3 and H3K27ac revealed lower 
signal intensity for the FOXN1 peaks marked by their own replicates (H3K4me3 (B) 
and H3K27ac (A); Figure 5.3) IDR analysis was not performed for these samples.  
Instead significant peaks were determined for each replicate for a 0.05 (H3K4me3 
mark; narrow peaks) and 0.1 (H3K27ac mark; broad peak) q-value threshold (MACS2) 










Figure 5.3: Genomic region profile plots and heatmaps over the FOXN1 IDR peak regions in 
newborn TECs for the FOXN1 and histone modification ChIP-seq datasets.  Total signal profiles 
(top section) over the FOXN1 IDR peak-defined regions [± 2kb from centre of the FOXN1 peak] show 
cumulatively enrichment scores for FOXN1 peaks from 1 week old TECs (FOXN1 biological replicates A 
and B: FOXN1 (A) and FOXN1 (B)), and for H3K4me3 and H3K27ac peaks for E12.5 TEPCs (H3K4me3 
biological replicates A and B; H3K4me3 (A) and H3K4me3 (B), H3K27ac biological replicate A and B; 
H3K27ac (A) and H3K27ac (B)).  Heatmap plots (bottom section) show for each FOXN1 IDR peak-
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defined region from 1 week old TECs the enrichment score for both FOXN1 replicates from 1 week old 
TECs (shown in gold-black colour scale) and for both replicates of each histone modification mark from 
E12.5 TEPCs: H3K4me3, and H3K27ac (shown in green-white, blue-white and red-white colour scales 


























5.2.1.5 Prediction of high confidence candidate direct FOXN1 targets in 
fetal TEPCs from overlapping FOXN1 binding sites in newborn TECs with 
accessibility histone marks in fetal TEPCs 
As shown in section 5.2.1.3, candidate direct FOXN1 targets were inferred based on 
the proximity (-5kb, +3kb) of the promoters of FOXN1-dependent genes in TEPCs to 
the FOXN1 confident peaks (IDR ≤ 0.05) from the FOXN1-tagged ChIP-seq dataset 
in newborn TECs (see Figure 5.1, steps 1-2 and 3).  This integrative analysis identified 
597 genes as candidate direct FOXN1 targets.  When the significant peaks of the 
histone modification marks detected in E12.5 TEPCs (q-value for H3K4me3 ≤ 0.05 
and for H3K27ac ≤ 0.1; see section 5.2.1.4) were mapped to genes, the vast majority 
of the 578 candidate direct FOXN1 targets in TEPCs (451 up-regulated and 127 down-
regulated, as shown Figure 5.1, step 4) possessed an H3K4me3 and/or an H3K27ac 
mark in their distal promoter area (-5kb, +3kb) as expected, since the list comprised 
TEPC expressed genes. 
Although the 578 candidate direct FOXN1 targets in TEPCs exhibited a FOXN1 
binding peak from newborn TECs as well as an H3K4me3 peak and/or an H3K27ac 
peak from fetal TEPCs in the region (-5kb, +3kb) around their TSS, these peaks did 
not necessarily coincide.  When the H3K4me3 and H3K27ac peaks were overlaid with 
the distal FOXN1 binding peaks, 107 (67 up-regulated and 40 down-regulated) genes 
exhibited marks at a different location from the FOXN1 binding site (Figure 5.1, step 
5).  This suggested that the non-overlapping FOXN1 peaks from the newborn TEC 
population were not located in an open chromatin area in TEPCs, and that they could 
not be regulating the particular genes via direct binding.   The remaining genes in 
which the FOXN1 and H3K4me3 and/or FOXN1 and H3K27ac peaks overlapped 
included: 269 (231 up-regulated, 38 down-regulated) with FOXN1 overlapping with 
both histone modification marks, 146 (107 up-regulated, 39 down-regulated) with 
FOXN1 overlapping only with the H3K4me3 mark and 56 (46 up-regulated, 10 down-
regulated) with FOXN1 overlapping only with the H3K27ac mark (Figure 5.4).  All 
471 genes with one or more FOXN1 peaks from newborn TECs overlapping with one 
or both histone modification marks from fetal TEPCs are present in my most confident 
candidate list for FOXN1 direct targets in fetal TEPCs.  Among these candidates were 
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the widely known FOXN1 targets, Ccl25 and Dll4, which were shown to be up-
regulated after transient transfection of mouse embryonic stem (ES) cells with Foxn1 
by QRT-PCR analysis (Nowell et al., 2011), as well as the recently identified FOXN1 
direct targets in 1 week old cTECs, Psmb11 and Cd83, whose expression was lost or 
reduced in HEK293 cells expressing FOXN1 if their FOXN1 binding sites located in 
genes near promoter were mutated (Žuklys et al., 2016) (Figure 5.4).  Further 
evaluation of these targets, including comparative analysis versus FOXN1 targets 
specifically predicted in newborn cTECs, and pathway enrichment analysis between 

















Figure 5.4: Volcano plots of the FOXN1 candidate targets in fetal TEPCs.  Each point represents one of the 471 FOXN1 candidate targets in fetal TEPCs that have 
an overlapping FOXN1 binding peak from newborn TECs with a histone modification mark from fetal TEPCs around gene’s distal promoter region (-5kb to +3kb from 
gene’s TSS).  In the left graph, genes with FOXN1 peaks overlapping with A) both H3K4me3 and H3K27ac marks are shown in blue, B) only an H3K4me3 mark are shown 
in green and C) only an H3K27ac mark are shown in red.  Location of FOXN1 known targets is shown in the right graph and gene names have been coloured based on 
the FOXN1 peak overlap.  The x-axis shows the log2-transformed fold changes as calculated from the differential expression analysis between E10.5 and E12.5 timepoints 
from the TEPC Developmental series (Chapter 3, section 3.2.2) with limma package in R.  The y-axis depicts the adjusted p-value (here the false discovery rate), with a 




5.2.2 Comparative analysis and insights on the highly confident 
direct candidate FOXN1 targets in fetal TEPCs 
In their study, Žuklys et al. (2016) integrated the IDR FOXN1 peaks from 1 week old 
(newborn) TECs with transcriptomic data depicting gene changes in 1 week old cTECs 
and 1 week old mTECs between Foxn1wt*/wt* and Foxn1wt*/- mice.  As previously 
described, the Foxn1wt* allele expresses the FOXN1 protein tagged with a flagged 
peptide, and mice homozygous for this allele (Foxn1wt*/wt*) demonstrated an overall 
normal phenotype and Foxn1 expression levels, with a mildly reduced cellularity 
which was still capable of supporting thymocyte development (Žuklys et al., 2016).  
In comparison, the heterozygous mice for the Foxn1wt* allele (Foxn1wt*/-) demonstrated 
a thymus of significantly reduced size, decreased Foxn1 expression, disorganised 
corticomedullary segregation and multiple large cysts.  A large number of genes were 
found to be differentially expressed (DE) from this analysis in newborn cTECs (8,378 
DE genes) and mTECs (11,690 DE genes).  Furthermore, to get a more confident set 
of genes that are regulated by FOXN1 in newborn cTECs,  Žuklys et al. designed triple 
mutant mice (Psmb11-rtTA::tetO-Cre::Foxn17,8loxP/loxP; designated iFoxn1Δ7,8), in 
which induction with doxycycline (Dox) drives a cTEC-specific deletion of exon 7 
and 8 in the Foxn1 locus.  Prior to Dox exposure, mice demonstrated an overall normal 
thymus phenotype, TEC architecture and intrathymic T-cell development.  However, 
the thymi of Dox-treated mice demonstrated significantly reduced Foxn1 levels, 
decreased cellularity and specific reduction of thymocytes subpopulations (Lin-
CD44+CD25+CD4-CD8- and Lin-CD44-CD25+CD4-CD8-) by day 3 after treatment.  
Differential expression analysis of the cTEC transcriptomic datasets from 1 week old 
iFoxn1Δ7,8 mice prior to, and 3 days after, Dox treatment identified 2,506 DE genes 
regulated by FOXN1.  Finally, the gene overlap of the differentially expressed genes 
between cTECs in Foxn1wt*/wt* and Foxn1wt*/- mice, and the differentially expressed 
genes in cTECs from  iFoxn1Δ7,8 mice prior to and 3 days after Dox treatment was 
integrated with the 9,012 IDR FOXN1 peaks (IDR) from the analysis of the FOXN1-
tagged ChIP-seq dataset by Žuklys et al. based on distance of genes TSS to the FOXN1 
peak (5kb upstream or 100 bases downstream) and identified 450 highly confident 
candidate direct FOXN1 targets in cTECs. 
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Comparison of the 450 highly confident direct FOXN1 targets in newborn cTECs 
(Žuklys et al., 2016) with my highly confident 471 candidate direct FOXN1 targets in 
fetal TEPCs showed that 102 of these targets were commonly shared between the two 
datasets, with these genes having a FOXN1 peak overlapping with an H3K4me3 
and/or an H3K27ac mark in fetal TEPCs.  Apart from these 102 common targets 
between TEPCs and cTECs, 369 candidate direct FOXN1 targets in fetal TEPCs 
(identified from this analysis) did not constitute candidate direct FOXN1 targets in the 
1 week cTEC population.  Possible reasons for the absence of these 369 candidate 
targets from the newborn cTEC population include differential binding or regulation 
of these genes between cTECs and mTECs since the FOXN1-tagged ChIP dataset 
comes from a mixed cTEC-mTEC population and it would be possible that some of 
the FOXN1 binding sites result from unique FOXN1 binding only in one of the two 
populations.  In this respect, 65 of the 369 genes were more strongly or equally 
expressed in newborn (1 week) mTECs compared to cTECs of the same age, 
suggesting potential regulation of these genes only in mTECs.  Additionally, technical 
reasons could explain why genes with FOXN1 binding sites proximal to their promoter 
may not result as differentially expressed between cTEC samples that express normal 
and defective levels of FOXN1.  For instance, even though Foxn1 mRNA levels were 
significantly reduced by day 3 after Dox treatment, FOXN1 protein levels may still 
reside in the cells allowing part of genes to continue to be regulated from  iFoxn1Δ7,8 
mice prior to and 3 days after Dox treatment.  In support of this, on day 3 after Dox 
exposure, iFoxn1Δ7,8 mice maintained a fairly normal intrathymic T-cell development.  
Alternatively, genes may be not strongly impacted by the absence of FOXN1 in the 
given period of time.  Finally, it is possible that our reanalysis of the FOXN1-tagged 
ChIP-seq dataset by Žuklys et al. assigned more distal FOXN1 peaks to genes, since  
I have defined a more extended window (-5kb, +3kb) to match genes TSSs to FOXN1 
regulatory peaks compared to the Žuklys study (-5kb, +100b). 
To better understand the behaviour of the predicted FOXN1 targets in fetal TEPCs, I 
plotted the 471 highly confident candidate direct FOXN1 targets across the TEPC 
Developmental series dataset (E10.5, E11.5 and E12.5 timepoints) from fetal TEPCs 
(Figure 5.5) using the pheatmap function in R and observed them in accordance to a) 
the expression of the same genes in 1 week old cTEC/mTEC populations, b) the 
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provided highly confident cTEC targets (Žuklys et al., 2016) and c) the FOXN1, 
H3K4me3 and H3K27ac binding overlap landscape.  Gene targets with overlapping or 
alternative binding sites for FOXN1 and H3K4me3/H3K27ac were equally distributed 
across the genes (shown in Figure 5.5) showing no obvious patterns of preference for 
promoter or enhancer marks towards up-regulated or down-regulated groups of genes.  
Approximately 80% of the direct FOXN1 target genes that were differentially 
expressed between E10.5 and E12.5 timepoints from the TEPC Developmental series 
dataset were up-regulated with Foxn1 increase supporting the predominantly 
activating role of FOXN1 in fetal TEPCs, as similarly suggested in the newborn cTEC 
population (Žuklys et al., 2016).  The vast majority of the direct FOXN1 target genes 
in fetal TEPCs, which are up-regulated with increase in Foxn1 expression from day 
E10.5 to E12.5 (TEPC Developmental series), were found more highly expressed in 
cTECs, and the opposite trend was observed in mTECs as expected, since FOXN1 is 
more highly expressed in the cTEC population.  Lastly, overlapping FOXN1 targets 
with the 450 highly confident direct FOXN1 targets in newborn cTECs are shown to 
mark only the up-regulated proportion of the gene list, overlapping mostly with genes 







Figure 5.5: Heatmap of the high confidence FOXN1 target candidates in fetal TEPCs. Expression 
levels of the FOXN1 target candidates in TEPCs are shown across the TEPC Developmental series and 
Foxn1 Allelic series datasets. Samples cluster according to their Foxn1 expression level (red bar on top 
of the heatmap; also in agreement with Chapter 3, section 3.2.1). Rows (representative of genes) have 
been colour-annotated based on differential expression in TECs for an FDR ≤ 0.05 and |FC| ≥ 1.5 (red: 
higher expression in cTECs, blue: higher expression in mTECs, grey: not differentially expressed or not 
statistically significant), overlap with the high confidence FOXN1 targets in cTECs (yellow bars; Žuklys 
et al., 2016) and presence of FOXN1-H3K4me3/H3K27ac overlapping/alternative peaks around their 






Heatmap of FOXN1 candidate targets in fetal TEPCs  
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5.2.3 Comparative analysis and insight of the highly confident 
direct candidate FOXN1 targets in newborn cTECs 
To complement the analysis in section 5.2.2 and better understand why the high 
confidence candidate direct FOXN1 targets in newborn cTECs (Žuklys et al., 2016) 
were not identified from the integrative analysis of candidate FOXN1 targets in early 
TEPCs, the unique FOXN1 targets in cTECs were analysed across the embryonic data 
series (Chapter 3, section 3.2.1).  When the 348 FOXN1 cTEC-specific targets (450 
excluding the 102 common targets) were mapped to the TEPC Developmental series 
and the Foxn1 Allelic series datasets, 12% of these genes (42/348 genes; see Table 
5.1) were not detected at all in the TEPC datasets.  Of those genes that were expressed, 
270 (see Table 5.1) did not pass the significance threshold in the differential 
expression analysis between the E10.5 and E12.5 timepoints and therefore were 
excluded from been considered as FOXN1 targets in our analysis.  These genes may 
have a different dependence on FOXN1 in the fetal and newborn cTEC populations or 
they may have been too variable among replicates in the fetal TEPC Developmental 
series and did not pass the FDR and FC defined thresholds.  An additional 22 genes 
(see Table 5.1) were not FOXN1-dependent, based on the pairwise comparison 
between Foxn1high and Foxn1low phenotypic samples from the fetal Foxn1 Allelic 
series independently of the developmental stage (for details see Chapter 3, section 
3.2.2).  Again, differential regulation or variability may explain the lack of these genes 
from our list.  A minority of 10 genes (both dependent and with a FOXN1 peak) had 
an IDR FOXN1 peak (IDR ≤ 0.05) in their distal promoter (-5kb, +3kb), however, this 
peak did not overlap with any of the histone modification marks (H3K4me3, 
H3K27ac) in fetal TEPCs; these genes are potentially regulated by a different factor 
in early development that binds to a different accessible region close to genes 
promoter, while FOXN1 could become involved in their regulation later on in 
development (newborn stage).  Lastly, 4 genes (see Table 5.1) did not have an IDR 
FOXN1 peak, based on our reanalysis of the published FOXN1-tagged ChIP-seq data.  
The reanalysis did not identify as many peaks as the ones identified by Žuklys et al., 












Table 5.1: Unique FOXN1 targets in newborn cTECs compared to targets in fetal TEPCs.  List of 
potential causes of the absence of uniquely identified FOXN1 targets in newborn cTECs from the fetal 
TEPC population.  Genes per list are mutually exclusive. 
 
Taken together, the comparative analyses presented in section 5.2.2 and 5.2.3 have 
described two major classes of genes that are directly regulated by FOXN1: a) genes 
regulated in both fetal TEPCs and newborn cTECs and b) genes regulated only in 
newborn cTECs.  Genes in category (a) could be subdivided into i) genes at which the 
FOXN1 ChIP-seq peaks from newborn cTECs overlapped with both H3K4me3 and 
H3K27ac marks from fetal TEPCs, ii) genes at which the FOXN1 ChIP-seq peaks 
from newborn cTECs overlapped only with the H3K4me3 mark from fetal TEPCs, iii) 
genes at which the FOXN1 ChIP-seq peak from newborn TECs overlapped only with 
the H3K27ac mark from fetal TEPCs and iv) genes at which the FOXN1 ChIP-seq 
peak from newborn cTECs did not overlap with either H3K4me3 or H3K27ac from 
fetal TEPCs (see Figure 5.4). 
 
5.2.4 Differential FOXN1 binding profiles in fetal TEPCs and 
newborn TECs 
To better understand the differences between the genes regulated directly by FOXN1 
in fetal TEPCs and newborn cTECs, and genes regulated directly by FOXN1 only in 
newborn cTECs, the overall signals from the ChIP-seq  FOXN1  (newborn mixed TEC 
population), H3K4me3, and H3K27ac (fetal TEPCs) datasets were plotted for 4 
Unique FOXN1 targets in cTECs ( versus TEPCs ) 
Not detected   42 / 348 
Not differentially expressed 270 / 348 
Not solely FOXN1-dependent 22 / 348 
Non-overlapping FOXN1 peak 10 / 348 
No FOXN1 peak  4 / 348 
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different clusters of regions: the FOXN1 IDR peaks that overlap with a) H3K4me3, b) 
H3K27ac, c) both H3K4me and H3K27ac marks (clusters a, b and c define common 
candidate direct FOXN1 targets in fetal TEPCs and newborn TECs) or d) none of the 
histone modification marks (cluster d defines unique candidate direct FOXN1 targets 
only in TECs, and suggest differential regulation of these genes in fetal TEPCs by 
other factors) and peak intensity for FOXN1 was compared between these groups (see 
Figure 5.6).  FOXN1 IDR peaks from newborn TECs that have no overlap with either 
of the histone modification marks (“only FOXN1”; Figure 5.6) from fetal TEPCs 
demonstrated the strongest signal intensity for FOXN1 compared to all other groups, 
suggesting stronger binding for FOXN1 in regions that are accessible in newborn 
TECs and not in fetal TEPCs.  No major differences were observed among the other 
groups for the FOXN1 dataset, suggesting similar binding intensity of FOXN1-
H3K4me3, FOXN1-H3K27ac and FOXN1-H3K4me3/H3K27ac sites, allowing 






Figure 5.6: Genomic region profile plots and heatmap clusters over the FOXN1-H3K4me3, FOXN1-
H3K27ac, FOXN1-H3K4me3-H3K27ac and FOXN1 IDR overlapping peaks for the FOXN1 and 
histone modification ChIP-seq datasets.  Total signal profiles (top section) show cumulatively 
enrichment scores for FOXN1 peaks from 1 week old TECs (FOXN1 biological replicates A and B: 
FOXN1 (A) and FOXN1 (B)), and for H3K4me3 and H3K27ac peaks from E12.5 TEPCs (H3K4me3 
biological replicates A and B; H3K4me3 (A) and H3K4me3 (B), H3K27ac biological replicate A and B; 
H3K27ac (A) and H3K27ac (B)) over regions defined by computed k-means clusters, Cluster 1: FOXN1-
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H3K4me3 (dark blue) , Cluster 2: FOXN1-H3K27ac (light blue), Cluster 3: FOXN1-H3K4me3/H3K27ac 
(green) and Cluster 4: only FOXN1 (orange) ± 2kb from the centre of the FOXN1 peak.  Heatmap plots 
(bottom section) show for each cluster the enrichment score for both FOXN1 replicates from 1 week old 
TECs (gold-black colour scale) and for both replicates of each histone modification mark from E12.5 
TEPCs: H3K4me3 and H3K27ac (green-white, blue-white and red-white colour scales respectively).  

























5.2.5 Motif discovery in regions defined by FOXN1 peaks in 
newborn TECs and histone modification marks in fetal TEPCs 
Following the differential FOXN1 binding analysis presented in section 5.2.4, I 
undertook a de novo motif discovery analysis to test if the differential peak intensity 
of FOXN1 in regions uniquely bound by FOXN1 in newborn TECs and regions bound 
by FOXN1 in newborn TECs that overlap with accessible histone modification marks 
in fetal TEPCs resulted from a different FOXN1 binding motif under the 
aforementioned regions.  FOXN1 IDR peaks in newborn TECs that did not overlap 
with the histone modification marks in fetal TEPCs were used to predict enriched 
binding motifs uniquely bound by FOXN1 in TECs, while overlapping FOXN1 IDR 
peaks in newborn TECs with either an H3K4me and/or an H3K27ac mark in fetal 
TEPCs were used to predict enriched binding motifs predicted to be bound by FOXN1 
in both fetal TEPCs and newborn TECs.  To examine the integrity of our analysis, the 
H3K4me3/H3K27ac peaks in fetal TEPCs that were not overlapping with the FOXN1 
IDR peaks in newborn TECs were used.  Since FOXN1 did not ChIP on these regions 
(even though FOXN1 is expressed already at E12.5 TEPCs and the regions are 
accessible based on the ChIP-seq analysis of the histone modification marks in the 
same TEPC population), these regions should be controlled by other direct regulators, 
therefore no FOXN1 binding motifs should be identified in the area under the histone 
modification mark.  Additionally, motif discovery analysis of the non-FOXN1-
overlapping histone modification regions could potentially identify alternative binding 
sites of FOXN1 (differential regulation in fetal mouse) or binding motifs of other 
regulators. 
Motif discovery analysis was performed using two different motif discovery tools 
(MEME-ChIP; Machanick and Bailey, 2011 and RSAT; Thomas-Chollier et al., 
2011).  MEME-ChIP uses two complementary discovery algorithms to perform ab 
initio motif discovery analysis.  These algorithms are MEME (Bailey et al., 2006) and 
DREME (Bailey, 2011). MEME uses expectation maximisation to discover 
probabilistic models of single or combined transcription factor binding motifs 
(TFBM), while DREME uses a less complex, non-probabilistic algorithm to predict 
single TF binding events.  The RSAT peak-motifs tool (Thomas-Chollier et al., 2011) 
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implements complimentary word based approaches to perform ab initio motif 
discovery analysis.  Oligo-analysis (van Helden et al., 1998) and dyad-analysis (van 
Helden et al., 2000a) algorithms discover over-represented oligonucleotides or spaced 
pairs respectively, while position-analysis (van Helden et al., 2000b) and local-word-
analysis algorithms  identify positionally biased oligonucleotides.  Previous literature 
has discussed extensively how results from different motif discovery algorithms can 
vary greatly even if they are executed with same parameters because the underlying 
method is different and has suggested using more than one algorithm to improve motif 
discovery (Tompa et al., 2005).  A recent survey focusing only on online accessible 
motif discovery tools showed that results consistent between tools are more reliable 
(Tran and Huang, 2014).  In the same study, results from MEME-ChIP and RSAT in 
a benchmarking study were found to highly overlap.  Thus, I have selected these two 
tools to use for this analysis. 
The motif discovery analysis revealed the previously identified canonical FOXN1 
binding site 5’-GACGC-3’ (Nakagawa et al., 2013; Schlake et al., 1997; Žuklys et al., 
2016) and a newly identified slightly extended FOXN1 motif with the same penta-
peptide core sequence (GACGC) under the IDR FOXN1 peaks (IDR ≤ 0.05) 
overlapping with either or both histone modification marks (H3K4me3, H3K27ac) in 
fetal TEPCs, as well as, the ones that did not overlap and uniquely defined FOXN1 
binding sites in newborn TECs.  De novo motif discovery analysis for the H3K4me3 
and H3K27ac marks in fetal TEPCs that do not overlap with the FOXN1 IDR peaks 
in newborn TECs did not identify the canonical FOXN1 motif.  In the latter case, 
accessible regions in fetal TEPCs without FOXN1 binding evidence are potentially 
controlled by other transcription factors. 
From this, I conclude that FOXN1 bound peaks in newborn TECs that overlap with 
histone modification marks in fetal TEPCs identify the very same FOXN1 motif with 
the FOXN1 bound peaks in newborn TECs that are uniquely accessible in TECs (no 
overlap with histone modification marks from fetal TEPCs).  Importantly though, a 
slight variation of the RSAT identified motif, with the adenosine in the 6th position of 
the y-axis in Table 5.2 (green “A”) to be not as conserved, could suggest that other 
regulators may bind co-operatively in some of the uniquely accessible FOXN1 regions 
in TECs and this motif could be the outcome of the averaged profiles of two different 
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existing motifs.  Therefore, differences in binding intensity between the overlapping 
and non-overlapping IDR FOXN1 peaks could be partially explained by differential 
binding of the overlapping and the non-overlapping regions.  Additionally, the lack of 
an enriched FOXN1 motif in the accessible regions of the fetal TEPCs marked by the 
histone modification marks suggests that the FOXN1 binding motif is not generally 
enriched in the accessible regions of the genome, but it is specifically located under 
the FOXN1 ChIPed peaks. 
 
 MEME RSAT 
















NONE - NONE - 
 
Table 5.2: De novo identification of canonical and extended FOXN1 binding motifs in the regions 
under the IDR FOXN1 peaks in newborn TECs that overlap (or not) with histone modification 
marks in fetal TEPCs.  Table depicts FOXN1-identified motifs in the regions under the FOXN1 bound 
peaks in newborn TECs that overlap with histone modification marks (H3K4me3 and H3K27ac) in fetal 
TEPCs (common peaks) and under the FOXN1 bound peaks in newborn TECs that are uniquely 
accessible in TECs (no overlap with histone modification marks in fetal TEPCs; unique FOXN1).  The 
dash (“-“) symbol is used when no similar motifs to the previously identified canonical and alternative 
FOXN1 motif are identified (regions under the histone modification marks that do not overlap with IDR 
FOXN1 peaks from newborn TECs; Unique H3K4me3-H3K27ac).  The statistical significance of the 
enrichment (E-value) assigned by the de novo motif discovery tools, MEME-ChIP and RSAT is also 
provided in the table. 
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5.2.6 Nodal points that FOXN1 regulates in fetal TEPCs during 
thymus organogenesis  
In sections 5.2.1 to 5.2.5, I have described an integrated analysis of transcriptional, 
regulatory and accessibility datasets, which identified confident candidate FOXN1 
target genes in fetal TEPCs, while FOXN1 peak and binding motif differences among 
fetal TEPCs and newborn TECs were also discussed thoroughly.  I next wished to 
investigate the molecular mechanisms that FOXN1 may regulate via its targets and 
how these may control TEPC progression. 
As described in Chapter 4 (section 4.2.1), to predict the signalling pathways that are 
enriched between the E10.5 and E12.5 TEPC developmental stages, all differentially 
expressed genes (in number 15,321) from the comparison above (analysis with limma) 
were identified and used as a ‘Pre-Ranked Gene List’ in GSEA (Subramanian et al., 
2005) against the edited ConsensusPathDB database (Kamburov et al., 2011) to predict 
biological pathways (or processes) that alter between these two developmental stages.  
Only pathways with an FDR ≤ 0.25 were considered as enriched and these were 
selected for further analysis (see Table 5.3 and Table 4.1 for pathways and Chapter 
2, section 2.3.3.6 for interpretation of the GSEA results). 
FOXN1, similar to other transcription factors, can interact with specific pathways by 
targeting their intrinsic regulators.  Since this analysis aims to identify nodal points in 
early TEPC progression directly regulated by FOXN1, I compared the genes 
contributing to the core enrichment of each pathway (Table 5.3 and Chapter 4, Table 
4.1) to the 471 high confidence candidate direct FOXN1 targets in fetal TEPCs 
identified in section 5.2.1 (see Figure 5.7) and I used the overlap of this comparison 
to select the enriched pathways that are directly regulated by FOXN1 during the 
undifferentiated (E10.5) – differentiating TEPCs (E12.5) transition.  The generated list 
of 39 candidate direct FOXN1 targets was used to group the selected pathways into 
broader biological categories (Figure 5.7, A-F gene clusters) based on the presence of 
ligands, receptors, signalling molecules or machinery subunits. 
Among the pathways in Table 5.3, the TCR SIGNALING (#10), DOWNSTREAM 
TCR SIGNALING (#13), COSTIMULATION BY THE CD28 FAMILY (#27) and T-
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CELL RECEPTOR SIGNALING PATHWAY (#51) candidates suggest increased 
activity of T-cell specific pathways in the E12.5 TEPCs, an enrichment that could 
indicate T-cell contamination.  However, a potential contamination of the RNA-seq 
samples would be difficult based on the fact that hematopoietic progenitors migrate to 
the mesenchymal capsule of the thymus around E11.5, but they are not observed 
among epithelial cells until around E12 (Itoi et al., 2001).  Moreover, even if T-cell 
precursors were present among the obtained cell population of thymic epithelial cells, 
sorting these cells for EPCAM and PLET1 should remove any non-epithelial 
cells.  Additionally, a closer look to the core enrichment genes of these pathways can 
resolve any dispute, since the involved genes are not T-cell specific genes.  On the 
contrary, they seem to be mostly ligands, receptors, transcription factors and 
intermediate molecules (H2-Aa, Prkcq, Pag1, H2-Eb1, Nfkb1, Nfkbia, Zap70, Ube2v1 
in #10; H2-Aa, Prkcq, H2-Eb1, Nfkb1, Nfkbia, Ube2v1 in #13; H2-Aa, Cd274, 
Pdcd1lg2, H2-Eb1, Map3k8, Lyn, Ptpn6, Cd80 in #27 and Prkcq, Nfatc2, Pak6, 
Nfatc1, Map3k8, Tec, Fos, Map3k14, Nfkbie, Nfkbia, Vav3, Zap70, Jun, Ptpn6, Cblc, 
Il4 in #51) that could be involved in alternative signalling pathways, however, in this 
case these genes (together) have qualified to surpass the enrichment analysis threshold 
and result in enrichment of the aforementioned pathways.  This observation highlights 
again the inefficacy of the manually curated pathways and/or the pathway enrichment 
analysis tools to accurately predict the biological reality in the different cell types 
(previously discussed in Chapter 4, section 4.2.1), since existence of T-cell specific 
genes should be required to allocate enrichment to T-cell specific pathways. 
Based on the enriched pathways between the E10.5 and the E12.5 developmental 
stages during TEPC differentiation (shown in Table 5.3) and their core enrichment 
genes that were also identified to be high-confidence FOXN1 direct targets (shown in 
Figure 5.7, I conclude that FOXN1 could directly regulate the downstream cytokine 
signalling, the antigen processing and presentation program, NF-κB and NOTCH 
signalling pathways and protein degradation (gene groups depicted in Figure 5.7).  














Table 5.3: List of signalling pathways whose activity increases during the developmental 
progression from E10.5 undifferentiated TEPCs to E12.5 TEPCs.  In sequence, the table provides 
name of each pathway (GS follow link to MSigDB), number of Pre-Ranked genes identified per pathway 
(size), enrichment score of each pathway (ES), enrichment score of each pathway normalised for the 




Figure 5.7: Heatmap of the high confidence FOXN1 target candidates that regulate enriched 
signalling pathways in fetal TEPCs.  Expression levels of the FOXN1 target candidates involved in 
signalling pathways in TEPCs are shown across the TEPC Developmental series and Foxn1 Allelic series 
datasets.  Genes (rows) have been colour-annotated based on presence of an FOXN1-H3K4me3 
overlapping/alternative peak around their TSS (green/blue; see also Figure 5.4), overlap with the high 
confidence FOXN1 targets in cTECs (yellow bars; Žuklys et al., 2016) and differential expression in TECs 
with statistical significance for an FDR ≤ 0.05 and |logFC| ≥ 0.585 (red: higher expression in cTECs, blue: 
higher expression in mTECs, grey: not differentially expressed or not statistically significant).  Genes 
were ordered and categorised in 6 groups [A-F] based on their biological role or signalling activity.  A: 
Cytokines with group subclustering into FOXN1 targets (Ccl25, Kitl), IL-7 signalling (Il7, Cish) and IFN-γ 
signalling (Ifngr1, Ifngr2, Jak2, Irf1, Stat1), B: Antigen processing and presentation programme, C: 
Degradation with group subclustering into proteasome (Psmb11, Psmb10, Psmb9) and proteases (Ctsl, 
Capn1, Capn2), D: T-cell regulation with group subclustering into NF-κB signalling (Bcl10, Nfkb1, 












5.3.1 FOXN1: a potential pioneer factor 
The analysis presented in this chapter has provided further insight into the FOXN1 
binding landscape and the FOXN1 gene regulatory network in fetal TEPCs.  It has also 
highlighted the central role of FOXN1 in the establishment of the thymic system 
through comparative analysis of the FOXN1 binding landscape in newborn TECs with 
the chromatin accessibility landscape in fetal TEPCs.  The latter analysis has 
demonstrated that the binding landscapes of FOXN1 in these two developmental 
stages are highly similar, suggesting regulation of the same programmes in both early 
(fetal TEPCs) and late (newborn TECs) TEC differentiation stages.  The highly similar 
predicted landscape for FOXN1 binding in combination with known literature where 
reversion of a null allele of FOXN1 can initiate the thymic programme in nude TECs 
(Nowell et al., 2011) and where forced FOXN1 expression in an un-related population 
of cells (MEFs) converted these cells into TECs (Bredenkamp et al., 2014b) suggests 
that FOXN1 may be able to open chromatin in the regions that it binds, in order to 
apply the same regulatory programme in the above cell types.  This would be more 
obvious in the case of MEFs, since they constitute a TEC-unrelated population and 
FOXN1 would have to bind and initiate the expression of genes that are not normally 
expressed in MEFs to establish the thymic program.   
In other words, FOXN1 may be acting as a ‘pioneer’ factor: pioneer transcription 
factors can bind to specific DNA motifs, open chromatin and formulate the 
transcriptional landscape of the cells accordingly (Zaret and Carroll, 2011).   In more 
detail, FOXN1 could bind FOXN1-specific DNA sequences within “closed” 
chromatin and instruct the chromatin to remodel.  Chromatin remodelling would then 
make “hidden” DNA sequences accessible to regulatory factors (general transcription 
factors, activators, RNA polymerase II) which would bind and interact with each other 
to enable initiation of gene transcription (see also Chapter 1, section 1.5.1).  Even 
though FOXN1 has been shown to act as an activator, analysis in section 5.2.1.3 
identified 129 genes as candidate direct FOXN1 targets whose expression drops with 
increase in Foxn1 expression, demonstrating a potential repressive role for FOXN1 
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that has not been observed before (this was suggested in Chapter 3, section 3.3).  
Taking into consideration its potency as a pioneer factor, FOXN1 could cause gene 
silencing by binding alongside repressors or corepressors.  These factors could in turn 
cause local domain blanketing that would impair activator recruitment and would 
repress transcription.  Nevertheless, to verify or reject the hypothesis of FOXN1 
exhibiting pioneer factor activity, chromatin accessibility datasets in fetal TEPCs pre 
and post FOXN1 initiation would be required to identify FOXN1 regulated regions 
that are in closed formation in the absence of FOXN1 and become accessible just after 
FOXN1 is activated through FOXN1 direct binding to chromatin. 
 
5.3.2 A first-described high-confidence list of FOXN1 direct 
targets in fetal TEPCs and dynamic regulation of pathways 
The analysis described in this chapter has identified 471 candidate direct FOXN1 
target genes that are expressed in fetal TEPCs, and a “most” confident list of 102 
FOXN1 targets that have been predicted to be directly regulated by FOXN1 in both 
fetal TEPCs and newborn cTECs.  Several of the FOXN1 targets in TEPCs were also 
shown, via complimentary pathway enrichment analysis, to directly regulate a list of 
important biological pathways for thymic function.  TEPC pathways directly regulated 
by FOXN1 include downstream cytokine signalling (activation of cytokine receptors 
in TECs), the antigen processing and presentation program (AP&P programme), 
protein degradation, NF-κB signalling and NOTCH signalling.  Based on the current 
literature, most of these pathways can be interconnected through loops of 
positive/negative regulation (see below).  Additionally, the role of FOXN1 in the 
maintenance of the antigen processing and presentation programme and protein 
degradation pathways has already been demonstrated in newborn cTECs (Žuklys et 
al., 2016). 
In the next paragraphs, the FOXN1-regulated pathways are described in more detail in 





5.3.3 FOXN1 drives and maintains the antigen processing and 
presentation programme via multiple mechanisms 
One of the main regulators of the antigen processing and presentation (AP&P) program 
in multiple cell types is the interferon gamma IFN-γ signalling pathway (Dong et al., 
1999; Muhlethaler-Mottet et al., 1998; Piskurich et al., 1998, 1998; Rohn et al., 1999).  
Below, I discuss the potential role of IFN-γ in FOXN1-mediated regulation of the 
AP&P pathway in TECs. 
 
5.3.3.1 General mechanism of interferon gamma signalling  
The interferon gamma signalling pathway (Figure 5.8; Reith et al., 2005) involves 
signalling via the JAK-STAT pathway (reviewed in Schroder, 2003).  IFN-γ binds to 
the IFN-γ receptor (IFN-γR; consisting of the IFNGR1 and IFNGR2 subunits).  This 
changes the conformation of the receptor, leading to auto-phosphorylation (and 
activation) of JAK2, which in turn transphosphorylates (and activates) JAK1 (Briscoe 
et al., 1996).  These events lead to the release of the STAT1 homodimer from the 
receptor (Greenlund et al., 1995).  Free STAT1 reaches the nucleus where it binds to 
gamma activated site (GAS) elements at the promoter of genes to initiate or suppress 
IFN-γ regulated gene transcription (Decker et al., 1997; Meraz et al., 1996).  Many of 
the STAT1 regulated genes are transcription factors (such as IRF1; Pine et al., 1994) 
which drive the next wave of transcription by binding to IFN-stimulated response 
elements (ISRE) at the promoter regions of target genes (Harada et al., 1989; Nelson 
et al., 1993), with IRF1 to be able to promote transcription of STAT1.  A number of 
genes involved in the IFN-γ signalling pathway, Ifngr1, Ifngr2, Jak2, Irf1, Stat1, have 
been all predicted to be candidate direct FOXN1 targets in fetal TEPCs based on the 
analysis in this chapter (section 5.2.1), indicating a very consistent regulation of the 
IFN-γ signalling by FOXN1 at multiple levels. 
With respect to the antigen processing and presentation program, IFN-γ regulates both 
constitutive and induced expression of MHC class II (MHCII) (Boehm et al., 1997), 

















Figure 5.8: Regulation the MHCII programme through direct binding of the interferon gamma 
activated STAT1 and IRF1 on the pIV promoter of Ciita.  The general mechanism of IFN-γ is depicted 
in upper section: IFN-γ binds to the IFN-γ receptor (IFN-γR; consisting of the IFNGR1 and IFNGR2 
subunits) and changes IFNGR1 receptor conformation (through activation of JAK1 and sequentially 
JAK2) which enables the recruitment of a STAT1 pair.  STAT1-homodimer phosphorylation releases the 
dimer from the receptor and free STAT1 reaches the nucleus where it binds to GAS elements at the 
promoter of genes and can activate or suppress IFN-γ regulated gene transcription.  IRF1 is one of the 
main targets of STAT1 that will then drive the next wave of transcription by binding to IFN-stimulated 
response elements (ISRE) at the promoter regions of target genes.  Direct binding on the pIV CIITA 
promoter is shown in lower section: IFN-γ activated STAT1 and IRF1 bind on the TEC specific promoter 
(pIV) that includes a GAS and an IRF-specific binding motif within the proximal promoter of CIITA and 









5.3.3.2 MHC class II antigen presentation pathway and IFN-γ 
IFN-γ is a key regulator of the MHCII antigen processing and presentation programme 
(Schroder, 2003).  Professional antigen presenting cells (B-cells, macrophages and 
dendritic cells) and TECs are the only cell types that constitutively express MHCII 
(LeibundGut-Landmann et al., 2004), and treatment with IFN-γ can lead to further up-
regulation of the MHCII molecules in the majority of these cells.  Additionally, in cells 
that do not constitutively express MHCII, IFN-γ comprises the most potent inducer of 
MHCII expression (LeibundGut-Landmann et al., 2004). 
 
5.3.3.3 The MHC class II transactivator (CIITA) 
Typically, IFN-γ regulates expression of MHCII genes by targeting the pIV promoter 
of the class II transactivator (CIITA, see Figure 5.8).  This transactivator has been 
characterised as the “master control factor” of the MHCII antigen presentation 
programme because it can activate on its own both genes encoding classical MHCII 
molecules and those encoding accessory proteins needed for MHCII antigen 
presentation (LeibundGut-Landmann et al., 2004).  The pIV promoter contains a GAS 
element and an E-box that are bound cooperatively by STAT1 and USF-1, as well as 
an IRF1-consensus motif that is occupied by IRF1.  These elements exist within a 
300bp region and are necessary for CIITA induction in most cells (LeibundGut-
Landmann et al., 2004). 
 
5.3.3.4 CIITA and TECs 
The pIV promoter regulates expression of the MHCII molecules in TECs 
(Muhlethaler-Mottet, 1997) and it is essential for maintenance of MHCII gene 
expression in both cTECs and mTECs (Waldburger, 2003; Waldburger et al., 2001).  
pIV knockout mice (MHCII- TECs) demonstrate strong reduction of CD4+ T-cells due 
to ablation of positive selection since this process requires MHCII+ cTECs 
(Waldburger, 2003).  The same mice also showed a reduction in genes that encode 
peripheral tissue antigens in mTECs.  This process normally promotes tolerance to 





5.3.3.5 FOXN1 consists part of the unknown mechanism that maintains 
CIITA’s expression and the MHC class II programme in the absence of IFN-γ 
signalling 
The mechanism by which IFN-γ induces CIITA and MHCII expression in TECs 
(constitutive expression of MHCII molecules) appears to differ from that operating in 
other cells that constitutively express MHCII (APCs).  Although treatment with IFN-
γ further up-regulates CIITA in TECs, loss of essential components of the IFN-γ 
signalling – including IFN-γ, IFN-γR, IRF1 and STAT1; did not alter positive selection 
of CD4+ cells, suggesting that an alternative mechanism must mediate pIV activation 
in TECs (Reith et al., 2005).  The unknown mechanism of pIV activation is believed 
to depend on signals provided by the thymic microenvironment because TECs lose 
expression of MHCII if cultured in a monolayer ex vivo, while they maintain MHCII 
expression in reaggregate thymic organ cultures (Anderson et al., 1993; Reith et al., 
2005) or in vivo.  A potential model for FOXN1-mediated regulation of MHCII is 
discussed below.  
Thymic epithelial cells seem to possess a unique mechanism for maintaining/ 
recovering the MHCII antigen presentation programme if IFN-γ signalling is 
disrupted.  FOXN1 is the master regulator of TEC differentiation, and is expressed 
only in thymic epithelial cells and keratinocytes (which do not constitutively express 
MHCII).  FOXN1 expression is also lost when TECs are cultured in a monolayer and 
this observation has suggested that its maintenance may require signals from a 
surrounding mesenchymal population, cell-cell contact and proper vasculature.  This 
suggests that FOXN1 could potentially regulate the IFN-γ independent mechanism 
that maintains MHCII antigen presentation.  Furthermore, the analysis presented above 
shows that FOXN1 can directly bind Ciita; Ciita is not expressed in E10.5 TEPCs, but 
is expressed once Foxn1 has been initiated.  Thus, FOXN1 might be responsible not 
only for maintenance of the MHCII antigen presentation program in TECs, but also 
for its initiation. 
Finally, in agreement with the role of FOXN1 in regulating the MHCII AP&P, Ctsl, 
which facilitates MHCII maturation through processing of the MCHII molecules 
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invariant chain (Honey et al., 2002; Hsieh et al., 2002), was predicted to belong in the 
high confidence candidate direct FOXN1 targets list 
Our data suggest that FOXN1 regulates the MHCII AP&P program at two levels:  by 
targeting CIITA directly and via the IFN-γ signalling pathway; since STAT1 and IRF1 
(which bind to the CIITA promoter region) are both candidate direct targets of FOXN1 
in TEPCs.  Although loss of each of these factors individually has been reported not 
to affect CD4+ thymocyte selection and therefore by extension MHCII antigen 
processing and presentation, the effect of loss of both (Irf1-/- and Stat1-/- mice) on 
activation of CIITA in TEC has not been tested. 
In conclusion, this analysis strongly suggests that FOXN1 directly activates and 
maintains the MHCII program through FOXN1-targeted IFN-γ signalling or through 
direct binding to the Ciita pIV promoter under both normal and disrupted IFN-γ 
signalling conditions. 
 
5.3.4 The FOXN1-NOTCH interplay in determining TEC 
specification 
The importance of the NOTCH signalling pathway in early TEPC differentiation has 
been extensively discussed in Chapter 4, section 4.3.4 with the NOTCH canonical 
pathway shown to play a critical role in mTEC specification.  In brief, ablation of 
NOTCH signalling (NOTCH loss-of-function; LOF) in undifferentiated E10.5 TEPCs 
(when FOXN1 is still inactive) led to a complete loss of the mTEC compartment, while 
blocking NOTCH signalling at later stages (RBPJ deletion under the control of the 
Foxn1 promoter in E12.5 TEPCs) caused a lesser reduction in the mTEC number (Liu 
et al., 2017, submitted).  On the other hand, reinforcement of NOTCH signalling by 
overexpression of NOTCH intracellular domain (NOTCH gain-of-function; NOTCH 
GOF) restricted TEC lineage differentiation (retention of PLET1 staining, Dong Liu), 
and even though cells also lacked differentiation markers (Figure 4.11), it did not lead 
to forced mTEC differentiation (Figure 4.11). 
NOTCH signalling was identified as one of the signalling pathways down-regulated 
with significance in TEPCs between E10.5 and E12.5 (section 4.2.1.2; Figure 4.1, 
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Figure 4.6) with Notch3, Dll1, Dll3, Rbpj and Msx2 genes (Figure 4.3) contributing 
to the core enrichment of the pathway.  Unlike the rest of the genes contributing to the 
pathway’s core enrichment, Rbpj was also identified as a high confidence candidate 
direct FOXN1 target in fetal TEPCs (Figure 5.7; Group E), and one of the very few 
genes to be seemingly repressed by FOXN1 up-regulation.  This finding is consistent 
with the less severe effect on mTECs of Rbpj deletion via Cre under the control of 
Foxn1 promoter (see Chapter 4, section 4.3.4), since if FOXN1 is a natural repressor 
of RBPJ, the Rbpj knockout would simply slightly amplify that effect. 
Additionally, clustering of the TEPC and TEC-specific lineage markers for NOTCH 
loss-of-function (LOF; RBPJ deletion under the control of the Foxn1 promoter in 
E12.5 TEPCs), NOTCH gain-of-function (GOF: NICD overexpression) and control 
samples presented in Chapter 4, section 4.2.3.3 (Figure 4.11) identified multiple 
cTEC markers (Ctsl, Krt8, Ly75 and Psmb11) to show a reduced expression pattern in 
the E14.5 GOF samples compared to the E14.5 controls.  Both Psmb11 and Ly75 have 
been predicted to be high confidence candidate direct FOXN1 targets in newborn 
cTECs, with Psmb11 to also be experimentally verified (via mutation of the FOXN1 
binding site analysis) as a direct FOXN1 target in cTECs (Žuklys et al., 2016).  
Additionally, Ctsl and Krt8 have been predicted as high confidence candidate direct 
FOXN1 targets in fetal TEPCs.  Taken together, these results suggest that blockage of 
the cTEC progression by NOTCH may be mediated by repression of the expression 
and/or activity of FOXN1.  Partial FOXN1 repression by NOTCH expression may 
explain how NOTCH protects the mTEC lineage from higher levels of FOXN1 
induction. 
The relationship between FOXN1 and NOTCH was further explored by Dr Kathy 
O’Neil who has generated Rosa26CAG-FL-STOP-FL-Foxn1-IRES-GFP transgenic mice 
(designated iFoxn1), which provide a model where Foxn1 overexpression can be 
induced under the control of Cre  (Bredenkamp et al., 2014b).  In particular, male 
Foxn1Cre mice were mated with female iFoxn1 mice to produce double transgenic 
litters which constitutively overexpress Foxn1 in TECs (designated TgFoxn1).  
Analysed E17.5 TgFoxn1 thymi revealed the presence of very few mTECs, and a 
highly similar phenotype with the one observed by the NOTCH LOF model (Liu et 
al., 2017, submitted).  Additionally, RT-qPCR analysis demonstrated a three-fold 
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increase in Foxn1 expression, while a two-fold reduction of Notch1 and Notch3 in 
mTECs.  Therefore, molecular interactions seem to support the phenotypic similarities 
between FOXN1 gain-of-function and NOTCH loss-of-function.  Importantly, 
analysis in this chapter has identified among the high confident candidate direct 
FOXN1 targets in fetal TEPCs, Foxn1 to also constitute a FOXN1 target itself.  Thus, 
after Foxn1 initiation, FOXN1 may be able to further boost its own expression through 
auto-regulation. 
In summary, investigation of NOTCH signalling pathway and NOTCH gain-of-
function experiments reveal cross repressive modulations between FOXN1 and 
NOTCH, suggesting a regulatory model in early TEPC differentiation, in which 
NOTCH signalling protects the emergence of the mTEC compartment during an early 
defined time-window, FOXN1 expression represses NOTCH and a FOXN1-NOTCH 
interplay determines if TEPCs will acquire the cTEC or the mTEC fate. 
 
5.3.5 A potential role for Tfap2a in the early TEPCs 
Analysis in this chapter has revealed a similar expression pattern of Rbpj with the 
transcription factor Tfap2a (Figure 5.7), with high Tfap2a expression levels to be 
associated with immature cells and Tfap2a expression drop to relate to cells 
developmental progression.  The role of TFAP2A (also commonly known as AP2) has 
not yet been investigated in the thymic epithelium.  Nevertheless, Tfap2a has been 
shown to play an important role in both the epidermis and the neural crest (NC) cell 
gene regulation.  In the epidermis, AP2 is necessary (but not sufficient) for epidermal 
gene expression (Leask et al., 1991).  Early studies have shown evidence for AP2 
protein binding directly to the proximal promoter of Keratin 14 (K14) and other 
epidermal-specific genes, however, additional binding of other transcription factors in 
a distal K14 element contributes to tissue-specific expression of K14 (Leask et al., 
1991).  Since keratins K14 and K5 have been associated with mitotically active 
keratinocytes (Nelson and Sun, 1983), and their down-regulation occurs upon further 
keratinocyte differentiation (different pairs of keratins are switched on then) (Fuchs 
and Green, 1980; Moll et al., 1982; Sun et al., 1984), it could be inferred that AP2 
expression is linked to a more immature cell phenotype. Furthermore, Wang et al. 
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(2011) reported that Tfap2a acts within the same genetic pathway with Forkhead Box 
D3 (Foxd3) during early neural crest cells development, with combined loss of these 
factors (Tfap2amob and Foxd3mos) to cause nearly complete absence of NC-derived 
tissues.  Their findings indicated that both factors are necessary for NC specification, 
but their role is still important during the earliest steps of the NC precursor cell 
development.  Taken together, the above studies suggest that Tfap2a plays a significant 
role in early progenitor cell progression, with tissue-specificity possibly determined 
by the action of other regulatory factors.  Similarly, it is possible that in the thymic 
epithelium, expression of Tfap2a is required in the early specification and development 
of TEPCs, with FOXN1 up-regulation (which belongs in the same protein family with 
FOXD3) to lead to Tfap2a down-regulation by direct binding to the Tfap2a enhancer 


















In conclusion, Chapter 5 has investigated the mechanisms via which FOXN1 
regulates early fetal thymic epithelial progenitor cell differentiation, in order to better 
understand its dynamic role in the establishment of a fully functional thymus.  
Comparative analysis of FOXN1 ChIP-seq datasets in newborn TECs with histone 
modification ChIP-seq datasets in fetal TEPCs demonstrated high similarity in the 
FOXN1 binding landscape in newborn TECs with the chromatin accessible landscape 
in fetal TEPCs.  This finding, in combination with predicted biological pathways in 
fetal TEPCs and newborn cTECs that are commonly regulated by FOXN1, suggests 
that FOXN1 may create a similar transcriptional landscape in these two different 
developmental stages in the mouse thymus.  This finding could enhance the already 
suggested (Vaidya et al., 2016) role of FOXN1 as a pioneer factor which can establish 
and maintain a FOXN1-specific thymic landscape given a chromatin substrate; 
however, further experiments would be necessary to prove the pioneer role of FOXN1.  
This model of pioneer activity could also explain how FOXN1 is able to lead the 
conversion of an unrelated cell type into TECs which are also able to support the 
































































The large amount of bioinformatics datasets generated and analysed during this study 
has rendered the need to store and share these data in an easy and manageable way, 
but to also allow downstream analysis and visualisation of the presented datasets that 
may assist in other ongoing research projects.  Currently, there are only two online 
databases providing expressional profiling of immune cell types:  the Gene expression 
commons (Seita et al., 2012) and the Immunological Genome Project (Immgen; Heng 
et al., 2008) databases.  The majority of the expressional information available in both 
platforms has been derived mostly from microarray experiments, with only Immgen 
providing RNA-seq profiling for 34 immune cell types, from which only one dataset 
relates to the thymic epithelium (mTEC population isolated from 6 week old C57BL/6J 
mice, sorted on CD45-Ly51loMHCIIhiEpCAMhi).  Gene expression commons uses a 
very large number (>10,000) of various microarray datasets as a common reference to 
overcome the variable sensitivities of each probeset and in that way the intrinsic bias 
in the expressional range of genes per probeset is normalised, providing reliable gene 
expression levels among the different microarray experiments (Seita et al., 2012).  
However, downstream analysis and visualisation capabilities for these microarray 
profiles is limited.  On the other hand, Immgen offers more flexibility in terms of 
downstream investigation methods (differential expression and gene correlation 
analysis) of the existent datasets, however, this functionality has been built to fit 
mostly the nature of the microarrays technology (Heng et al., 2008).  Therefore, there 
is an obvious gap in the availability of whole transcriptome profiling datasets for 
immune cell populations, in particular representative populations of the thymic stroma, 
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and a further need for appropriate subsequent analysis and normalisation of these 
RNA-seq datasets to create new hypotheses and answer different biological questions.   
In Chapter 6, I present an online database for easy access, analysis and visualisation 
of curated bioinformatics datasets of the thymus (ThymiBase).  ThymiBase currently 
consists of RNA-seq datasets which represent the global transcriptomic profiles of 




















ThymiBase is an interactive web application that I have built under the Shiny package 
(Chang et al., 2016) in R.  The Shiny package provides an online application 
framework that enables easy building of interactive web application with R.  The Shiny 
package also offers a “reactive” environment that automatically binds inputs and 
outputs together and in combination with the available prebuild widgets that are 
available, users can build applications that are responsive, powerful and with a delicate 
design with minimal effort.  Details on ThymiBase’s specific inputs – outputs and 
methods are described in the commented code that launches the database (available in 
the thesis electronic supplement), while the functionality of ThymiBase’s main 















6.3 RESULTS / DISCUSSION 
 
6.3.1 A curated collection of thymic datasets 
In order to meet the needs for a data storage and analysis repository, I have generated 
a bespoke database, named ThymiBase, which is a curated, thymus-specific collection 
of next generation sequencing datasets (outline shown in Figure 6.1).   ThymiBase 
was created to accommodate the bioinformatics data generated during this PhD project 
and to provide a platform for easy access of post-analysed bioinformatics datasets to 
other researchers.  The graphical environment of this platform allows scientists with a 
basic bioinformatics knowledge to analyse and integrate already normalised RNA-seq 
data.   Because my PhD studies were part of a bigger European consortium, designated 
ThymiSTEM (www.thymistem.org), this database could also assist substantially in 
terms of data sharing across collaborative labs in the future. 
At the moment, ThymiBase consists of 7 broad RNA-seq datasets of multiple samples, 
namely, a Developmental series of fetal TEPC samples [RNA-seq data from biological 
triplicates per stage provided by Harsh Vaidya, Blackburn lab (unpublished); see 
also Chapter 2, section 2.2.1], a Foxn1 Allelic series of fetal TEPC data [RNA-seq 
data from singular biological samples provided by Stephanie Tetelin, Blackburn lab 
(unpublished); see also Chapter 2, section 2.2.1], an E12.5 RBPJ LOF series of fetal 
TEPC data, an E14.5 RBPJ LOF series of fetal TEPC data, an E14.5 RBPJ GOF series 
of fetal TEPC data [all RBPJ series were provided by Dong Liu; Blackburn lab (Liu 
et al., 2017, submitted); see also Chapter 2, section 2.2.1.3], cTEC and mTEC 
subpopulations from 1 week old (newborn) mice and mTEC subpopulations from 4 
week old (adult) mice [merged RNA-seq data from similarly sorted individual and 
biological duplicates obtained and reanalysed from GEO public repository: GEO 
accession codes GSE44945 (St-Pierre et al., 2013) and GSE53110 (Sansom et al., 
2014); for details see Chapter 2, section 2.2.1.4].  Taken together the above datasets 
are representative of several distinct thymic epithelial subpopulations in mouse and of 
different developmental stages of the thymic epithelium during mouse development 
(fetal, newborn, adult). 
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The raw sequenced files of the aforementioned datasets have been processed following 
the generic pre-analysis (described in Chapter 2, sections 2.3.1-2.3.2) and core-
analysis (described in Chapter 2, sections 2.3.3.1 and 2.3.3.2) pipelines to obtain data 
tables of normalised gene counts per dataset.  These normalised data tables can be 
further inspected using several visualisation methods or they can also be used for 





Figure 6.1: ThymiBase database panel.  ThymiBase’s generic preface consists of a sidebar menu (shown on the left in black background) and different main panels 
(shown always on the right in light blue background) which can be selected from the former sidebar menu.  The “Database” main panel here includes a lay summary of 
the available RNA-seq samples available in ThymiBase (listed in section 6.3.1).  Samples have been manually annotated for multiple categories (shown here in table 
header).  The experiment to which each sample belongs can be seen from the Dataset column in the table.  The normalised gene counts (data normalisation explained in 
Chapter 2, sections 2.3.3.1 and 2.3.3.2) for each of these datasets are provided in the “Gene counts per dataset” tab (shown in the purple bar).
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6.3.2 An interface to support easy reanalysis of data 
ThymiBase currently provides different types of visualisation and data analysis for 
advanced investigation of the available (or user-provided) gene expression count 
tables from RNA-seq datasets.  The current preface of ThymiBase is divided into two 
sections: a side-bar menu that allows navigation through the different panels and a 
main panel section, where the sidebar-selected main panel is displayed (Figure 6.1).  
In the sidebar menu, the user can select which main panel to be displayed from eight 
options: The thymus (AN OVERVIEW), About ThymiBase, Quick Tutorial, 
Database, Samples Inspection, Data Integration, Analysis on-the-fly, Enquiries (see 
sidebar menu in Figure 6.1).  To simplify the navigation process of the ThymiBase 
components (panels) in the sidebar menu, the Samples Inspection, Data Integration 
and Analysis on-the-fly main panels include a selection of subpanels in relevance to 
the main panel. 
Under Samples Inspection in the side-bar menu exists the “Cluster datasets” option 
(see snapshot in Figure 6.2) which enables users to visualise selected datasets as 
hierarchical clustering dendrograms, heatmaps, or Principal Component Analysis 
(PCA) plots.  The R respective functions, hclust, pheatmap and prcomp (described in 
Chapter 2, section 2.3.3.3) are executed in the background to generate the plot, when 
the user clicks the Plot/Update plot button.  The users get to choose between the 7 
broad datasets (listed in section 6.3.1) or to upload their own gene counts tables. 
The “Analysis on-the-fly” panel in the sidebar menu includes a “Differential 
Expression” and a “Pathway Enrichment” analysis subpanels that allow users to run a) 
differential expression analysis (see snapshot in Figure 6.3) to investigate significant 
differences in the expression of genes between sample groups and b) gene set 
enrichment analysis (see snapshot in Figure 6.4) to predict enriched pathways from 
comparisons between selected sample groups.  For the differential expression analysis, 
the user can choose which samples to compare from one of the provided broad datasets 
(see section 6.3.1), and the analysis executes on-the-fly with the voom function from 
the limma package (Law et al., 2014) in R which runs in the background (for more 
details on the differential expression analysis with limma voom, see Chapter 2, 
section 2.3.3.5).  For the pathway enrichment analysis, users need to upload a ranked 
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gene list file (similar to GSEA’s ranked file, Subramanian et al., 2005) and a pathways 
database file to search against and identify enriched pathways based on the provided 
ranked list.  The “edited” ConsensusPathDB file contains 2,140 biological pathways 
in mouse (Kamburov et al., 2011; see also Chapter 2, section 2.3.3.6) and is provided 
from a scroll-down menu in the main panel as a pre-set database option (Figure 6.4).  
This analysis also executes on-the-fly, with the fgsea function (Sergushichev, 2016) in 
R to run in the background when the Run GSEA button is pressed.  The fgsea function 
produces similar results to the GSEA’s ‘Run GSEAPreranked’ module analysis 
(described in Chapter 2, section 2.3.3.6). 
Importantly, although this is a curated database focused on the cell types found into 
the thymus, most (if not all) of its components, including data inspection and analysis, 







Figure 6.2: ThymiBase visualisation panel.  In the “Cluster datasets” main panel here (see legend from Figure 6.1 for ThymiBase’s generic preface), users can inspect 
the available datasets (listed in section 6.3.1) from a scroll down menu (includes user-upload option) inside the “All data” box under the “Select samples to cluster” 
subheader.  In the same box under the “Plot based on” subheader, the “Number of top variable genes to plot” can be selected to cluster the datasets based on “Gene 
variability” with the rowVars function from the genefilter package (Gentleman et al., 2017) in R.  A number of graphical representations, namely heatmaps, PCA plots or 





Figure 6.3: ThymiBase panel for differential expression analysis.  In the “Differential expression” main panel here (see legend from Figure 6.1 for ThymiBase’s generic 
preface), users can run differential expression analysis between selected groups of samples from the available (listed in section 6.3.1) or user-uploaded datasets using 
the limma voom function (Law et al., 2014) in R which executes on-the-fly in the background (for details see Chapter 2, section 2.3.3.5).  The total table of the differentially 
expressed genes with genes log2 fold change (logFC), average log2 xpression for gene over all genes (AveExp), moderated t-statistic (t), raw p-value (P.value), adjusted 




Figure 6.4: ThymiBase panel for pathway enrichment analysis.  In the “Pathways enrichment” main panel here (see legend from Figure 6.1 for ThymiBase’s generic 
preface), users can run pathway enrichment analysis (see Chapter 2, sections 2.3.3.6) by uploading a ranked gene list file and selecting the ConsesusPathDB (Kamburov 
et al., 2011) or uploading their own database in the “Datasets” box.  The fgsea function (Sergushichev, 2016) in R will run in the background on-the-fly to generate the list 
of enriched pathways based on the provided inputs.  The total pathways table with the number of genes per pathway (size), enrichment p-value (Pval), BH-adjusted p-
value (Padj; Benjamini and Hochberg, 1995), enrichment score (ES; same as in  GSEA, Subramanian et al., 2005), normalised enrichment score for the mean value of 




In a nutshell, Chapter 6 demonstrates the development of a curated database of whole 
genome transcriptome (RNA-seq) datasets related to the thymus that allows easy 
access, sharing and downstream analysis of these stored datasets.  Currently, available 
expressional profiling databases of immune cells (Gene expression commons; Seita et 
al., 2012) and Immgen; Heng et al., 2008) are limited to microarray datasets (very few 
RNA-seq datasets included in Immgen, only one related to the thymic epithelium) 
while they offer none or mostly microarray-specific downstream analysis options for 
these datasets.  Another advantage of ThymiBase is that it offers multiple data 
visualisation methods to allow more precise data inspection prior to subsequent data 
analyses.  These methods are provided through a user-friendly graphical interface 
instead of the R environment to make easier the use of these analysis methods to non-
bioinformaticians.  Additionally, all incorporated analyses in the ThymiBase platform 
for all included or user-added datasets are executed “on-the-fly” and can run almost 
instantly in a laptop.  Finally, ThymiBase is a generic tool for inspection and analysis 
of RNA-seq datasets that is thymus independent (user-added datasets) and can also be 
of great use to non-thymus specialists.  The intention is to convert this platform into a 
publicly available repository to assist other scientists in gaining further biological 






















































  Concluding remarks 
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This thesis sets out to further our understanding of the transcriptional, regulatory and 
signalling networks that regulate fetal thymic epithelial cell (TEC) development, via 
in silico analyses.  In this chapter, I provide a summary of the main bioinformatics 
findings that have been presented in Chapters 3-6, accompanied by experimental data 
(provided by others as stated), when necessary, to validate or complement the 
computational predictions.  I also include a section of future work which may be 
required to solidify or validate some of these outcomes.  
 
7.1.1 A revised serial progression model of TEPCs into cortical 
and medullary TECs 
The main focus of Chapter 3 was to investigate the serial progression model 
(reviewed in Chapter 1, section 1.2.3.3) of the thymic epithelial progenitor cells 
(TEPCs) towards their functionally distinct differentiated lineages, cortical (c) and 
medullary (m) TECs, during early mouse development.  In Chapter 3, I showed that 
different maximum levels of Foxn1 in E12.5 TEPCs (from a Foxn1 Allelic series; raw 
sequence data provided by Stephanie Tetelin, Blackburn lab), effectively capture 
‘pseudo-timed’ snapshots of TEPC natural progression (TEPC Developmental series; 
raw sequence data provided by Harsh Vaidya, Blackburn lab), indicating that the 
precise expression levels of Foxn1 play a vital role in regulating TEPC identity.  Part 
of this analysis highlighted the high resemblance of the E10.5 TEPCs with the E12.5 
TEPCs, in which Foxn1 expression has been majorly blocked (E12.5 R/- and E12.5 
Nude samples).  These Foxn1-deprived samples are capable of surviving in vivo 
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indefinitely and giving rise to all TEC lineages upon Foxn1 reactivation (Jin et al., 
2014).  The highly similar transcriptional profiles of the E10.5 TEPCs with the Foxn1-
deficient samples, in combination with the high levels of PLET1 that E10.5 TEPCs 
exhibit (compared to the E12.5 TEPCs), strongly suggest that E10.5 TEPCs are more 
likely to consist a homogeneous TESC/TEPC (TEP/SC) population. 
Further comparative analysis of the E10.5 and E12.5 samples from the TEPC 
Developmental series revealed distinct patterns of expression for the differentially 
expressed genes when these genes were projected into newborn cTEC and mTEC 
representative populations (with cTECs expressing higher levels of Foxn1 compared 
to mTECs; raw sequence data obtained from GEO: GSE44945, St-Pierre et al., 2013 
and GSE53110, Sansom et al., 2014).  The above patterns were still apparent when 
only FOXN1-dependent genes were selected.  These results propose a both activatory 
and repressive role for FOXN1 in fetal TEPCs (with a repressive role for FOXN1 not 
to have been acknowledged before) and also suggest that variable levels of Foxn1 
expression per cell can lead to transcriptional heterogeneity.  Experimental data by 
O’Neill et al. (2016), showing a graded expression pattern for Foxn1 across the E13.5 
TECs, suggest that Foxn1 exhibits heterogeneous expression among the E13.5 TECs 
and hence imply that this heterogeneity may be already apparent among the E12.5 
TEPCs.  The above observation and a clonal analysis of the E12.5 TEPCs by Alison 
M. Farley (Blackburn lab), in which single E12.5 TEPCs gave rise mostly to cTECs, 
strongly suggest that E12.5 TEPCs exhibit heterogeneity, with the majority of them to 
comprise cTEC-fated progenitors.  The above evidence comes in contradiction with 
the E12 TEPC bipotency model proposed by Rossi et al. (2006), which demonstrated 
E12 TEPC bipotency at the single cell level.  However, this inconsistency can be 
explained by the drop in Foxn1 levels when TEPCs are kept in culture (Rossi et al., 
2006), from which we can argue that E12.5 TEPCs exist in a fated but transient state, 
which can be pushed back upon a reduction in Foxn1 levels. 
As indicated in the previous paragraph, the majority of the E12.5 TEPCs constitute 
cTEC-fated progenitor cells (cTEPCs).  These cTEPCs would most likely exhibit 
higher levels of Foxn1 expression, compared to other existing bipotent or mTEC-fated 
cells; undifferentiated TEPCs are characterised by low Foxn1 levels, while the cortical 
component exhibits higher Foxn1 expression compared to the medullary component.  
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The remaining cells among the E12.5 TEPCs are thus characterised by lower levels of 
Foxn1 and may constitute undifferentiated TEPCs and/or mTEC-fated progenitor cells 
(mTEPCs).  It is also possible that mTEPCs among the E12.5 TEPCs exhibit a 
transcriptional profile more similar to the profile of the E10.5 undifferentiated TEPCs 
(the bipotent progenitors).  Notably, the mTEPC population, if existent, must appear 
prior to the ClaudinhiSSEA1+ mTEC stem cell population included in the TEC serial 
progression model summarised by Takahama et al. (2017), since E10.5-E12.5 TEPCs 
do not yet express the SSEA1 marker. 
In summary, in Chapter 3, I have used in silico analysis, in conjunction with 
experimental evidence (provided as stated in the text by others, Blackburn lab), to 
demonstrate an early TEPC progression model (see Figure 3.15) which encompasses 
the existence of a common bipotent TEPC at day E10.5 of mouse development (when 
cells still exist at an undifferentiated state and express only low levels of Foxn1) and 
a more immature TEPC type and/or an mTEPC one among cTEPCs at day E12.5 of 
mouse development.  Our data in combination with the Rossi et al. paper (2006) 
suggest that the E12.5 cTEPCs or (m)TEPCs exist in a transient state, where lineage 
restriction can be amended by reduction of Foxn1 expression. 
 
7.1.2 An in silico model of the intrinsic and extrinsic cues acting 
in the early undifferentiated TEPC state: NOTCH signalling in 
mTEC specification  
In Chapter 4, I have examined the intrinsic and extrinsic signalling cues that act on 
the early undifferentiated TEPC state, through pathway enrichment analysis of the 
expressional differences between TEPCs at timepoints just prior to and after the 
establishment of the TEC differentiation programme.  In this chapter, I generated an 
unbiased in silico model that describes signalling pathway activity during fetal thymus 
development in vivo (Chapter 4, Figure 4.6), and identified candidate genes which 
could improve TEP/SC maintenance and proliferation in vitro.  The predicted 
signalling pathways from this analysis denote the complete deactivation of the SHH 
pathway, which normally protects the formation of the parathyroid, and the early 
specification of the progenitor cells towards the thymic fate.  This analysis has also 
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identified the WNT non-canonical ligand, Wnt5a, as being strongly down-regulated 
between E10.5 and E12.5 TEPCs (when cells become more differentiated), the timing 
of which is consistent with the morphological switch of TEPCs from a monolayer of 
polarised cells (E10.5) to a more complex and well-defined structure (E12.5) which 
characterises the thymic system.  The high levels of Wnt5a expression in E10.5 TEPCs 
may also reflect a potential role for WNT5A in the regulation of cells self-renewal.  
Therefore, ablation or reinforcement of WNT5A expression in the early thymic 
epithelium could reveal interesting insights regarding its biological function in vivo, 
while provision of WNT5A in TEPC culture could aid TEPC survival and expansion 
in vitro.  The signalling pathway analysis in Chapter 4 has predicted down-regulation 
of ligands that normally activate the FGF and IGF signalling pathways.  Since these 
pathways are active during early thymus development (see Chapter 1, section 1.2.4), 
absence of their ligands may represent a TEPC switch from a partially cell autonomous 
system to a system depending on extracellular provision of ligands from neighbouring 
cells (for instance from the NCC-derived mesenchyme and potentially incoming 
haematopoietic progenitor cells). 
Among the predicted pathways, this analysis has identified the NOTCH signalling 
pathway to be highly active in the early undifferentiated TEPCs.  Further 
bioinformatics analysis, accompanied by experimental validation (Dong Liu) of 
NOTCH loss-of-function data (raw sequence data provided by Dong Liu, Blackburn 
lab), has highlighted NOTCH as a potent regulator of mTEC specification in a short 
but well-defined early TEPC time window (Liu et al., 2017, submitted).  Additionally, 
the RNA-seq analysis of NOTCH gain-of-function data (raw sequence data provided 
by Dong Liu, Blackburn lab), indicated a developmental block in cTECs and a high 
expression of the PLET1 marker (related to progenitor activity of cells), suggesting 
that the transient state of TEPCs could be fine-tuned or potentially pushed back to a 
less differentiated state through altered signalling of NOTCH (Chapter 4, section 
4.2.3.3).  Collectively, the bioinformatics analyses that I present in Chapter 4, have: 
a) improved the current picture of the signalling mechanisms that govern maintenance 
and specification of TEPCs before FOXN1 orchestrates differentiation towards both 
TEC lineages, b) identified WNT5A as a potential regulator of cell polarity and 
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proliferation in early TEPCs and c) highlighted the importance of NOTCH signalling 
in early mTEC specification and TEPC maintenance. 
 
7.1.3 FOXN1: A master regulator of the thymic system and a 
potential pioneer factor 
In Chapter 5, I explored the role of the central thymus regulator, FOXN1, in TEC 
differentiation.  For this purpose, I applied an integrative analysis of FOXN1-
dependent genes in fetal TEPCs, FOXN1 binding sites in newborn TECs (raw 
sequence data obtained from GEO: GSE75219, Žuklys et al., 2016) and histone 
modification marks in fetal TEPCs (raw sequence data provided by Harsh Vaidya, 
Blackburn lab).  With this analysis, I aimed to predict high confidence candidate direct 
FOXN1 targets in fetal TEPCs.  In summary, 471 genes were predicted as candidate 
direct FOXN1 targets in fetal TEPCs.  Also, a “most” confident list of 102 genes from 
the above targets has been shown to be directly regulated by FOXN1 in both fetal 
TEPCs and newborn cTECs.  Genes involved in Cytokine signalling, the Antigen 
processing and presentation (AP&P) programme, protein degradation, NF-κB 
signalling, VAV-SHB signalling and NOTCH signalling exist among the 471 
candidates.  From these, the AP&P programme and NOTCH signalling are further 
discussed in this thesis.  With evidence of FOXN1 binding in the proximal promoters 
of Irf1, Stat1 and Ciita (genes involved in the IRF signalling), it is likely that FOXN1 
consists part of the unknown mechanism which regulates expression of the MHC class 
II AP&P programme in TECs.  FOXN1 has also been found to target genes involved 
in the NOTCH signalling pathway, which has been shown to control mTEC 
specification and TEPC maintenance in Chapter 4 (section 4.3.4); the FOXN1-
NOTCH interplay is overviewed in section 7.1.4.  
High similarity of the chromatin accessibility landscape in fetal TEPCs with the 
FOXN1 binding sites in newborn TECs, in combination with known literature (Bleul 
et al., 2006; Bredenkamp et al., 2014b), have indicated a potential pioneer role for 
FOXN1 in the thymus.  Even though FOXN1 has been shown to act as an activator, 
129 of the 471 high confidence candidate direct FOXN1 targets in fetal TEPCs were 
down-regulated with an increase in Foxn1 expression, showing that FOXN1 could also 
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directly repress these genes.  Thus, FOXN1, as a pioneer factor, could cause gene 
activation/silencing by binding nearby (co)activators/repressors, and induce or block 
the expression of proximal genes through them.  Further bioinformatics analyses and/ 
or experimental validation would be required to prove the pioneer potency of FOXN1. 
 
7.1.4 Role of the FOXN1-NOTCH interplay in fetal TEPCs and 
potential mechanisms of how it deciphers fate specification 
during TEPC progression 
The analysis presented in Chapter 4 demonstrated an important role for NOTCH 
signalling in mTEC specification and TEPC maintenance, while the analysis in 
Chapter 5 highlighted FOXN1 as a potent regulator of NOTCH in fetal TEPCs.  In 
particular, a NOTCH positive feedback loop has been shown to safeguard the mTEC 
population (Chapter 4, section 4.2.3.1), with blockage of its expression causing a 
partial or total developmental block in the emergence of mTEC expression (Chapter 
4, section 4.2.3).  Additionally, a partial block in cTEC differentiation and reduction 
of Foxn1 levels occurred (without an imposition of the mTEC fate) when NOTCH was 
overexpressed in TEPCs (Chapter 4, section 4.2.3.3), suggesting a potential role for 
NOTCH in TEPC maintenance.  FOXN1 has been predicted to down-regulate RBPJ, 
the main transcriptional mediator of NOTCH, through direct binding on the distal Rbpj 
promoter (Chapter 5, section 5.3.2), succeeding down-regulation of NOTCH 
signalling upon TEPC differentiation.  The analysis of FOXN1-tagged ChIP-seq data 
in newborn TECs (Chapter 5, section 5.3.2) also provided direct binding evidence of 
FOXN1 at the Foxn1 locus, indicating that FOXN1 could regulate its own expression.  
Notably, enforced FOXN1 expression in TEPCs (Dr Kathy O’Neil) led to a 
phenotype similar to the one observed by NOTCH ablation, demonstrating a FOXN1 
repressive role over NOTCH.  Taken together, the above findings propose an in silico 
regulatory model, in which FOXN1-NOTCH exhibit mutual repressive roles in 
configuring the balance in early fetal TEPC differentiation in mouse, with NOTCH 
permitting the emergence of mTECs, and FOXN1 promoting cTEC and mTEC 
differentiation.  The collective model of FOXN1-NOTCH interplay in early TEPC 





Figure 7.1: Model of the FOXN1-NOTCH interplay in TEPC progression.  In this model, the mutual 
repressive roles FOXN1-NOTCH, in combination with their auto-regulation (FOXN1 through direct 
binding of its own promoter, see Chapter 5, section 5.3.2; and NOTCH via a positive feedback loop 
through its targets, see Chapter 4, section 4.2.3.1), are shown to drive normal TEPC progression 
towards both TEC lineages.  NOTCH signalling has been shown to safeguard the mTEC population, with 
ablation of its expression during early thymus development causing a partial or total developmental block 
in the mTEC emergence (Chapter 4, section 4.2.3).  In an opposite fashion, enforced expression of 
FOXN1 has been experimentally demonstrated to also block mTEC progression (Dr Kathy O’Neil).  
NOTCH down-regulation with an increase in FOXN1 expression could be achieved by direct binding of 
FOXN1 on RBPJ’s distal promoter (as shown in Chapter 5, section 5.3.2).  Additionally, NOTCH 
enforced expression did not enforce mTEC fate; however, it partially blocked cTEC emergence, 
proposing a role for NOTCH in the maintenance of TEPCs.  Together, the above findings contributed to 
a FOXN1-NOTCH mutual repressive model that configures the balance in early fetal TEC regulation, 
with NOTCH permitting mTECs emergence and maintaining the TEPC state, and FOXN1 promoting 






Despite the invaluable role that the FOXN1-NOTCH interplay exhibits in the early 
progression of TEPCs, the mechanisms by which fate specification is deciphered 
among the E10.5 TEPCs when Foxn1 expression is initiated are still unknown.  This 
section proposes two alternative versions of how TEPC specification may occur, based 
on current knowledge and the analyses presented in this thesis.  NOTCH signalling is 
well-known to be involved in the specification of highly complex biological outcomes 
(Artavanis-Tsakonas, 1999; Fortini, 2009; Lai, 2004), with NOTCH achieving its 
regulation through different modes of action, namely: lateral inhibition, fate decisions 
and inductive signalling.  Lateral inhibition is used to describe lineage specification of 
a cell among a group of equivalent cells, while the other two modes take place within 
non-equivalent cells.  Since TEPCs are likely to comprise a very homogeneous 
population prior to FOXN1 expression, I am going to explore how lateral inhibition 
could be establishing lineage-restricted fates among these bipotent progenitors.  
Similar to the well-characterised example in the embryonic neuroepithelium in 
Drosophila (see Chapter 1, section 1.4), stochastic variation (possibly driven by 
stochastic up-regulation of Foxn1) may lead to the increase of NOTCH ligands (DLL4 
is a known FOXN1 direct target), with a transcriptional positive feedback loop 
magnifying this difference (Figure 7.2, Mechanism A).  Because of their high level 
of DELTA expression, these TEPCs would not be able to express NOTCH (cis-
inhibitory interactions; Heitzler and Simpson, 1993), resulting in a salt and pepper 
pattern where the DELTA-high, signal-sender cells will differentiate into cTECs, 
while the NOTCH-high, signal-receiver cells will become mTECs.  Alternatively, 
despite E10.5 TEPC homogeneity, because NOTCH signalling receptors are already 
lowly expressed as early as E10.5 (Chapter 3), these cells could exhibit asymmetric 
expression of these receptor proteins (potentially activated by neighbouring cells), 
forcing the adjacent TEPCs to become the signal receivers (Figure 7.2, Mechanism 
B), and enable higher expression of FOXN1 in those cells, leading again to a salt and 







Figure 7.2: Potential fate decision mechanisms for the E10.5 TEP/SCs.  The figure presents two 
alternative mechanisms by which TEPC specification may be resolved within the E10.5 undifferentiated 
TEPCs.  Mechanism A illustrates the scenario in which stochastic expression of Foxn1 may increase 
the expression levels of the NOTCH ligand (DELTA) in the same cells, forcing their adjacent cells to 
become the NOTCH signal receivers and creating a salt and pepper pattern with an increase in Foxn1 
expression.  Alternatively, mechanism B proposes a model in which few of the E10.5 TEPCs already 
express NOTCH receptors (or other intermediate molecules), which have been activated by neighbouring 
cells (NOTCH ligands are not expressed yet within the thymic epithelium).  NOTCH-receiver cells would 
possibly safeguard the mTEC fate of themselves, allowing the remaining cells to reach high Foxn1 levels 
which will then up-regulate the NOTCH ligands and convert these cells into the NOTCH-sender cells 
(salt and pepper pattern).  In both scenarios of this model, the DELTA-high, signal-sender cells 












In Chapter 6, I introduce the development of ThymiBase, an interactive database with 
a user-friendly graphical interface (see Figure 6.1), to provide a platform for easy 
access, analysis and integration of curated bioinformatics datasets.  This platform can 
yield further insight for other collaborative or public research groups which may put 
this information in the context of other data.  This database demonstrates an advantage 
against other currently available immune cell expressional profiling databases, 
because (unlike the other databases) it grants access to whole transcriptome expression 
datasets focused on the thymus system and also offers different analysis components 
specialised in further examining this type of data.  ThymiBase’s encapsulated analysis 
components can run on-the-fly and almost instantly on a laptop.  While this platform 




















7.2 FUTURE WORK 
 
7.2.1 Single cell RNA-seq analysis of E12.5 TEPCs 
To validate the revised serial progression model of TEPCs into cortical and medullary 
TECs proposed in Chapter 3, in which Foxn1 exhibits (a bimodal; O’Neill et al., 
2016) heterogeneous expression among the E12.5 TEPCs with a predicted rare 
mTEPC population to exist among E12.5 cTEC-fated cells, single cell (sc) RNA-seq 
data from the E12.5 TEPC population need to be generated.  These data will provide 
a per cell quantification of the Foxn1 levels in E12.5 fetal TEPCs, to confirm or 
contradict the presence of FOXN1low and FOXN1medium/high TEPCs.  Identification of a 
FOXN1low population among the E12.5 TEPCs will allow better characterisation of 
this population, to determine if indeed these cells comprise an mTEPC population 
expressing high levels of Claudins and mTEC markers or a bipotent TEPC population.  
Prediction of a unique gene signature for the potential (c/m)TEPC populations among 
the E12.5 fetal TEPCs could then be used to potentially identify the same populations 
or their derivatives in other stages during thymus development. 
 
7.2.2 Validation of FOXN1’s pioneer activity in TEPCs 
The analysis in Chapter 5 in combination with known literature (Bleul et al., 2006; 
Bredenkamp et al., 2014b) have suggested FOXN1 to demonstrate pioneer activity in 
TECs.  In order to prove FOXN1’s pioneer role in the thymus, evidence of chromatin 
“opening” events due to FOXN1 expression is necessary.  To collect this evidence, 
chromatin accessibility datasets (ChIP-seq, ATAC-seq) need to be generated from a 
TEC population prior to FOXN1 initiation (at E10.5 developmental stage; 
undifferentiated TEPCs) and after establishment of its expression (at E12.5 
developmental stage; differentiating TEPCs).  Since ChIP-seq data from histone 
modification marks obtained from E12.5 fetal TEPCs and a reference FOXN1 binding 
site dataset from newborn TECs have already been analysed in Chapter 5, generation 
of the same histone modification marks in E10.5 TEPCs would give a direct measure 
of determining whether FOXN1 bound sites in fetal TEPCs are in close formation prior 
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to FOXN1 initiation and become accessible with FOXN1 expression.  This would be 
sufficient evidence to propose that FOXN1 is acting as a pioneer factor in TECs. 
 
7.2.3 ThymiBase: additional components and ChIP-seq data 
Future plans for ThymiBase include expanding the current downstream analysis 
components of the platform to allow integration of RNA-seq datasets with a) other 
available RNA-seq datasets (through correlation to lineage-specific markers) or b) 
newly added ChIP-seq datasets (through assignment of peaks to the nearest gene) for 
identification of potential gene targets.  Integration of the available (or user-provided) 
transcriptomics datasets with other expressional datasets can be used to infer sample 
similarities or similar gene regulation across different data based on co-expression 
analysis of multiple datasets for specific markers.  Selection of lineage-specific 
markers based on prior knowledge will allow tracing the developmental and 
differentiation stages of samples, for instance, if two different datasets highly correlate 
with the same marker (e.g. an early differentiation marker).  Relying on markers 
correlation for dataset integration may also be an intelligent option when batch effect 
correction is not possible due to confounded factors of the different experiments and 
cannot be applied.  Furthermore, integration of the available (or user-provided) 
transcriptomics datasets with ChIP-seq added datasets can be used to infer regulation 
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